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Figures 
 
Chapter1 
 
 Figure 1.1:   The structure of human heart. 
Human heart consists of four chambers: right and left atria and 
right and left ventricles. The atria and ventricles are separated by 
atrioventricular valves (AVs); the atria and arteries are separated 
by semilunar valves. 
 Figure 1.2:   Anatomical structure of vasculature system. 
This imagines showing the three layers of blood vessel and how 
the blood flow basically circulates within the vascular system. 
Figure 1.3:  The pie charts showing the percentage of all global death in 
different diseases. 
The red part represents the death number of cardiovascular 
disease which occupies about 30% of all global death. 
 Figure 1.4:   The progression of atherosclerosis 
A) Activated EC increase its permeability that allow diffusion of 
LDL inside vascular wall which in turn attract adhesion and 
migration monocytes and macrocytes. B) Fatty streak is the first 
sign of an atherosclerotic plaque which can be observed in 
children age 10 to 14. At early stage fatty streaks appear as 
yellow grease which running along the artery wall. C) As fatty 
streaks progress to intermediate lesions, they form a fibrous cap 
that isolate the lesion form blood flow. D) The complicated 
lesion occurs when the fibrous cap breaks and expose 
sub-endothelial layer to platelets and complement factors triggers 
a thrombotic response. 
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Figure 1.5:   The Cytoskeleton 
 
Figure 1.6:   Structural comparison of Merlin and ERM proteins. 
(A)  The amino acid sequence of the erythrocyte protein 4.1 
superfamily. Varies colour bars show the location of different 
domains. The oval blue shapes represent FERM membrane 
protein binding domains (also called N-ERMAD). The yellow 
and golden region represent α-helix domain. The actin binding 
domains on C-terminal are depicted by green box which is 
absent on merlin. (B) Showing the varies binding site of ERM 
and their binding partners. 
Figure 1.7:   Crystal structure and superposition of the FERM domains.  
A, colour 3D crystal structure represent the merlin FERM 
domain. Merlin FERM contains three subdomains, subdomain A 
is colour as green, subdomain B is colour as blue-green and 
subdomain C is colour blue respectively. Gray represents the 
C-terminal α-helical segment that is linked to FERM domain by 
linker region (brown). B, Comparison of the FERM domain in 
merlin (blue) with radixin (brown). The arrow shows the deletion 
site of merlin. 
Figure 1.8:   Haemodynamic force 
Shear stress: the frictional force of blood flow against the 
endothelium. Cyclic strain: the physical stretch to the vessel 
generated by the circulating blood pressure. 
Figure 1.9:   Endothelial mechanosensors.  
The figure shows the endothelial mechanosensors and their 
localizations. Ion channels, ATP channels, heterotrimeric G 
proteins, glyocalyx and G-protein-coupled receptors (GPCRs) 
exist on apical surface and transfer various mechanical stimuli. 
PECAM-1, VE-Cadherin and ECAM-1 present at literally cell 
membrane and involved in cell communication. Integrins, 
meanwhile connect the cell to ECM.  
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Figure 1.10   General structure of an Integrin molecule 
 
Figure 1.11   Structural elements of a migrating cell 
A migrating cell forms distinct functional structures on its 
leading edge. These structures include filopodia and lamellipodia. 
Adhesion is the first step of migration, which initially from 
formation of lamellipodium. Lamellipodium contains highly 
dynamic actin filaments and plays important role in the 
development of adhesion complexes. Filopodia is small bundles 
that projected beyond the cell edge. The migrating cells first 
form transits adhere in the lamellipodium which is mediated by 
cell membrane adhesion receptors. The transit adhesion then 
mature to large dot-like adhesion named as focal complex. As 
the migrating progress, focal complex can be further stabilized 
and mature into a relatively more stable structure- focal adhesion. 
Doral stress fibre which composed of actin filaments connect to 
the substrate and act as scaffold for myosin. The arrow showing 
the direction of cell migrating. 
Figure1.12   The structure of uPAR  
The urokinase receptor contains three domains named D1,D2 
and D3. They are attached by internally disulphide bond. uPAR 
is anchored to the cell membrane by the 
glycosyl-phosphatydil-insositol (GPI) tail. Domain 1 and the 
D1-D2 bind contain a vitronectin binding site while D1 and D3 
contain uPA binding sites. Soluble uPAR is released from cell 
membrane by cleavage of the GPI anchor. 
 
Chapter 2 
Fig 2.1:    Haemocytometer counting chambers 
Under a 10X objective lens, viable cells in the four squares 
(G1-G4) in each corner of the counting chamber were counted. 
Cells touching top and right lines of a square were not counted, 
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while cells on the bottom and left side were counted. This 
procedure prevented the accidental double-counting of cells. 
 
Figure 2.2:   (A) The ADAMTM counter and (B) loading of an AccuChip. 
To count cells, cell suspensions were mixed with both solutions 
at a 1:1 ratio and 20 µl of each mixture loaded into an AccuChip 
cell count chip. Once inside the ADAMTM instrument, the chip 
was then processed, with the result displayed on the LCD screen. 
Fig. 2.3:  Illustration of the orbital shaker and its operation during shear 
stress studies 
 
Fig.2.4:    Ibidi® flow system used in laminar shear studies.  
(A): Ibidi® pressure pump connected to Ibidi® flow unit and 
Y-shaped slide. (B): Illustration of Y-shaped and straight Ibidi® 
µ-slides, which allow different forms of shear stress to be 
investigated. 
Figure 2.5:  Illustration of the computer-controlled Flexercell system 
apparatus, and its mechanism of operation in vascular cyclic 
strain simulation. 
 
Figure 2.6:   Wet transfer cassette assembly 
The cassette was inserted into the Trans Blot Module with the 
black side facing to the same colour. Proteins were transferred at 
100 V for 2 hrs. or overnight at 4°C in the cold room at 50V 
while stirring. 
 
Figure 2.9:   Microporator apparatus 
A) The base unit generates electrical parameters necessary for 
transfection of DNA and siRNA into cells. B) The apparatus 
utilises a tube (containing the electroporation buffer) and custom 
pipette used to deliver the electroporation parameters to the cells 
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suspended within a gold-plated pipette tip. C) The microporation 
kit containing the necessary microporation solutions, tips and 
microporation tubes. 
Fig 2.7:    xCELLigence® system 
The xCELLigence® system (Roche, Basal, Switzerland) is a 
novel system that allows monitoring of cell migration, adhesion 
and proliferation in real time without any labeling A) 
xCELLigence® system used for cell adhesion and migration 
assays. B)  CIM- plate for migration assay. C)  E-plate for 
adhesion and proliferation assay. 
 
Chapter 3 
Figure 3.1:  Human Aortic Endothelial cell (HAECs) morphological a 
lterations in response to LSS and DSS compared to static control 
cells.  
HAECs were sheared at 10 dynes for 24 hrs. using the Ibidi® 
system.  B) Compared with the static control (A), HAECs 
realigned in the direction of LSS. White arrows indicate the 
direction of flow.  No uniform F-actin realignment was 
observed under DSS conditions.  Images are representative.  C) 
Site of curvature.  D) Site of bifurcation. 
Figure 3.2:   F-actin staining.  
Confluent HAECs were exposed to LSS (10 dynes/cm
2
, 24 hrs.), 
and monitored for F-actin realignment using confocal 
microscopy (phalloidin stain for F-actin). Results indicated that 
HAEC F-actin filaments realigned in the direction of flow under 
shear stress. The white arrows show the directions of LSS. 
  Figure 3.3:    The effect of shear stress on Merlin protein expression  
Following exposure of 10 dynes/10cm
2
 of physiological, laminar, 
shear stress over a 24 hr. time period using the orbital rotator, 
cell lysates were analysed by Western blot.  Studies A) were 
conducted on sub-confluent cells seeded at 10
4
cells/cm
2
.  
Studies B) were conducted on fully-confluent cells seeded at a 
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density of 10
5
cells/cm
2
.  C) Histograms represent fold change 
in band intensity relative to un-sheared controls and are averaged 
from three independent experiments.  All values were 
controlled for equal loading by equalising for corresponding 
GAPDH protein. 
Figure 3.4:     The effect of shear stress on Phosphorylated Merlin protein 
expression  
Following exposure of to 10 dynes/10cm
2
 of laminar shear stress 
over a 24 hr. time period using an orbital rotator, both 
sub-confluent cells (seeded at 10
4
 cells/cm
2
) and fully-confluent 
cells (seeded at 10
5
 cells/cm
2
) were lysed and analysed by 
Western blotting.   Histograms represent fold change in band 
intensity relative to un-sheared controls and were averaged from 
three independent experiments.  All values were controlled for 
equal loading by equalising for corresponding GAPDH protein. 
Figure 3.5:      The effect of cyclic strain on Merlin protein expression  
Following exposure of to 5% and 10% cyclic strain over a 24 hr. 
time period using the Flexercell Tension Plus
™
 FX-4000T
™
 
system, cell lysates were analysed by Western blotting. A) 
Histograms represent fold change in band intensity relative to 
un-strained controls and were averaged from three independent 
experiments. B) Western blot analysis of Merlin expression 
(75KD) in HAECs following 24 hr. cyclic strain.  All values 
were controlled for equal loading by equalising for 
corresponding GAPDH. 
Figure 3.6:    The effect of cyclic strain on Phosphorylated Merlin protein 
expression  
Following exposure of to 5% and 10% cyclic strain over a 24 
hours period using a Flexercell Tension Plus™ FX-4000T™ 
system, cell lysates were analysed by Western blot.  Histograms 
represent fold change in band intensity relative to unstrained 
controls and were averaged from three independent experiments.  
All values were controlled for equal loading by equalising for 
corresponding GAPDH. 
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Figure 3.7:  The effect of 20% cyclic stretch on Phosphorylated Merlin 
protein expression  
Following exposure of 20% cyclic stretch at time point of 1 
minute, 5 minute and 10 minute using the Flexercell Tension 
Plus
™
 FX-4000T
™ 
system, cell lysates were analysed by 
Western blot.  A) Western blot analysis of Phosphorylated 
Merlin expression (75KD) in HAECs after exposure to 20% 
cyclic strain at different time points.  B) Histograms 
represent fold change in band intensity relative to 
un-stretched controls and were averaged from three 
independent experiments.  All values were controlled for 
equal loading by equalising for corresponding GAPDH. 
Figure 3.8:     Merlin mRNA expression change under haemodynamic 
stimulus. 
A) Following exposure of 10 dynes/10cm
2 
of laminar shear 
stress over a 24 hr. time period using the orbital rotator, and 
B) following exposure of 5% and 10% cyclic strain over a 
24 hr. time period using the Flexercell Tension Plus
™
 
FX-4000T
™
 system, Merlin mRNA was extracted and a 
two-step QRT-PCR carried out using specific primer sets for 
the measurement of Merlin gene expression.  Results were 
normalised to the housekeeping gene, 18s, and histograms 
represent normalised values relative to the un-sheared 
control. 
Figure 3.9:   The effect of shear stress on vascular endothelial cells and 
Merlin co-localisation with F-actin 
HAECs were exposed to static and 10 dynes/cm
2
 laminar 
shear stress for 24 hrs. Cellular localisation of Merlin was 
analysed by immunofluorescent imaging, co-staining for 
F-actin and monitoring of Merlin (green) with F-actin 
(yellow) by standard fluorescent microscopy.  HAEC 
F-actin filaments realigned in the direction of flow under 
LSS while and no F-actin filaments realignments were 
observed under static conditions.  (Arrow showing the 
direction of blood flow). 
Figure 3.10:    Merlin localisation by immunofluorescence microscopy. 
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Cellular localisation of Merlin was analysed by 
immunofluorescent imaging.  Arrows indicate Merlin 
localisation with action at the stress fibres (A), focal 
adhesions (B), cell-cell junction (C), and lamellipodia 
leading edges (D). 
Figure 3.11:    The application of haemodynamic force to endothelial cell 
HAECs expose to multiple haemodynamic forces in the 
vasculature including the shear stress of blood flow and 
generate myosin-dependent contractile and actin 
polymerisation mediated tensile forces through ECM. The 
close-up of a FA showing the actin stress fibre binding into 
focal adhesion complex which anchored to the ECM through 
integrins. 
Figure 3.12:    Merlin phosphorylation.  
Merlin inactivation occurs by phosphorylation at serine 518 
in the C-terminal by either p21-activated kinase (PAK) or 
cAMP dependent protein kinase A (PKA). The 
phosphorylation of merlin leads to de-association of its 
C-terminal from N-terminal which promote cell growth 
 
Chapter 4 
Figure 4.1:     Cell–matrix adhesions and their downstream regulation.  
Cell-ECM adhesions mediated by numerous integrins and 
recruit many cytoplasmic proteins.  The recruitment of 
different cytoplasmic proteins leads to various downstream 
signalling cascades which regulate diverse cell fates.   
Figure 4.2:    Validation of Immunoprecipitated merlin on a western blot.  
Following the immunoprecipitation of merlin from Human 
Aortic Endothelial Cell lysate, a portion of the precipitated 
sample was tested on a Western Blot to verify the elution 
contained merlin. A clear band is observed in the eluted 
merlin protein sample, while no any band can be seen from 
both control resin samples. 
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  Figure 4.3:   Optimisation of Merlin siRNA concentrations. 
HAECs were transfected with Merlin siRNA at different 
concentration using microporator (Digital Bio), and cells were 
then incubated at 37oC for 48 hr. Cell lysates were analysed by 
western blot.  A) Western blot analysis of Merlin (75KD) 
expression change after transfected with siRNA. B) Histograms 
represent fold change in band intensity relative to scrambled 
controls.  . All values were controlled for equal loading by 
equalising for corresponding GAPDH. 
  Figure 4.4:  The effect of ECM on Merlin absent HAECs adhesion 
 
The effect of ECM on Merlin absent HAECs adhesion was 
studied using xCelligence system. Merlin knock down HAECs 
were seeded into E-plate which was pre-coated with fibronectin 
(Green), fibrinogen (Blue), Laminin (Pink) and Vitronectin 
(Cyan), at a concentration of 30,000 cells/well.  Plate with no 
coating (Red) was set as control. Results appear to indicate that: 
the graphs shows merlin absent HAECs preferential adhesion to 
VN and Histograms represent slope changes according with CI 
value of ECMs related to no-coating control.  
Figure 4.5:   The role of Merlin absence on HAECs –ECM adhesion. 
 
The role of Merlin absence on HAECs –ECM adhesion was 
studied using xCelligence system. Merlin knock down HAECs 
were seeded into E-plate which was pre-coated with fibronectin 
(A), fibrinogen (B), Laminin (C) and Vitronectin (D), at a 
concentration of 30,000 cells/well. Graphs illustrate that absent 
of Merlin (Red) increase HAECs adhesion to all ECM compared 
with scrambled control (Green). 
Figure4.6:   The role of Merlin absence on HAECs’ migration. 
 
The role of Merlin absence on HAECs migration was studied 
using xCelligence system. Merlin knock down HAECs were 
seeded into CIM-plate at a concentration of 30,000 cells/well. 
Graphs illustrate that absent of Merlin (Green) increase HAECs 
migration compared with scrambled control (Blue). Histograms 
represent slope change according with CI values related to 
scrambled control. 
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Figure 4.7:  The role of laminar shear stress on Merlin absent HAECs 
adhesion. 
The role of laminar shear stress on HAECs adhesion was studied 
using xCelligence system. Following 10 dynes/cm
2
 24 hours 
shear, both scrambled and merlin absent cells were seeded into 
E-plate at concentration of 30,000cells/well. Graphs illustrate 
that the effect of LSS on absent of Merlin HAECs adhesion. 
Green: scrambled control; Blue: merlin knock-down; Pink: 
sheared; Cyan: merlin knok-downed+sheared. Histograms 
represent slope change according with CI values. 
Figure 4.8:  The role of laminar shear stress on Merlin absent HAECs 
migration. 
The role of laminar shear stress on HAECs adhesion was studied 
using xCelligence system. Following 10 dynes/cm
2
 24 hours 
shear, both scrambled and merlin absent cells were seeded into 
E-plate at concentration of 30,000cells/well. Graphs illustrate 
that the effect of LSS on absent of Merlin HAECs migration. 
Cyan: scrambled control; Pink: sheared; Green: merlin 
knock-down; Blue: merlin knok-downed+sheared.   
Histograms represent slope change according with CI values. 
Figure 4.9:   The role of cyclic strain on Merlin absent HAECs adhesion. 
The role of cyclic strain on HAECs adhesion was studied using 
xCelligence system. Following 10% 24 hours strain, both 
scrambled and merlin absent cells were seeded into E-plate at 
concentration of 30,000cells/well. Graph illustrate that the effect 
of cyclic strain on merlin absent HAECs adhesion: Green: 
scrambled control; Blue: merlin knock-down; Pink: strained; 
Cyan: merlin knok-downed+sheared. Histograms represent the 
slope change according to the CI value.  
Figure 4.10:    The role of cyclic strain on Merlin absent HAECs migration. 
The role of cyclic strain on HAECs adhesion was studied using 
xCelligence system. Following 10% 24 hours strain, both 
scrambled and merlin absent cells were seeded into E-plate at 
concentration of 30,000cells/well. Graph illustrate that the effect 
of cyclic strain on merlin absent HAECs migration: Green: 
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scrambled control; Blue: merlin knock-down; Pink: strained; 
Cyan: merlin knok-downed+sheared. Histograms represent the 
slope change according to the CI value. 
Figure 4.11:   The model of merlin “open and close conformation”.  
Xu demonstrated that merlin binding to polymerized actin at its 
N-terminal domain mapping to residues 178–367. This 
interaction is not affected folding of merlin which is considered 
as “close conformation”. The “closed conformation” may serve 
as a docking site that allows merlin interacts with its critical 
effector proteins that fail of merlin growth suppressor function. 
In contrast, interaction of merlin with microtubules exists in an 
‘‘open conformation”. Merlin is unable to associate with 
microtubules in the ‘‘closed conformation”, due to the losses of 
the correct conformation necessary for this association.   
Figure 4.12: Crosstalk between actin filaments and microtubule, and their 
interaction with focal adhesion.  
Microtubules are stabilized at the plus ends and oriented towards 
to the leading edge of migrating cell where it interacts with FA. 
Several proteins are involved in the processes, including 
cross-linker proteins which possess both actin- and 
microtubule-binding domains and actin-based motor protein 
myosin. The local targeting of microtubules modulates the 
activities of Rho family GTPases, resulting in the regulation of 
focal adhesion turnover 
 
Chapter 5 
Figure 5.1:   uPA-uPAR and their interacting receptors 
Figure 5.2:  The role of RGDs mediated integrin inhibition on the HAECs 
adhesion 
The role of RGDs mediated integrin inhibition on wild type 
HAECs adhesion was studied using xCelligence system. HAECs 
were seeded into E-plate which was pre-treated with either 
RGD1, RGD2, or RGD3, at a concentration of 30,000cells/well. 
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Untreated cells were used for control. Graphs illustrate that 
compared with untreated control; RGD inhibitors significantly 
decrease HAEC’s adhesion. The histogram represents slope 
changes according with CI value change of RGDS treated 
HACEs related to no-treated control. 
Figure 5.3:  The inhibitions of RGD inhibitors on uPA mediated HAECs 
adhesion 
 
The inhibition of RGDs inhibitors on uPA mediated wild type 
HAECs adhesion was studied using xCelligence system. HAECs 
were seeded into E-plate which was pretreated with uPA and 
either RGD1, RGD2, or RGD3 (the concentration is described in 
material and method), at a concentration of 30,000cells/well. 
Untreated cells were used for control. Graphs illustrate that 
compared with untreated control; uPA increases HAECs’ 
adhesion which is significantly inhibited by addition of RGD 
inhibitors. The histogram represents slope changes according 
with CI value change.  
Figure 5.4:  The inhibition of RGDs inhibitors on D2A mediated wild type 
HAECs adhesion 
 
The inhibition of RGDs inhibitors on D2A mediated wild type 
HAECs adhesion was studied using xCelligence system. HAECs 
were seeded into E-plate which was pretreated with D2A and 
either RGD1, RGD2, or RGD3 (the concentration is described in 
material and method), at a concentration of 30,000cells/well. 
Untreated cells were used for control. Graphs illustrate that 
compared with untreated control; D2A increases HAECs’ 
adhesion which is significantly inhibited by addition of RGD 
inhibitors. The histogram represents slope changes according 
with CI value change. 
Figure 5.5:  The inhibition of RGD inhibitors on SRSRY peptide mediated 
HAECs adhesion. 
 
The inhibition of RGDs inhibitors on SRSRY mediated wild type 
HAECs adhesion was studied using xCelligence system. HAECs 
were seeded into E-plate which was pretreated with SRSRY and 
either RGD1, RGD2, or RGD3 (the concentration is described in 
material and method), at a concentration of 30,000cells/well. 
Untreated cells were used for control. Graphs illustrate that 
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compared with untreated control; SRSRY increases HAECs’ 
adhesion which is significantly inhibited by addition of RGD 
inhibitors. The histogram represents slope changes according 
with CI value change. 
 
 
Figure 5.6:  The role of RGD-1 mediated integrin inhibition on the merlin 
absent HAECs adhesion 
 
The role of RGD1 mediated integrin inhibition on the merlin 
absent HAECs adhesion was studied using xCelligence system. 
Both Merlin absent and scrambled control HAECs were seeded 
into E-plate which was pre-treated with RGD1 at a concentration 
of 30,000cells/well. Untreated scrambled control HAECs were 
used as control. Graphs illustrate that compared with untreated 
control, the treatment of RGD 1 inhibitor significantly reduce the 
effect of merlin absence on HAECs adhesion. The histogram 
represents slope changes according with CI value change. 
 
Figure 5.7:  The role of RGD-2 mediated integrin inhibition on the merlin 
absent HAECs adhesion 
 
The role of RGD2 mediated integrin inhibition on the merlin 
absent HAECs adhesion was studied using xCelligence system. 
Both Merlin absent and scrambled control HAECs were seeded 
into E-plate which was pre-treated with RGD2 at a concentration 
of 30,000cells/well. Untreated scrambled control HAECs were 
used as control. Graphs illustrate that compared with untreated 
control, the treatment of RGD 2 inhibitor reduce the effect of 
merlin absence on HAECs adhesion. The histogram represents 
slope changes according with CI value change. 
 
Figure 5.8:  The role of RGD-3 mediated integrin inhibition on the merlin 
absent HAECs adhesion 
 
The role of RGD-3 mediated integrin inhibition on the merlin 
absent HAECs adhesion was studied using xCelligence system. 
Both Merlin absent and scrambled control HAECs were seeded 
into E-plate which was pre-treated with RGD3 at a concentration 
of 30,000cells/well. Untreated scrambled control HAECs were 
used as control. Graphs illustrate that compared with untreated 
control, the treatment of RGD3 inhibitor significantly reduce the 
effect of merlin absence on HAECs adhesion. The histogram 
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represents slope changes according with CI value change. 
 
 
Figure 5.9:  The role of RGD-1 mediated integrin inhibition on the merlin 
absent HAECs migration 
 
The role of RGD-1 mediated integrin inhibition on the merlin 
absent HAECs adhesion was studied using xCelligence system. 
Both Merlin absent and scrambled control HAECs were seeded 
into upper chamber of CIM-plate at a concentration of 
30,000cells/well.  The lower chamber was pre-treated with 
RGD-1 inhibitor. Graphs illustrate that compared with untreated 
control; RGD-1 inhibitors significantly reduce merlin absent 
HAEC’s migration. The histogram represents slope changes 
according with CI value change. 
 
Figure 5.10:  The role of RGD-2 mediated integrin inhibition on the merlin 
absent HAECs migration 
 
The role of RGD-2 mediated integrin inhibition on the merlin 
absent HAECs adhesion was studied using xCelligence system. 
Both Merlin absent and scrambled control HAECs were seeded 
into upper chamber of CIM-plate at a concentration of 
30,000cells/well.  The lower chamber was pre-treated with 
RGD-1 inhibitor. Graphs illustrate that compared with untreated 
control; RGD-2 inhibitors reduce merlin absent HAEC’s 
migration slightly. The histogram represents slope changes 
according with CI value change. 
Figure 5.11:  The role of RGD-3 mediated integrin inhibition on the merlin 
absent HAECs migration 
 
The role of RGD-3 mediated integrin inhibition on the merlin 
absent HAECs adhesion was studied using xCelligence system. 
Both Merlin absent and scrambled control HAECs were seeded 
into upper chamber of CIM-plate at a concentration of 
30,000cells/well.  The lower chamber was pre-treated with 
RGD-1 inhibitor. Graphs illustrate that compared with untreated 
control; RGD-3 inhibitors significantly reduce merlin absent 
HAEC’s migration. The histogram represents slope changes 
according with CI value change. 
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 Figure 5.12:  The comparison of RGD inhibitors on merlin knock-down 
HAEC motility. 
To compare of RGD inhibitors on merlin knock-down HAEC 
motility, the real time and label-free monitoring system, the 
xCELLigence® system was employed. Both Merlin knock-down 
and scrambled control HAECs were seeded into E-plate for 
adhesion studies or CIM-plate for migration assay of which had 
been treated with RGD inhibitors prior to beginning the 
experiment at a concentration of 30,000 cells per well. The figure 
A represents adhesion assay and the figure B represents 
migration assay. Results are averaged from three independent 
experiments ±SEM; *P≤ 0.05 vs control. 
Figure 5.13:   The effect of D2A peptides on P-merlin expression. 
 
HAECs were seeded into 6-well plate at a density of 
10
5
cells/cm
2
 and allowed to adhere and grow to confluence over 
a 24 hr. the cells were then exposed to 1nM D2A acutely for the 
times stated above. The effect of D2A peptides on P-merlin 
expression was then monitored by western blotting. Histograms 
represent fold change in band intensity relative to untreated 
control. 
Figure 5.14:   The effect of SRSRY peptides on P-merlin expression. 
 
HAECs were seeded into 6-well plate at a density of 
10
5
cells/cm
2
 and allowed to adhere and grow to confluence over 
a 24 hr. the cells were then exposed to 100nM SRSRY acutely 
for the times stated above. The effect of SRSRY peptides on 
P-merlin expression was then monitored by western blotting. 
Histograms represent fold change in band intensity relative to 
untreated control. 
 
  Chapter 6: 
Figure 6.1:    The critical role of merlin in uPAR mediated motility regulation 
By expose to haemodynamic forces or other activate factors such 
as D2A and SRSRY, HAECs are able to sense the environmental 
change by cell surface receptors including uPAR and integrin and 
transduce the signal inside cell which in turn either depress 
expression of merlin or increase merlin phosphorylation. The 
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loss of merlin activity results free of integrin binding site that 
promote interaction between integrin and the integrin–actin 
linkage proteins including talin, vinculin,  Kindlins and 
α-actinin. The Rac, CDC42 and Rho pathways are then activated 
following the binding of above proteins to integrin which in turn 
lead to formation of various functional migration structures such 
as filopodia, lamellipodia and stress fiber. 
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Abstract 
 
Atherosclerosis is a disease characterised by the development and progression of many 
physiological changes within the vessel walls of the cardiovascular system.   The 
principle hallmark change is thickening and loss of elasticity of the arterial wall.  
Atherosclerosis normally occurs at large and medium-sized muscular elastic arteries; the 
aorta, coronary and cerebra, principally at the site of arterial bifurcation and regions of 
high curvature. At such sites, the more complex blood flow pattern such as disturbed 
shear stress pattern forms which contributes to the development of atherosclerosis. 
Endothelial integrity plays a pivotal role in normal blood vessel function and the 
disruption of which will lead to the initiation and progression of atherosclerosis. The 
actin cytoskeleton and its dynamics, provides endothelial structural integrity and well as 
playing a pivotal role in many cellular processes, such as gene transcription, signal 
transduction, and cell cycle. Cytoskeletal homeostasis can be greatly disrupted by many 
factors, such as inflammation and haemodynamic forces. Altered actin dynamics 
underpins many (patho-) physiological processes in endothelial cells such as migration, 
differentiation, proliferation and adhesion. 
 
Merlin, an actin adaptor proteins which belong to the ERM protein family, has been 
well characterised as a tumour suppressor. In this study, we utilized various novel 
techniques including for hemodynamic modelling of biomechanical forces to subject 
human aortic endothelial cells to specific shear stress and cyclic strain at both biological 
and pathological levels. We demonstrated that merlin is highly sensitive to 
haemodynamic stimuli including shear stress and cyclic strain. Merlin is seen to localise 
at many sites of dynamic actin such as focal adhesion, cell-cell contact, stress fibre and 
leading edge of migrating cell. This study has also demonstrated that merlin plays an 
important role in the regulation of HAEC adhesion and migration through integrin 
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mediated pathways. Knock-down of merlin greatly increased HAEC adhesion and 
migration. By using various ECMs, it has been show that merlin knock-down HAECs 
preferentially adhere to vitronectin and Fibronectin; both of them contain the adhesive 
sequence (RGD) that selectively binds to integrins such as αvβ3. This was further 
illustrated using various specific RGD inhibitors, which demonstrated that merlin 
orchestrated migration was principally mediated by αvβ3. Moreover, we also discovered 
another cell surface receptor-uPAR is involved during merlin-integrin mediated 
mechano-transduction.  Overall, we have demonstrated for the first time that merlin 
plays a crucial role in the vasculature. 
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Chapter One 
 
 
Introduction 
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1.0 Introduction. 
 
1.1 The vascular system. 
 
The vascular system is a closed transport system composed of the heart, blood 
vessels, and capillaries, as well as the lymphatic system. The rhythmic and endless 
heart beatings promote unidirectional blood flow cycle within the cardiovascular 
system which provides humoral materials for cells in the body, including nutrients, 
and oxygen. The blood flow also removes cellular metabolic waste products, such as 
carbon dioxide for excretion. Meanwhile, through the blood transport, many 
hormones and other information materials reach their target organs which function 
to coordinate whole body functions and homeostasis, including the immune system, 
hemostasis and regulation of vascular tone.  
 
Blood circulation was first described by William Harvey in 1628 (Fishman 1982).  
However, he did not fully understand how blood flow exchange through tissue due 
to the technological limitations. In 1661, following the development of the 
microscope, an Italian scientist, Marcello Malpighi discovered capillaries between 
the artery and vein, supporting Harvey’s hypothesis (Toffoletto 1965). Since then, 
intensive studies have contributed to our current knowledge and understanding of 
the cardiovascular system and hemostasis.  
 
Any imbalance in the homeostasis of blood circulation can give rise to many 
patho-physiological conditions and metabolism disorders. In oxygen sensitive 
organs, such as the brain, unconsciousness may occur as soon as 3 minutes upon the 
loss of brain blood supply. More than half of patients suffer irreversible brain and 
heart damage after 10 minutes of blood circulation insufficiency.  
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  1.1.1 The basic structure of the cardiovascular system. 
1.1.1.1 Heart. 
The heart is an organ comprised principally of cardiac muscle, which plays a pivotal 
role in the cardiovascular system. It is essentially a pump, which not only keeps the 
blood circulating, but also ensures it flows in the right direction. The heart may be 
divided into two sides, right sides and left sides; the right side of the heart pumps 
blood to the lungs, while the left side pumps blood to the rest of the body (Figure 1).  
Each side of the heart can also be further divided into two chambers: the two upper 
chambers are named as the atria, and two lower chambers are named as the 
ventricles. 
 
The right atrium collects the deoxygenated blood from all around the body and 
passes it into the right ventricle. The deoxygenated blood is then pumped to the 
lungs by the right ventricle, where the blood is oxygenated. The oxygenated blood 
flows into the left atrium, and is transferred into the left ventricle, which pumps the 
oxygenated blood to the whole body. The atrium, ventricles and arteries are 
separated by a fibrous tissue structures, termed atrioventricular (AV) and semilunar 
valves, which ensure the correct, unidirectional flow of blood. 
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Figure 1.1:  Structure of the human heart. 
The human heart consist of four chambers: right and left atria and right and left ventricles.  The 
chambers are separated by atrioventricular valves (AVs), while the atria and arteries are separated by 
semilunar valves. (www.library.thinkquest.org/.../structure.htm) 
 
 
1.1.1.2 Blood vessels. 
Blood vessels can be basically divided to three separate subclasses: arteries, 
capillaries and veins. With the exception of capillaries, artery and vein share a 
common three layer structures: tunica adventitia, tunica media and tunica intima. 
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 (i) Tunica adventitia. 
As the outmost layer, the tunica adventitia is mainly comprised of loose elastic 
connective tissue and collagen fibres, which separates blood vessels from 
surrounding tissues and prevents over dilation of vessels during heart contraction.  
The main components of the connective tissue are fibroblasts, which have the ability 
to repair adventitia during injury. In some large vessels, tunica adventitia also 
contains tiny vessels that supply the essential nutrients to the vessel walls. 
 
(ii) Tunica media. 
The layer between tunica adventitia and tunica intima is named as tunica media that 
composed of elastic fibres and smooth muscle cells. The thickness and composition 
of this layer varies depending on the function and diameters of the vessels. For 
example, the large arteries which transport blood under high pressure contain 
proportionally more elastic fibres than SMCs, which therefore permit the vessels to 
dilate during heart contractions that reducing the resistance of circulation. The 
middle and small arteries, known as arterioles, contain more SMCs that play an 
important role in regulation of vascular tone. Many scientists believe that vascular 
smooth muscle is a subtype of fibroblasts, due to its ability to product extracellular 
matrix (ECM) such as collagen fibres and elastic fibres during the development of 
the artery. Under pathological conditions, SMCs migrate into the intima where they 
secret additional ECMs which in turn cause development of fatty streaks leading to 
atherogenesis.  
 
(iii) Tunica intima. 
The intima (tunica intima) is both the innermost and thinnest layer of the vascular 
wall, and may be further divided into endothelial and sub-endothelial layers. The 
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sub-endothelium is a thin layer of connective tissue located between the 
endothelium and the internal elastic lamina, containing a small amount of collagen 
fibres, elastic fibres, and a small amount of vertically parallel smooth muscle in 
some cases. The sub-endothelial layer provides a physical support for the 
endothelium, preventing the endothelium from experiencing overstretch and recoil.  
It also serves to regulate transportation of molecules between SMCs and the 
endothelium.  
 
 
Figure 1.2:  Anatomical structure of the vasculature system. 
This image illustrates the three-layered structure of blood vessels and the direction of blood flow as it 
circulates throughout the vascular system. 
(fhttp://legacy.owensboro.kctcs.edu/gcaplan/anat2/notes/APIINotes5%20Circulatory%20Anatomy.ht
m) 
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1.1.1.3 The endothelium. 
 
The endothelium is the mono inner layer of blood vessels and a basic component of 
the vasculature, which was originally considered to compartmentalise blood flow 
from the underlying tissues and matrix (Cines, et al. 1998). Intensive stud in the 
field of EC biology over the past three decades has shed much light on its complex 
function and role in the (patho)-physiology of the cardiovascular system. Located 
between the blood flow and, smooth muscle cells, and also surrounded by 
connective tissue and (ECM), endothelial cells are constantly exposed to physical 
and chemical stimuli, and act as a paracrine and endocrine organ to secrete many 
factors involved in the regulation of blood vessel tone, blood cell trafficking, 
hemostasis, permeability, proliferation, immunity, cholesterol level, and lipid 
homeostasis (Grover-Páez and Zavalza-Gómez 2009a) (Vanhoutte, et al. 2009).  
 
Under physiological conditions, the EC layer is referred to as “quiescent or inactive” 
and provides an anti-vasospasm, anti-inflammatory and, anti-coagulation 
environment, preventing aggregation of platelet (Aird, W.C. 2008). The “coble 
stone” morphology of endothelial cells form an intact barrier and elongate at the 
direction of blood flow providing a hemodynamically optimal surface for blood flow, 
reducing friction. Under normal blood flow, the endothelial barrier releases 
vaso-dilative substances including NO and PGI2 to relax vessel walls.  The 
production of an endothelium-derived relaxing factor (EDRF) by ECs was first 
described by Gurchaott and Zawadzhi in the early 1980s, which was later identified 
as NO by two research group (Palmer RM,1987. Ignarro LJ, 1987). NO is the main 
vaso-dilative factor that produced by endothelial nitric oxide synthase (eNOS), 
which then can easily diffuse into underlying SMCs due to its small size and thus 
induce vascular relaxation by modulating the calcium signaling in SMCs  
(Loscalzo and Welch 1995).   
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The release of NO and PGI2 also breaks down the pro-aggregating mediator ADP 
that in turn inhibits leukocyte and platelets interaction with the EC surface 
(Gryglewski 1995). Although the mechanism of NO release is complex, it is well 
established that hemodynamic forces are a major stimuli and regulator (Rubanyi, 
Romero and Vanhoutte 1986). Capable of sensing acute change in shear stress and 
mechanotransduction in the vessel wall tense, ECs undergo cellular and molecular 
adaption and release NO promptly. The action is particularly potent in larger arteries, 
which consist of thicker layer of SMCs. 
 
Under pathological conditions, endothelial cells constantly strive to achieve 
homeostasis, modulate leukocyte adhesion, tethering and transmigration, as well as 
regulating various cell fate and functions such as adhesion, migration, permeability 
and proliferation. Endothelial dysfunction occurs as a result of the “activation” of 
the endothelium caused by the imbalance of vascular regulatory mechanisms; which 
induce the damage to the arterial wall (Davignon and Ganz 2004). Change in EC 
morphology and phenotype is considered as the first sign of dysfunction, leading to 
the initiation development and progression of cardiovascular disease (Montecucco 
and Mach 2009). At athero-prone areas, ECs are exposed to cardiovascular risk 
factors, which change pattern of synthesis and secretion of various bioactive 
substances.  These alterations include change in EC surface charge, losing their 
non-thrombogenic ability and, accumulation of lipid droplets, which turn into foam 
cells latterly.  Chronic exposure to cardiovascular risk factors can utterly exhaust 
the protective system of EC and cause inflammation. As a consequence, ECs may 
lose integrity and detach into circulation (Sima, Stancu and Simionescu 2009b) 
(Sima, Stancu and Simionescu 2009a). The dysfunctional ECs process 
anti-hemostatic properties, including abnormal vascular tone, increase affinity to 
leukocytes and over production of cytokines and growth factors (Aird 2007). 
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1.1.2 Cardiovascular disease.  
 
The cardiovascular system comprises of the heart, arteries, veins and lymphatic 
system. As a result, cardiovascular diseases (CVD) are a class of diseases which 
involve heart and blood vessels and consequently include heart failure, arrhythmia, 
angina, hypertension, high cholesterol, and stoke amongst others.  
 
1.1.2.1 The epidemic of cardiovascular disease. 
 
The function of the cardiovascular system is so important that any pathological 
change can be vital. According to the World Health Organisation (WHO), CVD is 
the leading cause of global death (www.who.int/mediacentre/factsheets/fs317/en/). 
Cardiovascular disease causes more American deaths than cancer and this number is 
rapidly increasing each year. It is also estimated that 17.3 million people died from 
CVD around the world in 2008 which representing 30% of all global deaths and this 
number is expected to rise to 23.6 million in 2030. In Ireland, this Figure is even 
higher; approximately 10,000 people die from CVD annually; including coronary 
heart disease (CHD), stroke and other circulatory diseases. CVD is the most 
common cause of death in Ireland, accounting for 36% of all deaths. The largest 
number of these deaths relate to CHD - mainly heart attack - at 5,000.  22% of 
premature deaths (under age 65) are due to CVD 
(http://www.irishheart.ie/iopen24/about-us-t-1.html). 
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Figure 1.3: The pie charts showing the percentage of all global death from 
different diseases. 
The red section represents the number of deaths from CVD, which makes up approximately 30% of 
all global deaths.  (http://www.who.int/cardiovascular_diseases/en/) 
 
 
 
 
1.1.2.2 The risk factors of cardiovascular disease. 
 
The pathophysiology of CVD is varied and complex, hence there are many cellular 
and molecular mechanisms which contribute to the diseases. General risk factors of 
CVD include unhealthy diet (high cholesterol diet and salt intake), physical 
inactivity, over-consumption of alcohol and tobacco. Prolonged exposure to such 
unhealthy habits leads to intermediate risk factors, which includes high blood 
pressure, high serum cholesterol, raised blood glucose levels and obesity, which 
increases chances of developing CVD in the future. Among these risk factors, high 
serum cholesterol and unhealthy diet are the major causes of CVD, and as a result 
the principle focus for the of heart disease is mainly focused on reducing the level of 
serum cholesterol. Some studies have also shown that reduction of the amount of 
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daily salt intake led to over 25% of patients having a reduced chance of developing 
CVDs (Cook, et al. 2007). 
 
 
1.1.2.3 Atherosclerosis. 
 
Atherosclerotic disease is a condition whose physiological hallmark is the 
thickening and loss of elasticity of arterial wall. Underpinning this condition, is the 
excessive deposition of lipid, accompanied by a proliferation, migration and 
apoptosis of smooth muscle cells, unparalleled with altered ECM dynamics and 
fibrous matrix turnover, which gradually develop to necrotic cores with cholesterol 
crystals and calcification at a later stage. 
 
Atherosclerosis normally occur at large and medium-sized muscular elastic arteries; 
the aorta, coronary and cerebra, especially at the site of arterial bifurcation and 
regions of high curvature that results in complex blood flow patterns (Hahn and 
Schwartz 2009). At such sites, disturbed blood flow occurs, leads to formation of 
atherosclerotic plaques which in turn cause narrowing of blood vessels and luminal 
occlusion or even wall rupture at advanced stages (Orr, et al. 2006). In summary, 
pro-atherosclerosis risky factors include increased plasma lipids, hypertension, high 
glucose, obesity, lack of physical exercise and exposure to cigarette smoke (Hahn 
and Schwartz 2009). 
 
 
1.1.2.3.1 Pathogenesis of atherosclerosis. 
 
The pathogenesis of this disease is not fully elucidated. Despite dramatic progress in 
the field of cardiovascular research in recent years, the pathogenesis of 
atherosclerosis is still based on a variety of theories or hypotheses.  Among these 
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theories, lipid metabolism and biology as well as endothelial dysfunction are 
commonly accepted as being important in the initiation, development and 
progression of this condition. 
 
The lipid infiltration paradigm believes that the mechanism of disease is closely 
related to the lipid metabolism disorders. As atherosclerosis is characterized by 
excessive deposition and accumulation of lipids, especially low-density lipoprotein 
(LDL) cholesterol, the major pathological hallmark of the disease is the formation of 
the arterial wall plaques in which cholesterol and cholesteryl ester constitute the 
main components. Although the arterial wall is also capable of synthesizing 
cholesterol and other lipids, recent studies indicate that lipid in atherosclerotic 
plaques is mainly originates from plasma. Facilitated by lipoprotein, plasma 
cholesterol, is taken up into the intima of vascular walls and is then deposited on 
SMCs, causing their proliferation and migration. The excessive LDL can be 
engulfed by macrophages to generate foam cells. The accumulation of foam cells, 
together with SMCs, lipid-laden monocytes and T lymphocyte in the intima slowly 
leads to the development and progression of an early fatty streak which is the first 
stage of atherosclerosis. However, despite the improvement of pharmacological 
intervention to lower blood cholesterol, the number of deaths due to atherosclerosis 
is still increasing, suggests that there additional and more complicated molecular 
mechanism behind it.     
 
As previously mentioned, long term exposure to many stimuli such as 
hypercholesterolemia and perturbed/oscillatory shear stress, leads to significant 
alteration of normal vascular functions (Endemann and Schiffrin 2004) 
(Grover-Páez and Zavalza-Gómez 2009b). It is well accepted that loss of endothelial 
integrity is one of the first steps in development of atherosclerosis.  Activated ECs 
increase their permeability, allowing circulating LDL diffuse through the endothelial 
monolayer. The constant accumulation of LDL leads to attachment and migration of 
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monocytes and macrophages (Figure 1.4 A).  The dysfunctional ECs also secret 
adhesion molecules and chemoattractants that result in the adhesion, tethering and 
transmigration of leukocyte. All these factors contribute the initiation of 
atherosclerosis. 
 
 
1.1.2.3.2 Pathological changes. 
 
Atherosclerosis can be classified into three different stages: formation if fatty streaks, 
development of fibrous plaques, and finally establishment of complicated lesions.  
 
Formation of fatty streaks is the earliest change and becoming more common in 
young people, even being observed in children as young as aged 10 to 14.  Fatty 
streaks are usually confined within the arterial intima, and appear as fat depositions, 
a few millimeters to a few centimeters in length, which running along the artery wall 
(Figure 1.4 B).  At the early stage, the fatty streaks consist of only monocytes and 
macrophages.  Adhesion of monocytes and macrophages to Ecs is driven and 
potentiated by excessive oxidized lipoprotein particles which   contain mainly 
cholesterol and cholesterol esters, as well as phospholipids and triglycerides.  
Dysfunctional EC contribute to atherosclerotic development due to increased 
permeability, allowing LDL diffuse into the arterial wall (Hadi, Carr and Al Suwaidi 
2005). Prolonged exposure of macrophages with LDL leads to formation of foam 
cells (Zhou, et al. 1999). Fatty streaks are latterly linked by lipid-filled SMCs which 
may undergo apoptosis and develop into a necrotic core.  SMCs are also important 
in the formation of fibrous caps, and contribute in maintaining plaque stability 
(Arroyo and Lee 1999). Fatty streaks are flat or only slightly higher than the 
endothelium; therefore it does not affect local circulation and is present well before a 
clinical threshold. 
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Fatty streaks may be reversible or alternatively be the foundation of an 
atherosclerotic plaque.  Fibrous plaques are also located within the arterial intima 
which results in thickening and expansion of the arterial wall (Figure 1.4 C).  As 
the lesion progresses to the intermediate stage, fatty streaks develop into fibrous 
plaques and form a fibrous wall which isolates the lesion from blood flow.  These 
contain a mixture of collagen fibers, as well as a large numbers of lipid-laden SMCs, 
macrophages and lymphocytes.  Activated ECs release chemoattractants and 
adhesion molecules leading to adhesion of leukocytes (Springer 1994). These 
adhesion molecules mainly belong to the selectin and integrin families, along with 
the IG superfamily (Carlos and Harlan 1994).  As fibrous plaque grows, it occludes 
the arterial lumen and may cause stenosis.  Some research has indicated that less 
than 50% stenosis will result in acute myocardial infarctions (Ambrose, et al. 1988b) 
(Ambrose, et al. 1988a). 
 
The complicated lesion occurs when the fibrous cap ruptures (Figure 1.4 D). 
Although atherosclerosis is progresses slowly over time, it sometimes takes ten 
years to develop, but this stage can be vital.  The exposure of the sub-endothelial 
layer of the arterial wall (made of collagen, elastin fibers and SMC) to platelets and 
complement factors triggers a thrombotic response. Fibrous plaques may be 
classified as either stable or vulnerable.  Stable plaques consist of more SMC and 
collagen, while vulnerable plaques consist of more lymphocytes.  Although stable 
plaques cause stenosis, it leads to less serious clinical problems such as stroke and 
heart attack due to its stability (Stoneman and Bennett 2004). 
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Figure 1.4:  The progression of atherosclerosis 
A) Activated ECs increase permeability, allowing diffusion of LDL inside the vascular wall, which in 
turn attract adhesion and migratory monocytes and macrocytes.  B) Fatty streaks are the first sign of 
an atherosclerotic plaque, and may be observed in children aged 10 to 14.  At the early stage, fatty 
streaks appear as yellow grease running along the artery wall.  C) As fatty streaks progress to 
intermediate lesions, they form a fibrous cap, which isolates the lesion from blood flow.  D) 
Complicated lesions occur when fibrous caps break and expose the sub-endothelial layer to platelets 
and complement factors, triggering a thrombotic response (Montecucco and Mach 2009).    
(http://www.heartsite.com/AMI_slides/html/aSlide_07.html) 
 
 
  
52 
 
1.2 The cytoskeleton.  
 
The cytoskeleton is a filamentous protein network in cells, which maintains the 
cell’s shape, and its functional polarity.  It extends throughout the cell and attaches 
to the plasma membrane and cell organelles, regulating their organization.  
Cytoskeleton is composed of three filamentous systems; microfilament, 
microtubules and intermediate filaments, which occupy about 20–30 percent of the 
cytosol weight.  Instead of a fixed structure, the cytoskeleton is very dynamic – it 
can be assembled within 1 minute and can last from few minutes to few hours, 
depending on physical and biochemical stimuli. The three sub structures of  the 
system can be easily distinguished by their size and components; microfilaments are 
constituted by actin and actin binding proteins (ABPs), 8–9 nm in diameter, and are 
organized into a two-stranded twisted structure.  Microtubules are stiff hollow 
tubes comprised by protein tubulin and microtubule-associated proteins (MAPs).  
The diameter of microtubules is much larger than microfilaments (approximately 
24nm long).  Intermediate filaments are slightly larger than microfilaments, 
approximately 10 nm in diameter, and have a rope-like structure (figure 1.5).  
Essentially, each of the filament systems has its own distinct function; 
microfilaments normally accumulate at the edge of migrating cells and generate 
functional structures such as lamellipodia, filopodia and stress fibers, with the aid of 
actin-binding proteins, as well as acting as tracks for ATP-powered myosin motor 
proteins, which underpins the mechanism for muscle contraction. Microtubules form 
the basic framework throughout the cell, providing scaffold support for organelles 
and also form contractile rings during cell mitosis.  One of the functions of EC 
cytoskeleton is to provide cellular structural integrity, and does so by regulating 
endothelium permeability, cell-cell and cell-substratum adhesion, in addition to cell 
migration (Lee and Gotlieb 2002) (Lee and Gotlieb 2003). Endothelial integrity 
plays a pivotal role in normal blood vessel function, disruption of which can lead to 
initiation and progression of atherosclerosis. 
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Figure 1.5: The Cytoskeleton. 
Cytoskeleton is composed of three filamentous systems; microfilament, microtubules and 
intermediate filaments. Composed of actin and actin binding proteins (ABPs), microfilament are 8–9 
nm in diameter, and are organized into a two-stranded twisted structure that normally accumulate at 
the edge of migrating cells and generate functional structures such as lamellipodia, filopodia and 
stress fibers. Microtubules are stiff hollow tubes comprised by protein tubulin and 
microtubule-associated proteins (MAPs). The diameter of microtubules is much larger than 
microfilaments (approximately 24nm long) and forms the basic framework throughout the cell, 
providing scaffold support for organelles and also form contractile rings during cell mitosis.  
Intermediate filaments are slightly larger than microfilaments, approximately 10 nm in diameter, and 
have a rope-like structure (Goldman et al., 1999). 
 
 
1.2.1 Actin and actin binding proteins.  
 
Actin is the basic building block of microfilaments, and is an abundant intracellular 
protein in eukaryotic cells.  In vertebrates, three isoforms of actin (α, β, and γ) are 
found.  Only expressed in muscle cells, α-actin is involved in muscle contraction in 
association with myosin. In contrast, β and γ are found together in almost all 
non-muscle cells.  Actin is highly conserved, and arose from an ancestral bacterial 
gene.  Actin exists in two forms; a globular monomer G-actin, and a filamentous 
polymer, comprising of G-actin subunits, F-actin.  G-actin polymerizes into F-actin 
filaments when cations are added in solution.  When ionic strength is lowered, 
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F-actin depolymerizes.  G-subunits assemble in the same direction causing the 
filament to become polarized.  Hence, addition of subunits is favored at the (+) end 
and dissociation at the (-) end. 
 
Two actin-related proteins play crucial roles in polymerization. ARP2 and APR3 
nucleate, and cause branching of G-actin into F-actin (Pollard and Beltzner 2002) 
(Dyche Mullins and Pollard 1999).  Capping proteins, gelsolin and cofilin, regulate 
growth by covering an end of the F-actin filament (Pottiez, et al. 2009) (Carlier, et al. 
1997).  Filaments assemble into two helices of actin subunits.  Actin filaments are 
found in a variety of different structures, such as filament bundles in microvilli, or in 
the meshwork of the leading edge, but mainly in the cell cortex (Chesarone and 
Goode 2009) (Mallavarapu and Mitchison 1999). These structures are organized by 
cross-linking proteins, which have one or two F-actin binding sites, and form a 
dimer with a similar molecule.  Dimers can result in linkages bonds that are further 
apart, such as α-actinin (McGough, Way and DeRosier 1994), found in stress fibers 
and filopodia.  Different cross-linking proteins give different structure and function 
to actin.  Filamin is highly flexible and is found stabilizing cross-links in meshwork 
(Stossel, et al. 2001).  Spectrin extends large distances and is found in the cell 
cortex (Viel and Branton 1996).  Actin filaments interact with the plasma 
membrane either laterally or at their end.  This is achieved through actin-binding 
proteins, such as ERM proteins in microvilli (as mentioned above).  Changes in 
actin structure are of great importance to its function, as it affects the shape of the 
cell, in addition to driving intracellular movements.  Actin filaments provide 
support and organisation in the cell cortex underneath the plasma membrane.  They 
make up the core of microvilli.  In epithelial cells they form the adherens belt that 
provides cellular strength.  Actin is also involved in cell migration (Ridley, et al. 
2003b).  It is initiated by formation of a large, broad membrane protrusion at the 
leading edge of the cell, referred to as a “lamellipodium”.  Actin filaments are 
rapidly cross-linked into bundles and networks here. Slender membrane projections 
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called “filopodia” stabilize the leading edge, preventing retraction. Movement of the 
cell is controlled by actin polymerization (Parsons, Horwitz and Schwartz 2010c).  
Migration is needed for processes such as fibroblast migration during wound healing, 
morphogenetic movements during embryonic development and chemotactic 
movements of immune cells. Cells have contractile microfilaments that attach to the 
substratum through specialized regions referred to as “focal adhesions”. These 
microfilaments form a contractile ring during cytokinesis which constricts to form 
two daughter cells.  
 
 
1.2.1.1 Actin in the Nucleus. 
 
Actin has been observed in the nucleus in several studies dating back to the 1970’s 
and 80’s, however, results were subject to scepticism due to perceived contamination 
with cytoplasmic actin, or it was thought to simply diffuse in and out of the nucleus.  
These findings were largely forgotten about and little attention or research was carried 
out in this area until, recently. However, a large number of papers have since been 
published on the subject in the last 5 years, highlighting the importance of actin in the 
nucleus. The paradigm of nuclear actin is now accepted, the quest is to decipher the 
function, organization and location of actin and its binding partners.  In the 
cytoplasm, actin is present in either the G or F-actin form, but in the nucleus, there 
may be different forms, involved in the various functions and cell fate decisions 
(Jockusch, et al. 2006a). Cytoplasmic actin F-actin can be identified by labeling with 
fluorescent phalloidin.  Phalloidin interacts with sites of actin monomer-monomer 
contacts found in F-actin but is usually not found in the nucleus (Olave, 
Reck-Peterson and Crabtree 2002). Using monoclonal mouse antibodies against actin, 
2G2 and 1C7 (which also recognize an epitope on G-actin and lower dimer, dimeric 
forms of actin observed in actin polymerization) it was found to stain the nucleus of 
many mammalian nuclei.  It recognized two different unconventional forms of actin 
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(Gonsior, et al. 1999) (Schoenenberger, et al. 2005). It is now thought “Actin can 
assume a variety of oligomeric or polymeric forms” (Jockusch, et al. 2006b). 
Actin-binding proteins could act to stabilize these unconventional forms of actin and 
could participate in specific nuclear activities, such as chromatin remodeling or RNA 
synthesis (Jockusch, et al. 2006a). In chromatin modifications, nuclear actin functions 
are clearly linked to the nuclear actin-related proteins APR’s; see table 1.1 (Blessing, 
Ugrinova and Goodson 2004). Nuclear pores, which will be discussed below, are 
wide enough to allow monomers of actin into the nucleus.  In addition, actin-binding 
proteins, which contain nuclear localization signals, could transport other forms of 
actin into the nucleus (Jockusch, et al. 2006a). Actin has been found at the 
nucleoplasmic filaments of the Nuclear Pore Complex and so may have a role in 
nuclear export (Hofmann, et al. 2001). The presence of actin-binding proteins in the 
nucleus has only recently been elucidated and the dynamic between cytoplasmic and 
unclear cytoskeletal moieties will be an intense focus of research in the future.  
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Table 1.1:  Nuclear actin-binding proteins 
 
*PI: the abbreviation of Isoelectric Points.  
(Blessing, Ugrinova and Goodson 2004)  
 
 
1.2.2 ERM family (Ezrin, Radixin, Moesin). 
 
A common function of actin cytoskeletal structures is to support or to change the 
shape of the plasma membrane.  ERM proteins are members of the erythrocyte 
protein 4.1 superfamily that are much conserved in evolution.  They are found in 
all metazoan genomes, but not in unicellular organisms, suggesting that they 
evolved in response to cell-cell communication (Saotome, Curto and McClatchey 
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2004). They are paralogs that probably arose due to gene duplication, and so have 
functional redundancy in vertebrates, which makes it hard to study them by gene 
knockout.  They appear to function widely as linker proteins that link 
microfilaments to the plasma membrane (Sato, et al. 1992). ERM proteins shear a 
common structure. C-terminal domain which attaches to the actin filaments and the 
N-terminal FERM domain attaches to the cytosolic face of transmembrane 
glycoprotein’s e.g. integrins.  ERM proteins come in an active actin-binding form, 
and an inactive folded conformation.  Extracellular signals cause conformational 
changes through the binding of PIP2 or phosphorylation. ERM proteins play an 
important role in maintaining cellular architecture and integrity. 
 
 
1.2.2.1 Merlin.  
 
Merlin (also called Schwannomin), a relatively new member of ERM family, was 
identified in 1993 (Rouleau, et al. 1993) (Trofatter, et al. 1993). It was found to be 
mutated or deleted in Neurofibromatosis type 2 (NF2) syndromes.  NF2 is an 
autosomal-dominantly inherited disease affecting central and peripheral nerves and 
causes schwannomas, meningiomas, and ependymomas (Ramesh 2004). The NF2 
gene was mapped to chromosome 22q12 (Scoles 2008), is approximately 100kb 
long and transcribes a protein 590 (isoform 2) or 595 (isoform 1) amino acids in 
length with a 60-75 KDa molecular weight (Shimizu, et al. 2002) (Shimizu, et al. 
2002).  At present, 10 Merlin isoforms have been identified; among which, isoform 
type 1 and isoform type 2 are most common and best characterized.  Merlin 
isoform I consists of 595 amino acids, while Merlin isoform II contains 590 amino 
acids,  due to their slight different C-terminal.  However, unlike isoform 1, 
isoform 2 is believed to lack tumor suppressor function (Gutmann, et al. 1999). 
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Merlin also belongs to band 4.1 superfamily, which includes ezrin, radixin, moesin 
and talin and are collectively known as ERM proteins (Trofatter, et al. 1993). ERM 
proteins interact with actin and membrane proteins, regulating cell membrane 
organization.  Merlin shares a common structure with this protein family; a tri-lobe 
N-terminal domain, a charged C-terminal, and is linked by a long α-helical region 
(Scoles 2008) (Figure 1.6).  However, unlike other ERM proteins that consist of the 
C-terminal actin binding sites, Merlin contains a low affinity actin-binding domain 
on the FERM domain at its N-terminal (Huang, et al. 1998) (Xu and Gutmann 1998).  
The structural similarity of Merlin with ERM proteins indicates that Merlin also 
functions as a scaffolding protein, connecting F-actin to trans-membrane proteins 
through the FERM domain. The FERM domain contains three globular sub-domains 
sharing 60-70% of the same sequences with other members of the ERM family 
(Figure 1.7) (Berryman, Gary and Bretscher 1995). The FERM region can also 
interact with the C-terminal of Merlin to form a homodimer, or interact with other 
ERM proteins to form heterodimers, resulting in an active state required for its 
tumor suppressor function. In this process, the C-terminal of Merlin acts as cap 
inhibiting the FERM domain bond to trans-membrane proteins (Huang, et al. 1998). 
 
The head to tail intra/inter molecular association does not exist in Merlin isoform 2, 
and may explain why isoform 2 lacks tumor suppressor function and associates with 
F-actin more efficiently.  The actin-binding site of Merlin is located at residues 
178-367 on the N-terminal.  Merlin can bind with F-actin directly through this 
domain, or indirectly via the other ERM proteins.  Phosphorylation of Merlin is the 
other important regulatory mechanism of its function. Merlin can be phosphorylated 
at serine 518 in the C-terminal by either p21-activated kinase (PAK) or cAMP 
dependent protein kinase A (PKA), resulting in disassociation of the C-terminal 
from FERM (Kissil, et al. 2002) which is required for its tumour suppressor activity 
and exist a inactivate state. Interestingly, some studies have shown that Merlin can 
only interact with F-actin while ERM proteins are able to bind both G and F-actin; 
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suggesting a unique functional role for Merlin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6:  Structural comparison of Merlin and ERM proteins. 
(A)  The amino acid sequence of the erythrocyte protein 4.1 superfamily.  Various colored bars 
show the location of different domains.  The oval blue shapes represent FERM membrane protein 
binding domains (also called N-ERMAD). The yellow and golden regions represent α-helix domains.  
The actin-binding domains on C-terminal are depicted by a green box, absent on Merlin. (B) 
Illustration of various binding sites of ERM and their binding partners. (Mangeat, Roy and Martin 
1999) 
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Figure 1.7: Crystal structure and superposition of the FERM domains.  
A) Colored 3D crystal structure representing the Merlin FERM domain.  Merlin FERM contains 
three sub-domains; sub-domain A (green), sub-domain B (blue-green) and sub-domain C (blue).  
Gray represents the C-terminal α-helical segment, linked to the FERM domain by a linker region 
(brown). B) Comparison of the FERM domain in Merlin (blue) with radixin (brown).  The arrow 
shows the deletion site of Merlin.(Shimizu, et al. 2002) 
 
 
Increasing evidence indicates that Merlin is a key regulator in actin polymerization, 
cytoskeleton remodeling, cell motility and cell proliferation.  Loss of Merlin results 
in disorganized stress fibers and cell adhesion.  Merlin also plays an important role 
during early embryonic development; loss of Merlin is embryonic lethal in both 
murine and fly models (Stamenkovic and Yu 2010). 
  
 
1.2.2.2 Ezrin. 
 
Ezrin is the only ERM protein detected in developing intestinal epithelial cells. 
Saotome and his colleagues found that in the absence of ezrin, abnormal villus 
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morphogenesis occurs (Saotome, Curto and McClatchey 2004).  Villi were found 
not to separate correctly during morphogenesis and leading to abnormal apical 
tension and, incomplete secondary lumen formation.  It also resulted in 
disorganization of apical junctions between cells, and of the terminal web from 
which microvilli project.  Ezrin knock-down in mice caused a loss of gastric acid 
secretion in parietal cells, which are normally rich in ezrin (Tamura, et al. 2005), 
caused by defects in the formation/expansion of canalicular apical membranes.  
Ezrin is present both in retinal pigment epithelium apical microvilli and basal 
infoldings and Müller microvilli.  In knockout mice, reductions in apical microvilli 
and basal infoldings in retinal pigment epithelium cells and Müller cells microvilli 
were seen, as well as microvilli inclusions in the cytoplasm of these cells which is 
not normally observed in the wild type but is found in microvillus inclusion disease 
(Bonilha, et al. 2006). Also retardation in the photoreceptor development was seen 
in knock out mice. 
 
 
1.2.2.3 Radixin. 
 
Radixin was originally identified as a constituent of adherence junctions in rat liver. 
Knockout mice were used to investigate the role played by radixin (Kikuchi, et al. 
2002). They found that mice which did not express radixin were normal at birth, but 
after 8 weeks, presented with liver injury, and morphology of bile canalicular apical 
cell surfaces became abnormal.  In radixin-absent mice, MRP2 protein was no 
longer present in bile canalicular membranes, indicating that radixin, which interacts 
with MRP2, may be necessary for localization/anchoring of the protein to the apical 
surface of the cells (Kikuchi, et al. 2002). Radixin is also highly expressed in the 
cochlear and vestibular stereocilia (Kitajiri, et al. 2004). There are two types of 
stereocilia, cochlear and vestibular stereocilia, which are essential for the 
transduction of acoustic and acceleration stimuli, respectively, into electrical signals.  
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Mice defective in radixin suffered from deafness but did not lose their balance.  
Ezrin was up-regulated and maintained in vestibular stereocilia but was not in 
cochlear stereocilia.  The former is an example of structural and functional 
compensation of one ERM protein by another and an example of an advantage in 
having functional redundancy (Kitajiri, et al. 2004). 
 
 
1.2.2.4 Moesin. 
Moesin is found primarily in endothelial cells, but is also co-expressed with ezrin in 
a few subsets of epithelial cells.  Moesin is the single ERM orthologue in 
Drosophila.  DMoesin gene was inactivated during oogenesis and actin filament 
attachment to the oocyte cortex was shown to be impaired (Jankovics, et al. 2002). It 
was also shown to disrupt cell shape and antero-posterior polarity by impairing the 
localization of maternal determinants caused by incorrect attachment of actin to the 
cortex (Polesello, et al. 2002). Speck, Hughes, Noren, Kulikauskas and Fehon 
showed that moesin functions in maintaining epithelial integrity by regulating 
cell-signaling events which affect actin organization and polarity by activating 
GTPase Rho using negative feedback (Speck, et al. 2003). 
 
DMoesin also has a structural role in photoreceptor morphogenesis.  Rhabdomeres 
(actin-rich) are columns of closely packed photosensitive microvilli.  
Down-regulation of moesin causes disruption of the membrane cytoskeleton that 
builds the rhabdomere. (Karagiosis and Ready 2004). The effect, again, is only to be 
seen in Drosophila as tests on mice showed little effect most likely due to functional 
redundancy (Doi, et al. 1999). 
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1.2.2.5 Lasp-1 (Lim and SH3 protein 1). 
 
Human MLN50 gene was found to be over-expressed in some breast carcinomas 
(Tomasetto, et al. 1995). The 261 amino acid sequence contained an N-terminal LIM 
motif and a C-terminal SH3 binding domain and is so now termed “lasp-1” and was 
the first in a new family of LIM proteins (Tomasetto, et al. 1995).  Lasp-1 also 
contains two nebulin-like actin binding repeats which have been shown to bind to 
actin, and have possible roles in organization of the actin cytoskeleton (Schreiber, 
Moog-Lutz and RÃ 1998) (Chew, et al. 2002). No specific function has been attached to 
lasp-1.  The different binding motifs suggest that it mediates many different 
protein-protein interactions as a scaffold for the formation of higher order complexes.  
Lasp-1 is a ubiquitously expressed protein that is found in varying degrees in 
non-muscle tissues.  Lasp-1 localizes in F-actin rich ion-transporting cells such as 
pancreatic and salivary
 
duct cells and it was shown to be focused around the cortical 
regions and leading edges of lamellae of parietal cells, as well as being a cytosolic 
protein its has recently been found in the nucleus (Chew, et al. 2000a) (Grunewald, et 
al. 2007a). Lasp-1, along with Ezrin, is phosphorylated in response to increases in 
cAMP, both have a SH3 domain plus similar intercellular localization, suggesting the 
functions are interdependent (Chew, et al. 1998). Phosphorylation of lasp-1 by an 
antagonist in parietal cells through the cAMP pathway increases acid secretary 
responses (Chew, et al. 2000b).  “Lasp-1 is a dynamic protein that transits from the 
cell periphery to focal adhesions upon stimulation with growth factors” (Lin, et al. 
2004).  Another example of the possible role of lasp-1 is the interaction with zyxin 
which is found in the focal adhesions of fibroblast cells and is a regulator of actin 
filament assembly (Li, Zhuang and Trueb 2004).  Interesting findings about cell 
migration and adhesion were found by Lin, Park, Lin, et al., 2004, as they stated that 
“depletion of lasp-1 protein from cells strongly inhibits cell migration in response to 
ECM proteins”.  However it did not diminish cell attachment and spreading occurred 
normally.  Also they found that over amplification of lasp-1 has the same effect on 
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migration, cell attachment and spreading.  This shows that for normal migration 
lasp-1 expression must remain within specific limits.  The inhibition of lasp-1 in 
breast cancer cells has shown a decrease in zyxin expression in focal contacts.  
Furthermore, over-expression of lasp-1 in kidney cells results in higher migratory 
rates.  Lasp-1 has also been shown to be absent from benign breast gland epithelial 
cells and to very high levels in breast carcinoma and lymph node metastasis 
(Grunewald, et al. 2006). Clearly, lasp-1 has important roles in proliferation, 
migration and signaling in cells.  It is likely that a focus on lasp-1 expression in 
cancers will be seen as a recent study found that it was highly expressed in 55.4% of 
malign breast carcinoma cells suggesting it may be used as a marker for cancer in the 
future (Grunewald, et al. 2007b). 
 
 
1.3 Haemodynamic force. 
 
The major function of the vascular system is to transport blood to tissues.  As a 
consequence, endothelial cells are constantly exposed to haemodynamic forces 
which are some of the most important extracellular stimuli that regulate endothelial 
function (Traub and Berk 1998). Cobblestone-shaped ECs elongate and align in the 
direction of blood flow. At the site of athero-prone areas, disturbed flow will 
interrupt EC alignment, NF-κb activation and subsequent inflammatory response 
(Orr, et al. 2006), adhesion and chemokine receptor expressions, leading to 
re-organisation of the cytoskeleton and cell-cell/cell-matrix junctional/adaptor 
protein expression change.  Several pro-thrombotic factors such as vWF are also 
released at regions of disturbed flow (Resnick, et al. 2003). 
 
Shear stress and cyclic strain are two forms of haemodynamic force.  As blood 
flow drag through the vessel walls, the fiction force is called “shear stress”, and is 
described by fictional force per area squared (Figure 3).  In a region of straight 
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blood vessels, the direction, force and pattern of blood flow is always the same and 
is referred to as “laminar shear stress”.  Under laminar shear stress, endothelial 
cells elongate in the same direction as blood flow.  At regions of arterial 
bifurcation and curvature, more complex flow patterns (e.g. disturbed flow, 
turbulent and oscillatory flow) are experience by the vessel wall.  Under 
physiological conditions, shear stress is controlled by arterial elasticity, and the 
value of shear stress is around 10-15 dyne/cm
2 
(Lehoux and Tedgui 2003). Three 
factors influence the value of shear stress; blood flow rate, blood viscosity and 
vessel radius. The equation below describes the relationship between these factors: 
 
 
Shear stress (dyne/cm
2) = 4μQ/π * (r)3 
 
Where: μ = blood flow rate,  π = blood viscosity,  r = vessel radius.   (Hunt et al. 
2002)    
         
                 
Cyclic strain is generated by circulating blood pressure against vessel walls, and 
results in a physical stretch to ECs (Figure 3).  Blood pressure is generated by 
periodic heart contraction; the driving force for blood flow.  Unlike shear stress, 
which is higher in smaller vessels, cyclic strain is most prominent in larger arteries 
due to its high blood pressure and decreases as it travels further.  In response to 
cyclic strain decrease, SMCs in peripheral smaller arteries contract to maintain 
physiological blood pressure (Hahn and Schwartz 2009). The relationship between 
cyclic strain and vessel dimension can be described by following equation: 
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T=Pr/h 
 
 
Where:  P= the blood pressure, r= the radius of the vessel, T =wall tension,   
h= the thickness of the wall (Lehoux and Tedgui 2003) (Folkow 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8:  Haemodynamic force 
Shear stress: frictional force of blood flow against the endothelium. Cyclic strain: physical stretch to 
the vessel generated by the circulating blood pressure (Hahn and Schwartz 2009). 
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1.4 Vascular Mechano-regulation. 
 
1.4.1 Mechanotransduction. 
 
Mechanotransduction is defined as the process by which cells convert mechanical 
factors into biochemical signals, which in turn results in change in cellular signaling, 
gate and function, including structural stability and morphogenetic movements.  
Shear stress and cyclic strain are the two main forms of stimuli which act on ECs, 
influencing their overall biology (Orr, et al. 2006). Acute hemodynamic changes 
include blood flow increase, elevated NO levels and induced relaxation of SMC.  
Over time, shear stress regulates expression changes of many genes that encode for 
adhesion molecules, growth factors, coagulation factors and chemoattractants (Chien, 
Li and Shyy 1998). Many studies have also shown the effect of cyclic stretch on 
vascular remodeling through integrin mediated pathways (Katsumi, et al. 2004). Cell 
membrane adhesion receptors and cytoskeletal structure are two important factors 
involved in Mechanotransduction (Hoffman, Grashoff and Schwartz 2011). Many 
mechanotransducers have been implicated in sensing flow, including integrins, ion 
channels, receptor tyrosine kinases, heterotrimeric G proteins, platelet and 
endothelial cell-adhesion molecule-1 (PECAM-1) and vascular endothelial 
(VE)-cadherin (Hahn and Schwartz 2009). 
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1.4.2 Mechanotransducers. 
 
1.4.2.1 Integrins. 
 
Many cell surface receptors are involved in cell adhesion, migration and 
mechanotransduction, among which, integrins are the best studied and characterized 
due to their importance in a multitude of cellular functions. Integrins are a family of 
transmembrane, cell-surface receptors that mediate interactions between the 
cytoskeleton and the extracellular matrix, and play an important role in cell 
“outside-in” and “inside-out” signaling, as well as in the regulation of cell 
morphology and function, such as cell motility, proliferation, apoptosis and 
differentiation (Schwartz and Assoian 2001a). Integrin consists of α and β subunits 
(Figure.1.10) and to date, at least 18 alpha (α) subunits and 8 beta (β) subunits in 
humans have been identified, generating 24 heterodimers. This diversity of integrin 
allows integrin binding to specific ECMs and the same ECM-induced adhesions 
through different integrins, and as such, can differentially affect adhesion dynamics 
and cell motility (Table.1.2). For example, on fibronectin a5b1 integrin-mediated 
adhesions are more dynamic than avb3-mediated adhesions that are associated with 
more persistent migration (Huttenlocher and Horwitz 2011a).  
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Figure1.10. General structure of an integrin molecule 
Integrins are heterodimers that consists of α and β subunits and to date, at least 18 alpha (α) subunits 
and 8 beta (β) subunits in humans have been identified, generating 24 heterodimers. The diversity of 
integrin allows integrin binding to specific ECMs and the same ECM-induced adhesions through 
different integrins, and as such, can differentially affect adhesion dynamics and cell motility 
http://personalpages.manchester.ac.uk/staff/j.gough/lectures/the_cell/cell_adhesion/page23.html  
 
 
Integrins transduce signals into the cell interior upon ligand binding.  Intracellular 
signals regulate ligand binding affinity through a process called “integrin activation”.  
Integrin activation is involved in such processes as platelet aggregation, leukocyte 
extravasation, and cell adhesion and migration, thus influencing such processes as 
hemostasis, inflammation and angiogenesis (Ratnikov, Partridge and Ginsberg 2005). 
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The actin binding protein, talin, plays an important role in integrin activation 
(Critchley and Gingras 2008). Talin binds the integrin β subunit cytoplasmic tail to 
the actin cytoskeleton. The arginine-glycine-aspartic acid (RGD) sequence in 
fibronectin was identified as a general integrin-binding motif (Takada, Ye and Simon 
2007). Integrins also recognize other non-RGD sequences in ligands and may be 
categorized into groups based on ligand-binding specificity; laminin-binding, 
collagen-binding, leukocyte and RGD-recognizing integrins (Takada, Ye and Simon 
2007). Gene deletion studies have demonstrated the essential roles for almost all 
integrins, with defects suggesting widespread contributions both maintenance of 
tissue integrity and promotion of cellular migration (Humphries, et al. 2000). 
 
 
 
Table 1.2: Different types of integrins and their specific binding proteins 
SUBUNIT 
COMPOSITION  
PRIMARY 
CELLULAR 
DISTRIBUTION 
LIGANDS 
α1β1 Many types Mainly collagens 
α2β1 Many types Mainly collagens; also laminins 
α3β1 Many types Laminins 
α4β1 Hematopoietic cells Fibronectin; VCAM-1 
α5β1 Fibroblasts Fibronectin 
α6β1 Many types Laminins 
αLβ2 T lymphocytes ICAM-1, ICAM-2 
αMβ2 Monocytes Serum proteins (e.g., C3b, 
Fibrinogen, Factor X); ICAM-1 
αIIbβ3 Platelets serum proteins (e.g.,  
Fibrinogen, von Willebrand 
factor, vitronectin); fibronectin 
α6β4 Epithelial cells Laminins 
(Hynes 1992) 
 
 
 
 
  
73 
 
1.4.2.2 G-proteins. 
 
G-proteins are another group of mechanotransducers that belong to GTPase 
superfamily.  They act as molecular switcher and are capable of binding GTP 
promoting the “on” condition while being turned “off” by changing GTP to GDP.  
G-proteins are critical in many endothelial functions, including control of 
endothelial permeability, proliferation and migration (Wieland and Mittmann 2003) 
(Knezevic, et al. 2009) (Hamm 1998). Up until now, two classes of GTPase have 
been identified which are involved in cell signaling; small and large G-proteins.  
The small G-proteins (also referred to as Monomeric G-proteins) include Ras and 
Ras-like protein.  During the last few decades, members of Ras-like proteins have 
been intensively studied due to their important role in regulation cell motility.  
Ras-like proteins consist of Rac, Rho and Cdc 42.  Rac is known to be involved in 
control of microfilament organization, which in turn regulates lamellipodia 
formation on the leading edge of migrating cell.  Rho is involved in regulation of 
stress fiber formation, while Cdc 42 is known involved in control filopodia 
formation (Etienne-Manneville and Hall 2002) (Burridge and Wennerberg 2004).  
 
Large G-proteins are heterotrimers composed of Gα Gβ and Gγ subunits which are 
located at the inner surface of the plasma membrane.  G-proteins are activated by 
transmembrane G-protein coupled receptors (GPCRs) and different GPCRs activate 
specific G-proteins inducing distinct cellular reactions.  The large G-proteins 
contain seven transmembrane domains; the Gβγ dimer secures the tight binding of 
protein to the cytoplasmic membrane and the Gα chain involved in changing GDP to 
GTP upon GPCR activation (Papadaki and Eskin 1997). Activation of G-protein 
releases the Gα sub-domain from Gβγ sub-domain; both of these sub-domains are 
then free to act on specific downstream effectors (Wieland and Mittmann 2003). 
 
Many studies have demonstrated that in response to shear stress, G-proteins are 
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involved in regulating vascular tone by regulating the secretion of NO, PGI2 and 
endothelin (Ohno, et al. 1993) (Berthiaume and Frangos 1992) (Kuchan and Frangos 
1993). Some studies have also shown that inhibition of G-protein blocked shear 
induced Ras activity (Gudi, Clark and Frangos 1996) (Gudi, et al. 2003). G-protein 
expression also changed under physiological shear stress in co-cultured ECS and 
SMCs (Redmond, Cahill and Sitzmann 1998). All these studies pointed to the fact 
that G-proteins play an important role in regulation of mechanotransduction.  
 
1.4.2.3 Ion channels. 
 
Among all cell membrane channels, ion channels are the simplest, due to their less 
ability to hydrolyze ATP.  They are trans-membrane proteins that control ion 
transportation across the membrane.  The “in and out flux” of ions establishes 
small voltage gradients cross the membrane.  Ions channels allow the fluxes of ions 
cross membrane much faster; for 10
6
 to 10
8
 ions per second while only 10
2
 to 10
5
 
ions per second for the other channels.  Selectivity and gating are two basic 
characteristics of ion channels.  Selectivity allows only one or a few types of ion to 
pass through the distinct channels, while gating is responsible for cells maintaining 
the resting membrane potential.  
 
Many ions channels have been shown to be involved in control of vascular functions 
(Martinac 2004) and among these channels, K
+
 and Cl
-
 have been intensively 
studied as they are responsible for machanotransduction. Olesen, Claphamt and 
Davies have demonstrated the activation of K
+
 channels response to shear flow in 
endothelial cells (Olesen, Claphamt and Davies 1988). This influx of K
+
 decreases 
the contraction of VSMCs, and in turn, dilates vessel walls.  Shear stress also 
activates Cl
-
 channels, which in turn induce out-rectifying of Cl- and cause 
membrane depolarisation (Barakat, et al. 1999). 
 
  
75 
 
1.5 Cell migration. 
 
Cell migration is an important biological event that is crucial in maintaining cell 
morphogenesis.  Indeed, abnormal cell migrations contribute to many human 
diseases, including cancer, immunodeficiency disorders and cardiovascular disease.  
Under physiological conditions, cell migration is required for immune surveillance, 
angiogenesis and tissue regeneration and repair (Huttenlocher and Horwitz 2011b) 
(Brakebusch, et al. 2002). Under pathological conditions such as infections, 
leukocytes are attracted by inflammatory signals and move towards to the infectious 
site.  The migration of ECs also helps repair injured vessel wall thus maintaining 
endothelial integrity.   
 
1.5.1 Mechanism of cell migration. 
1.5.1.1 The Lamellipodium. 
The adhesion of cell membrane integrins into extracellular matrices seems to be the 
first step in cellular migration.  By staining β3 subunits of integrin with green 
fluorescence protein, studies have illustrated that migrating cells form a functional 
protrusion region on the leading edge was initiated by polarization of cytoskeleton 
(Laukaitis, et al. 2001) (Ballestrem, et al. 2001). Lamellipodia, filopodia and 
membrane ruffles are distinct functional structures on cell membrane which are 
essential for cell migration.  In 1980, Abercrombie observed a protruded cell 
membrane structure at the front of migrating cells approximately 0.2 μm thick.  
This structure was subsequently termed “lamellipodium”, and termed “ruffles” when 
curled upwards (Abercrombie 1980). Later, J.P. Heath and B.F. Holifield 
demonstrated that these structures were based on actin polymerization (Heath and 
Holifield 1992). Currently, we have a clearer idea about these protrusion structures.  
The lamellipodium is a thin membrane protrusion about 0.2 µm in height at the front 
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of spreading and migrating cells or the cells leading edge (Small 1994). They are 
then described as membrane ruffles when they curl upward.  Filopodia are small 
bundles that projected beyond the cell edge.  Lamellipodia contains highly dynamic 
actin filaments and plays an important role in the development of adhesion 
complexes.  With the helps of many proteins such as Arp2/3, filamin, VASP and 
WAVE, these protruding structures adhere to underlying ECM, which is then stabilised 
and form another structure called a “focal complex”.   
 
1.5.1.2 Focal complex. 
Migrating cells first form transitional adhesions to the lamellipodium, which is 
mediated by cell membrane adhesion receptors.  To date, many cell surface 
adhesion receptors have been demonstrated to be involved in cell adhesion.  
Among these receptors, integrins are best characterised.  In response to adhesion 
cues, the extracellular domain of an integrin firmly attaches to their specific ligand 
which in turn causes conformational change of their cytoplasmic tails inducing its 
linkage to the cytoskeleton.  Large numbers of proteins are known to promote 
interaction of integrins to the cytoskeleton, among which talin, vinculin, kindlins 
and α-actinin are the most well studied and therefore characterised.  The initial 
adhesion (focal contact) then mature to large dot-like adhesions termed “focal 
complexes”. A focal complex is a dynamic multiprotein macro-structure 
approximately 1 µm in diameter and located directly behind the leading edge.  A 
focal complex can further stabilise and mature into a relatively more stable 
elongated plaque like structure known as a focal adhesion, approximately 2 µm in 
wide and 3-10 µm in length (Zimerman, Volberg and Geiger 2004). Focal 
complexes are widely distributed from the front of leading edge to the rear of the 
cell.  Due to its highly dynamic and transient nature, the components of focal 
adhesions are difficult to study.  Structural proteins in focal adhesion are listed in 
table1.3.  
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Figure 1.11 Structural elements of a migrating cell 
A migrating cell forms distinct functional structures on its leading edge.  These structures include 
filopodia and lamellipodia.  Adhesion is the first step of migration, which initially from 
lamellipodium formation.  Lamellipodium contain highly dynamic actin filaments and play an 
important role in the development of adhesion complexes.  Filopodia are small bundles that project 
beyond the cell edge.  Migrating cells first form transits adhering to the lamellipodium, which is 
mediated by cell membrane adhesion receptors.  The transit adhesion then mature to large dot-like 
adhesion termed focal complexes.  As migration progresses, focal complexes may further stabilise 
and mature into a relatively more stable structure- focal adhesion. Dorsal stress fibre which composed 
of actin filaments connect to the substrate and act as scaffold for myosin. The arrow shows the 
direction of cell migration.(Parsons, Horwitz and Schwartz 2010a)  
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Table1.3. Structural components of focal adhesion 
 
The table lists some structural proteins in focal adhesion. Integrins, syndecan IV and dystroglycan are 
located on surface of cell membrane while the rest proteins located within the cells. Cell surface 
proteins are involved in both anchorage and signalling transductions (for details of integrins please 
see section1.4.2.1). Cytoplasmic proteins are known to promote interaction of transmembrane 
proteins such as integrins to the cytoskeleton, among which talin, vinculin, kindlins and α-actinin are 
the most well studied and therefore characterised. Talin is another member of ERM protein family, 
which serves as a linker between integrins and actin. Vinculin is actin binding protein which masks 
the binding sites for talin and actin. α-actinin belongs to spectrin superfamily and is considered as an 
actin cross-linking protein. (Burridge and Chrzanowska-Wodnicka 1996)  
 
 
1.5.2 Regulation mechanism of cell migration. 
The promotion of actin polymerisations in migrating cells are controlled by the Rac, 
Cdc42 and Rho which are members of GTPases family. Rho GTPases are cell 
membrane proteins that act as molecular switches. The functions of Rho GTPases 
have been well studied; Rac is known to be involved in control of microfilament 
organisation, which in turn regulates lamellipodia formation on the leading edge of 
migrating cells. Rho is involved in regulation of stress fibre formation, while Cdc 42 
is known to be involved in control of filopodia formation. Studies have shown that 
Rac and Cdc42 are activated at the leading edge of migrating cells (Kurokawa, et al. 
2005), while RhoA is activated both at the cell rear and the leading edge (Kurokawa 
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and Matsuda 2005). Activated Cdc42 was observed at sites of filopodia formation, 
while activated Rac was expressed only in lamellipodia (Tapon and Hall 1997). 
Activation of Cdc42 seems to regulate and control the direction of cell migration; 
cells can form a leading edges when transfected with a dominant negative Cdc42 but 
do not migrate in the right direction (Lodish, H. et al. 2007).   
 
Activated Rac and CDC42 regulate actin polymerization through activation of the 
other two scaffolding proteins Wiskott–Aldrich syndrome protein (WASP) and 
WASP-family verprolin-homologous protein (WAVE), which in turn interact with 
ARP2/3.  Studies have also shown that H-Ras (a subset of the Ras protein family) 
inhibits activation of β1 and β3 integrins in Chinese hamster ovary cells (Kinashi, et 
al. 2000). Accumulation of the activated GTP state of Rac1 in membrane ruffles in 
live cells was observed (Nobes and Hall 1995). Rap1 meanwhile regulates the 
integrin high affinity state in lymphoid and ECs (Nolz, et al. 2008).  
 
 
1.6 The Urokinase Receptor (uPAR). 
1.6.1 The basic structure of uPAR. 
Urokinase receptors, multi-domain glycoproteins, are the other important cell 
membrane-associated adhesive receptors, which belong to the lymphocyte antigen 
6(Ly-6) superfamily (Ploug and Ellis 1994). uPAR contains a peripheral 
glycosyl-phosphatydil-insositol (GPI) tail and three LU (Ly-6 and uPAR domains) 
referred as D1, D2 and D3. uPAR is attached to the cell membrane by the 
glycosyl-phosphatydil-insositol (GPI) tail at the Gly 283 residue at the C terminus 
(Kjaergaard, et al. 2008). However, unlike integrins, which have trans-membrane 
domains and intracellular tails, this GPI domain does not span cell membrane (figure 
1.12).  uPAR is a heterogeneously glycosylated single polypeptide chain that 
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contains 313 amino acid residues.  From the beginning of the N-terminus, this 
single polypeptide is arranged into folded homologous, almost globular, structures; 
D1, D2 and D3 domains.  These domains exist as β-pleated sheets arranged into the 
three finger structures, ending with a small C-terminal loop (Llinas, et al. 2005). 
Domain 1 and the D1-D2 bind contain a vitronectin binding site while D1 and D3 
contain uPA binding sites.  As these binding sites are distinct, uPAR are able to 
bind both ligands simultaneously (Huai, et al. 2008). Furthermore, due to crosstalk 
between these ligands, the affinity of vitronectin to uPAR is increased by binding of 
uPA to uPAR (Gårdsvoll and Ploug 2007a).  
 
 
 
 
 
 
 
 
 
 
Figure1.12 uPAR structure 
The urokinase receptor contains three domains termed D1, D2 and D3.  They are attached by an 
internal disulphide bond. uPAR is anchored to the cell membrane by the 
glycosyl-phosphatydil-insositol (GPI) tail.  Domain 1 and the D1-D2 bond contain a vitronectin 
binding site, while D1 and D3 contain uPA binding sites.  Soluble uPAR is released from the cell 
membrane by cleavage of the GPI anchor. (Blasi and Carmeliet 2002a) 
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1.6.2 The function of uPAR.  
 
The functions of uPAR can be classified in three distinct ways; anchorage, protease 
and signaling.  As an anchorage receptor, uPAR is able to attach to many 
extracellular matrices, such as vitronectin, which in turn regulate cell motility and 
proliferation.  As a protease, uPAR is responsible for converting pro-urokinase into 
urokinase. uPAR is also involved in activation of plasminogen, which produces 
plasmin.  Both of these enzymes are required in proteolysis and fibrinolysis which 
are essential mechanisms to release the attachment of migrating cell from ECM and 
are also important elements during blood clot proteolysis.  As it is less of a 
cytoplasmic domain, uPAR mediates signals through other membrane receptors, 
such as integrin, receptor tyrosine kinase (RTKS) and G protein coupled receptors 
for outside-in signal transduction (Blasi and Carmeliet 2002). Among these 
receptors, integrins are the best studied and characterized.  Previous studies have 
shown that uPAR interacts with a number of the integrin family, specifically the 
heterodimers containing the β1, β2, β3 and β5 integrin subunits (Ragno 2006). Most 
recently, attention has focused on a less well characterized member of the integrin 
family-αvβ6, and its interaction with uPAR (Saldanha, et al. 2007). αvβ6 is thought 
to play a pivotal role in the metastasis and intra/extravasion of cancer cells via its 
interaction with uPAR (Ahmed, et al. 2002). It is also thought to play a role in the 
activation of Latency Associated Peptide (LAT or pro-TGF-β) and in 
epithelial-Mesenchymal Transition (EMT) (Wei, et al. 1996). 
 
Although the direct binding of uPA with integrins is controversial, accumulating 
evidence demonstrated the requirement of integrins in uPAR signaling. The 
interaction of uPAR with its agonists promotes integrin-mediated cell motility as 
well as cell proliferation (Blasi 1997) (Chapman 1997) (Degryse, et al. 1999). α5β1 
was demonstrated to be involved in uPA-uPAR-mediated migration in chinese 
hamster ovary cells. The vitronectin binding receptors, αvβ3, αvβ5, are other 
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integrins that are associated with uPAR (Montuori, et al. 2001).  
 
Urokinase is a single chain enzyme, with a molecular weight of 54 kDa.  The 
inactive state of urokinase is referred to as pro-uPA which can be activated by 
binding to uPAR (Prager, et al. 2004). Activated urokinase is comprised of two 
chains and is referred to as high molecular weight urokinase.  The association of 
urokinase to uPAR results in plasminogen activation, which then promotes cell 
migration by enhanced ECM proteolysis (Estreicher, et al. 1990).  
 
D2A and SRSRY peptides allow us investigate the interacting partner of urokinase 
receptor. D2A was first synthesized by Bernard Degryse and his colleagues 
(Bernard Degryse, et al 2005). Derived from the sequence of Domain 2, D2A 
peptides (H-Lle-Gln-Glu-Gly-Glu-Glu-Gly-Arg-Pro-Lys-Asp-Asp-Arg-OH) have 
been shown to interact laterally with αvβ3 integrin and induce cell migration, via 
outside-in signalling. SRSRY (Ser-Arg-Ser-Arg-Tyr) is another chemotactic peptide, 
derived form an uPAR sequence, which localized in the D1-D2 linker region. 
SRSRY peptides bind specifically to fMLP- a seven-transmembrane domain 
G-coupled receptor, and promote cell migration in this manner (Lucia Gargiulo, et al, 
2005). 
 
 
1.7 A brief summary  
 
Cardiovascular disease (CVD) refers to a group of diseases that involve dysfunction 
of heart and blood vessels, and consequently include heart failure, arrhythmia, 
angina, hypertension, high cholesterol, and stoke amongst others. According to the 
World Health Organisation (WHO), CVD is the leading cause of global death 
(http://www.who.int/mediacentre/factsheets/fs317/en/). It is also estimated that 17.3 
million people died from CVD around the world in 2008; a figure that represents 
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30% of all global deaths. This number is projected to increase to 23.6 million by 
2030. In Ireland, this figure is even higher; approximately 10,000 people die from 
CVD (coronary heart disease, stroke and other circulatory diseases) annually. CVD 
is the most common cause of death in Ireland, and accounts for 36% of all deaths. 
The largest number of these deaths relate to CHD - mainly heart attack - at 5,000. 
22% of premature deaths (under age 65) are due to CVD 
(http://www.irishheart.ie/iopen24/about-us-t-1.html). Globally, CVD are a heavy 
burden for the health care system, costing approximately €192 billion in the 
European Union in 2008 alone (Allender, et al. 2008). There are, therefore, 
significant socio- economic reasons, as well as medical, to further our knowledge of 
the underlying causes of CVD. This will contribute to overall knowledge and assist 
in developing efficient preventive (primary, secondary and tertiary) strategies for 
CVD. 
 
The pathophysiology of CVD is varied and complex, hence there are many cellular 
and molecular mechanisms which contribute to the disease. General risk factors of 
CVD include unhealthy diet (high cholesterol diet and salt intake), physical 
inactivity, and over-consumption of alcohol and tobacco. Prolonged exposure to 
such unhealthy habits leads to intermediate risk factors, which include high blood 
pressure, high serum cholesterol and raised blood glucose levels and obesity. These 
serve to increase the chances of developing CVD in the future. 
 
Our research mainly focused on atherosclerosis, a disease characterized by 
thickening and loss of elasticity of arterial wall.  Atherosclerosis normally occur at 
large and medium-sized muscular elastic arteries, such as the aorta, coronary and 
cerebra. It is especially prevalent at sites of arterial bifurcations and regions of high 
curvature that result in complex blood flow patterns (Hahn and Schwartz 2009). At 
such sites, disturbed blood flow occurs, and this leads to susceptibility towards the 
formation of atherosclerotic plaques. These, in turn, cause narrowing of blood 
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vessels and luminal occlusion, or even wall rupture at advanced stages (Orr, et al. 
2006a). 
 
The endothelium is the inner, mono layer of blood vessels. Due to their functional 
nature, blood vessels are constantly and directly subject to various stimuli, including 
haemodynamic forces manifested in the form of cyclic strain and shear stress.  
Endothelial cells sense and convert these mechanical forces into biochemical signals 
– known as bio-mechanotransduction- which, in turn, alters EC functions. Thus, 
within the inner layer of blood vessels, vascular endothelial cells undergo acute and 
prolonged adaptations in order to maintain vascular health. EC morphology and 
phenotypic change is considered to be the first sign of dysfunction, which leads to 
development and progression of cardiovascular disease. EC morphology is 
maintained by actin cytoskeleton (a filamentous protein network in endothelial cells) 
and is comprised of microfilaments, microtubules and intermediate filaments. Actin 
polymerization is a complex process that plays an important role in maintaining 
endothelial integrity. This process requires the recruitment of numerous proteins, 
including both extra-cellular (e.g. ECMs) and cytosolic proteins (e.g. filamentous 
proteins). Over the past three decades, studies (including those carried out within our 
laboratory) have highlighted the importance of ERM proteins in the regulation of 
cytoskeleton organisation. They appear to function widely as linker proteins that 
serve to connect microfilaments to the plasma membrane. Our previous work 
demonstrated that one member of ERM family, Moesin, is critically involved in EC 
functions, such as migration, angiogenesis, and barrier integrity. 
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1.8 The overall hypotheses and study aims 
 
1.8.1. Hypothesis 
In this thesis, we focused on a relatively new member of ERM family-Merlin. 
Merlin is another member of the ERM protein family that has been well 
characterized as a linker protein of cytoskeleton and cell membrane proteins. 
Mutation of Merlin (NF2 gene) contributes to development of neural tumors such as 
schwannomas, meningiomas, and ependymomas.  However, the role of Merlin in 
the regulation of actin cytoskeleton within the vasculature is poorly understood. 
Therefore, in this study, we sought to determine if Merlin is a mechanically-induced 
actin-binding protein essential to cellular adaptation and function. We believe that 
merlin is a hemodynamically regulated protein, which plays a crucial role in 
cytoskeletal dynamic in Human Aortic Endothelial Cells. Merlin plays an important 
role in regulation of HACE motility through αvβ3 integrins mediated pathway. We 
also hypothesis that uPAR, another cell surface receptor, is involved during 
merlin-integrin mediated mechanno-transduction.  
 
1.8.2 Study Objectives: 
In conclusion, maintenance of endothelial integrity is critical to normal blood 
homeostasis, and as an actin skeleton and cell membrane linker, the role of Merlin in 
maintaining endothelial integrity is unknown.  We therefore look to examine:  
 
 If physiologically relevant levels of laminar and disturbed shear affect the   
morphology of HAECs and If Merlin is a mechanically-regulated protein in 
the vasculature. The HAECs therefore will be exposed to haemodynamic 
forces both in forms of shear stress and cyclic strain via in vitro models.  
The merlin protein expression level and the merlin mRNA level after 
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simulate by haemodynamic forces will be examed by using western-blot and 
QRT-PCR. This examination will determine whether the transcriptional and 
translational expression level of merlin is mechano-regulated by vascular 
haemodynamic forces.  
 The role of merlin in regulation of HAECs motility. Merlin protein will be 
knocked-down by mean of transfection of merlin siRNA into HAECs using 
micropration. The efficiency of transfection will be examed by western-blot 
to ensure the 70-80% transfection efficiency.  The comparison of merlin 
knock-down HAECs and scrambled control HAECs motility both in form of 
adhesion and migration will be monitored using real time system 
xCelligence. 
 By using various ECM (including fibronectin, fibrinogen, laminin and 
vitronectin), RGD inhibitors (including RGD1,RGD2 and RGD3) and 
peptide (such as D2A and SRSRY) to exam through which mechanism 
merlin regulates HAECs motility.  
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Chapter Two 
 
Materials & Methods 
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2.1 Materials. 
2.1.1 Reagents and Chemicals. 
 
Abcam, Cambridge, UK 
Primary antibodies: Rabbit polyclonal to NF2/Merlin, Rabbit monoclonal (EP1863Y) 
to Moesin, Mouse monoclonal to Rac, Chicken polyclonal to cdc42, Mouse 
monoclonal to GFP, Mouse monoclonal to GAPDH (HRP), Rabbit polyclonal to 
Beta-Actin. 
Secondary antibodies: Rabbit polyclonal to Chicken IgY H&L (HRP), Goat 
polyclonal to Chicken IgG H&L (CY5). 
 
Aktiengeselischaft and Company, Numbrecht, Germany: 
Micro-tubes (0.5ml; 30x8mm); Micro-tubes (1.5 ml; 39x10mm); 6, 24 and 96-well 
plates; 2, 5, 10, and 25 ml serological pipettes; 2 ml aspirator pipettes; 15 and 50ml 
tubes; cell scrapers; 58 cm
2
, 152 cm
2
 tissue culture dishes. 
 
Ambion Inc., Tx, USA: 
Silencer
®
 pre-designed Merlin siRNA, Silencer
®
 pre-designed Moesin siRNA. 
 
Anachem UK 
Tips: 1-20 μl, 10-200, μl 100-1000 μl; 
Filtered tips: 1-20 μl, 10-200 μl, 100-1000 μl. 
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Applied Biosystems, CA, USA 
Scrambled control siRNA, High-Capacity cDNA Reverse Transcription Kits, Fast 
optical 96-well reaction plates (with adhesive covers),  
 
Barloworld-Scientific (London, UK) 
White flat-bottomed 96-well plates. 
 
Bachem AG (Switzerland) 
RGD inhibitors (H7630, 3164 and 3964) 
 
BioRad (CA, USA) 
10X Tris/Glycine/SDS transfer buffer, Coomassie stain, Goat monoclonal to Mouse 
IgG (HRP) secondary antibody, Thick mini trans-blot filter paper, Laemelli sample 
buffer, IScript cDNA synthesis kit, Precision plus protein marker. 
 
Cell signalling Technology Inc, MA,USA 
Primary antibodies: Rabbit polyclonal to Phospho-Merlin (Ser5180), Rabbit 
polyclonal to Phospho-Ezrin (Thr567)/Radixin (Thr564)/Moesin (Thr558). 
Secondary antibodies: Goat anti-rabbit IgG H+L (HRP). 
 
Cytoskeleton Inc, CO, USA 
Rac1, RhoA, cdc42 pull-down assay. 
 
DAKO, CA, USA: 
Fluorescent mounting media. 
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Dunn Labortechnik GmBH, Asbach, Germany: 
6-well Bioflex plates. 
 
Eppendorf, Cambridge, UK: 
50X TAE Buffer 
 
Eurofins MWG Operon (Ebersberg, Germany) 
Primer sets: NF2/Merlin, Moesin, 18s (human). 
 
Fermentas, York, UK: 
DNA Ladder, Protein Ladder. 
 
Invitrogen, CA, USA: 
Alexa Fluor
®
 488 F(ab‟)2 fragment of goat anti-rabbit IgG (H+L),  DH5α E-coli 
competent cells, DNase, RNase free distilled water, Phosphate buffered saline (PBS), 
SyberSafe
®
, Trizol. 
 
Integrated BioDiagnostics (ibidi), Martinsried, Germany: 
µ-slide I, μ-slide y-shaped. 
 
Labtech (East Sussex, UK) 
ADAMTM Counter kit, Microporation kit, Microporator tubes, solution E buffer, 
solution R buffer, 10 and 100 μl gold tips. 
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Lennox Laboratory Supplies LTD, Dublin, Ireland 
100% Industrial Methylated Spirits (IMS), 100% Ethanol 
 
Medical Supply Company (Dublin, Ireland) 
0.2 ml and 0.5 ml PCR tubes. 
 
Merck Bioscience, CA, USA: 
Proteoextract subcellular proteome kit,  
 
Millipore, MA, USA: 
Primary antidodies: Rabbit polyclonal to FAK antibody, Rabbit polyclonal to 
GAPDH antibody, Mouse monoclonal to β1 Integrin active conformations (HUTS-4) 
antibody,  
Secondary antibodies: Goat anti-rabbit IgG H & L (HRP). 
 
Mirus (WI, USA) 
TransIT
®
-2020 reagent, TransIT-siQUEST
®
 reagent. 
 
Nunc, Rochester, NY, USA: 
Cryovials. 
 
Pall Life Science, NY, USA: 
Acrodisc 32 mm syringe filter with 0.2 μm super membrane, nitrocellulose 
membrane.  
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Pierce Biotechnology, IL, USA: 
Bicinchoninic acid (BCA) assay kit, Restore stripping buffer, Supersignal west pico 
chemiluminescent substrate.  
 
Promocell, Heidelberg, Germany: 
Endothelial cell growth medium MV, Endothelial cell growth medium MV 
Supplement mix, Endothelial cell basal medium MV, Endothelial Cell Growth 
Supplement/Heparin (ECGS/H) 0.4% (v/v), Fetal Calf Serum (FCS) 5.0% (v/v), 
Endothelial Growth Factor (EGF) 10 ng/ml and Hydrocortisone 1 μg/ml. Cryo-SFM 
serum-free medium for cryopreservation, Human Aortic Endothelial Cells (HAECs). 
 
Qiagen, West Sussex, UK: 
DNase, HiSpeed Midi-prep kit. 
 
Roche Diagnostics, Basal, Switzerland: 
CIM-plates, E-plates, SYBR green (ROX), Protease inhibitor cocktail. 
 
R&D Systems, MN, USA 
Recombinant D2A and SRSRY peptides.  
 
Santa Cruz, USA 
Primary antibodies: Rabbit polyclonal to Merlin, Rabbit polyclonal to GAPDH.  
 
Sarstedt (Drinagh, Wexford, Ireland) 
2 ml aspirator pipettes, 10 cm cell culture dishes, 6-well cell culture plates, 96-well 
cell culture plates, cell scrapers, 0.2 ml eppendorf tubes, 1.5 ml eppendorf tubes, 2 
ml eppendorf tubes, 5 ml pipettes, 10 ml pipettes, 25 ml pipettes.  
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Sigma Chemical Company Ltd, Dorset, UK: 
2,3-diaminonaphthalene, autoradiography developing and fixer solutions, acetone, 
agarose, ammonium persulfate, ampicillin sodium salt, bradykinin, bromophenol 
blue, DAPI, DMSO, DNAse kit, EDTA, fetal bovine serum, FITC-dextran (40 kDa), 
glucose, glycerol, HEPES, LB agar, LB broth, magnesium sulphate, monopotassium 
phosphate, PBS tablets, penicillin-streptomycin (100X), Ponceau S solution, 
phosphoramidon, RPMI-1640 medium, sodium bicarbonate, sodium chloride, 
sodium deoxicholate, sodium dodecyl sulphate, sodium fluoride, sodium phosphate, 
sucrose, TEMED, trypsin-EDTA solution (10X), Triton
®
 X-100, trizma base, 
tryptone, Tween
®
20. 
Matrices: Fibronection, fibrinogen, Laminin and Vitronectin. 
 
Star Labs, Milton Keynes, UK: 
1μl (P2), 10 μl (P10), 20 μl (P20), 200 μl (P200) and 1000 μl (P1000) tips. 
 
Thermo Fisher Scientific, Leicestershire, UK: 
BCA reagent kit, BSA, glycine, isopropanol, Pierce Antibody Clean-up Kit, Pierce 
Co-IP kit, Super signal western-blot enhancer, trizmabase, weigh boats, RNase 
Away. 
 
VWR International Ltd. (West Sussex, UK) 
Methanol. 
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2.1.2. Instrumentation. 
 
Applied Biosystems, CA, USA 
Applied Biosystems 7500 Real Time PCR system with sequence detection software 
(SDS). 
 
Bennett Scientific Ltd., Devon, UK 
Clifton Duo Water Bath 
 
Bio-Rad, Hercules, CA, USA 
MJ-Mini gradient thermocycler. Mini-PROTEAN Tetra Cell system ( 4-gel system, 
which includes electrode assembly, Electrophoresis PowerPak
®
, companion running 
module, tank, lid with power cables, mini cell buffer dam, Transfer module) 
 
BioTEK, VT, USA 
Microplate Reader. 
 
Eppendorf, Cambridge, UK: 
Centrifuge5810R, Centrifuge 5430R. 
 
Flexcell International Corp, NC, USA 
Flexercell
®
 tension plus
™
 FX-4000T system. 
Global Medical Instrumentation Inc., MN, USA 
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Mikro 200R micro-centrifuge. 
 
Integrated BioDiagnostics (Ibidi), Martinsried, Germany 
Ibidi
®
 pump and flow system, Incubator. 
 
Labtech (East Sussex, UK) 
ADAM MC ™ Counter, Nikon® Eclipse TS100 phase-contrast microscope. 
 
Mason tech (Dublin, Ireland) 
Nanodrop 1000™ system 
 
Millipore, MA, USA 
Guava EasyCyte HT System. 
 
Nalgene, Rochester, NY, USA 
Cryo-freezing container. 
 
Olympus Inc., PA, USA 
Phase contrast microscope (Ck30). 
 
Roche Diagnostics, Basal, Switzerland 
xCELLigence
®
 system. 
 
Stuart Scientific Ltd, Staffordshire, UK 
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Vortex, Orbital Shakers (SSL1, SSM1), See-Saw Rocker, Block Heater, Rotator. 
 
Syngene, Cambridge, UK: 
G-Box fluorescence and chemi-luminescence gel documentation and analysis 
system. 
 
Taylor-Wharton, USA 
Liquid nitrogen cryo-freezer unit. 
 
Thermo Fisher Scientific, Leicestershire, UK 
Holten LaminAir laminar flow cabinet 
 
VWR International Ltd. (West Sussex, UK) 
Nalgene Mr Frosty
®
 Freezing Container for cryotubes, Haemocytometer 
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2.1.3 Preparation of stock solutions and buffers. 
 
2.1.3.1 Immuno-blotting. 
 
RIPA Cell Lysis Buffer Stock (1.28X) 
HEPES, pH7.5              64 mM 
NaCl                     192 mM 
Triton X-100              1.28% (v/v) 
Sodium Deoxycholate       0.64% (v/v) 
SDS                     0.128% (w/v) 
dH2O to final volume         500 ml 
 
 
RIPA Cell Lysis Buffer (1X) 
1.28X RIPA Stock           1X 
Sodium Fluoride           10 mM 
EDTA, pH8               0.5 mM 
Sodium Phosphate          10 mM 
Sodium Orthovanadate       1 mM 
Protease Inhibitors           1X 
 
 
Sample Solubilisation Buffer (4X) 
Tris-HCl, pH6.8            250 mM 
SDS                     8% (w/v) 
Glycerol                  40% (v/v) 
β-Mercaptoethanol          4% (v/v) 
Bromophenol Blue        0.008% (w/v) 
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Running Buffer (1X) 
Tris-HCl                  25 mM 
Glycine                  192 mM 
SDS                      0.1% 
 
 
Transfer Buffer (1X) 
Tris-HCl                  25 mM 
Glycine                  192 mM 
SDS                      0.1% 
Methanol                  20% 
 
 
TBS wash Buffer 
Tris-HCl, pH7.4                50 mM 
NaCl                        150 mM 
 
 
Coomassie Stain 
Coomassie Brilliant Blue R250    0.25 g 
Methanol:dH2O (1:1 v/v)         90 ml 
Glacial Acetic acid              10 ml 
(Filter the Coomassie stain using a 0.25 μm filter) 
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Coomassie Destain Solution 
Methanol : Acetic acid, mixed in a 50:50 ratio 
 
 
Stripping Buffer 
Tris-HCl, pH6.8              62.5 mM 
SDS                        2% (w/v) 
Β-Mercaptoethanol            100 mM 
 
 
 
2.1.3.2 Molecular Biology Buffers and Medium. 
 
SOC Media 
Tryptone                   2% (w/v) 
Yeast Extract               0.5% (w/v) 
NaCl                       10 mM 
KCl                        2.5 mM 
MgCl2                      10 mM 
MgSO4                     10 mM 
Glucose                     20 mM 
 
 
Luria-Bertani (L.B) Media 
Tryptone                  1% (w/v) 
Yeast Extract             0.5% (w/v) 
NaCl                      171 mM 
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Luria-Bertani (L.B) Agar (1L) 
Agar                         15 g 
Made up to 1L with L.B. media 
 
 
Antibiotics 
Antibiotic              Solvent        Final Concentration(μg/ml)      
Ampicillin              dH2O                100 
Kanamycin              dH2O                50 
Antibiotics dissolved with dH2O were sterilised using a 0.25 μm filter. 
 
 
DNA Loading Buffer 
Sucrose               40% (w/v) 
Bromophenol Blue     0.25% (w/v) 
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2.2 Methods 
2.2.1 Cell Culture Techniques 
 
2.2.1.1 Culture of human aortic endothelial cells (HAECs) 
 
HAECs were purchased from PromoCell GmbH (Heidelberg, Germany) and all 
HAEC culturing techniques were conducted in a highly clean and sterile 
environment using a Holten Lamin Air laminar flow cabinet.  Cells were visualized 
using a Nikon Eclipse TS100 phase-contrast microscope.  Cells were maintained in 
endothelial cell growth medium MV, supplemented with a separate 
SupplementMix
®
 of growth factors containing ECGS/H 0.4% (v/v), FBS 5.0% (v/v), 
EGF 10 ng/ml, hydrocortisone 1 μg/ml, 100 U/ml penicillin and 100 g/ml 
streptomycin.  Cells between passages 10-12 were used for experimental purposes 
and were maintained in a humidified atmosphere of 5% CO
2
/95% air at 37°C. 
 
 
2.2.1.2 Trypsinisation of cells 
 
As HAECs are a strongly adherent cell line, trypsinisation was required for the 
purposes of sub-culturing.  For trypsinisation, HAECs were passaged at 70-90% 
confluence.  In preparation, PBS trypsin and growth medium were warmed to 37°C 
in a water bath.  Growth medium was removed from culture dishes, and cells 
gently washed 2-3 times in sterile PBS to remove macroglobulin and other trypsin 
inhibitors present in the culture medium serum.  Approximately 100 µl of 
trypsin-EDTA (10% (v/v) in PBS) per cm
2
 of culture dish surface was subsequently 
added to the cells and incubated at 37°C for 5 min.  When approximately 50% of 
cells appeared loose, the cell culture dish was gently tapped on the side to remove 
cells from the culture surface.  Trypsinisation was inactivated upon addition of 
fresh growth medium containing FBS, and cells collected from suspension by 
centrifugation at 100x g for 5 minutes at room temperature.  Cells were 
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re-suspended in growth medium and counted using either a Neubauer chamber 
haemocytometer or ADAM MC™ cell counter.  Cells were typically split at a 1 in 
3 ratio.  
 
 
2.2.1.3 Cryogenic preservation and recovery of cells 
 
For long term storage, HAECs were maintained in a liquid nitrogen cryo-freezer unit 
(Taylor-Wharton, USA).  Following trypsinisation, HAECs were centrifuged at 
100x g for 5 minutes at room temperature and the supernatant removed. The cell 
pellet was re-suspended in 5.4 ml of freezing medium containing 20% (v/v) FBS, 
dimethylsulphoxide (DMSO) 10% (v/v) and 1% (v/v) penicillin/streptomycin.  1.8 
ml aliquots were transferred to sterile cryo-vials and frozen in a –80°C freezer at a 
rate of –1°C/minute using a Mr Freeze® cryo-freezing container.  Following 
overnight freezing at –80°C, cryo-vials were transferred to the cryo-freezer unit. 
 
For recovery of cells, cryo-vials were thawed rapidly in a 37°C water bath and 
added to a 58 cm
2
 cell culture dish containing 5 ml of pre-warmed (37°C) growth 
medium to dilute the DMSO.  After 24 hours incubation the medium was removed, 
cells were washed once in sterile PBS, and 7 ml of fresh growth medium added. 
 
 
2.2.1.4 Cell counting 
2.2.1.4.1 Haemocytometer 
 
For some experimental purposes and healthy cell growth, cells were seeded at 
precise numbers and densities.  This was achieved using a Neubauer chamber 
haemocytometer following trypan blue staining of which selectively color the dead 
cells. In preparation, approximately 20 µl of trypan blue was added to 100 µl of cell 
  
103 
 
suspension and 20 µl of this mixture loaded into the counting chamber of the 
haemocytometer.  Cells were visualized by phase contrast microscopy.  Viable 
cells excluded the dye, whilst dead cells stained blue due to compromised cell 
membranes.  Under a 10X objective lens, viable cells in the four squares (G1-G4) 
in each corner were counted (Fig 2.1).  Cells touching the top and right lines of a 
square were not counted, while cells on the bottom and left side were counted.  The 
number of cells was calculated using the following equation: 
 
 
 
 
 
Fig 2.1: Haemocytometer counting chambers. 
Under a 10X objective lens, viable cells in the four squares (G1-G4) in each corner of the counting 
chamber were counted.  Cells touching top and right lines of a square were not counted, while cells 
on the bottom and left side were counted.  This procedure prevented the accidental double-counting 
of cells (this figure is adapted from:  
 http://www.microbehunter.com/2010/06/27/the-hemocytometer-counting-chamber/). 
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2.2.1.4.2 ADAM MC™ Cell Counter 
 
Cell counts were also performed using an automated cell counter (ADAM MC™ 
cell counter, Digital Bio, Korea) (Fig 2.2), an instrument that utilizes fluorescent cell 
staining to determine total and viable cell count in a given sample. The ADAM 
MC™ unit contained fluorescence optics and image analysis software.  The optics 
obtained 40-60 fluorescent images, each read by moving automatic X and Y stages.  
Image analysis software then determined both total and viable cell numbers 
simultaneously.  The commercially supplied kit used two reaction reagents, 
solutions T and N.  Solution T stained both viable and non-viable cells while 
Solution N stained only viable cells. In brief, two 12 μl aliquots of a cell sample 
were taken; one aliquot was mixed with 12 μl of Solution N Accustain and the 
second with 12µl Solution T Accustain.  20 μl of each cell mixture was then loaded 
into the appropriately-labeled chamber in an AccuChip. The AccuChip was then 
loaded into the ADAMTM counter where 40-60 images were taken of the cell 
chambers and average cell number and viability calculated using the integrated 
image analysis software. 
 
 
Figure 2.2: (A) The ADAMTM counter and (B) loading of an AccuChip. 
To count cells, cell suspensions were mixed with both solutions at a 1:1 ratio and 20 µl of each 
mixture loaded into an AccuChip cell count chip.  Once inside the ADAMTM instrument, the chip 
was then processed, with the result displayed on the LCD screen (this figure is adapted from: 
http://www.labtech.ie/automated-cell-counter-stock-clearance). 
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2.2.2 Shear stress experiments 
 
2.2.2.1 Orbital rotation 
 
For laminar shear stress studies, orbital rotation was applied as per published 
protocol (Hendrickson, et al. 1999b).  HAECs were seeded into 6-well plates at a 
density of 10
5 
cells/cm
2 
for confluent studies and 10
4 
cells/cm
2
 for sub-confluent 
studies and then allowed to adhere for 24 hours. Culture medium was then removed, 
and 4 ml of fresh medium with growth serum was added.  HAECs were then 
sheared at 10 dyne/cm
2 
for 24 hours using an orbital rotator (Stuart Scientific Mini 
Orbital Shaker, Staffordshire, UK) set to the appropriate speed as determined by the 
following equation (Hendrickson, et al. 1999a). 
 
 
 
Where: 
α = radius of rotation (cm)          ρ = density of liquid (g/l)                        
n = 7.5 x 10-3 (dynes/cm2 at 37°C)               f = rotation per second 
 
Control plates containing un-sheared “static” endothelial cells were cultured in the same 
incubator, but on a different shelf to avoid vibrations caused by the orbital rotator. 
Following shearing experiments, cells were either: (i) harvested for Real-Time PCR 
measurement of mRNA expression levels; (ii) harvested for Western blotting to 
determine protein expression levels; (iii) transplanted either into 96 wells cell culture 
plate, or E-plates for adhesion assay; or into CIM-plates for migration assay.  
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Fig. 2.3: Illustration of the orbital shaker and its operation during shear stress 
studies 
 
 
2.2.2.2 Ibidi
®
 (Integrated BioDiagnostics) flow system 
 
The Ibidi
®
 pump system is a perfused flow system used to expose ECs to precisely 
controlled continuously shear stress on Ibidi
®
 μ-slides.  This allows either harvest 
of cells for Real-Time PCR measurement of mRNA expression levels experiments 
or fixation for immunocytochemical staining under flow conditions.  The system 
was microscope-friendly allowing for live imaging.  There are two forms of 
μ-slides: Y-shaped which can be used for disturbed shear stress study and straight 
shaped μ-slides which can be used for laminar shear stress study. For cell seeding, 
slides, tubes and medium were equilibrated overnight at 37°C.  Meanwhile, 
HAECs were diluted to a density of 1x10
6 
cells/ml, with 200 μl of this dilution 
applied into the hollow chambers of each slide.  HAECs were permitted time to 
adhere and grow to confluency (normally takes 24 hours), before μ-slides were 
connected to the pump system via its luer connectors in accordance with 
manufacturer's instructions (Fig. 24.).  During this procedure, care was taken to 
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avoid the introduction of air bubbles into the system, which could have resulted in 
damage to seeded cells.  Cells were subsequently exposed to laminar shear stress at 
10 dyne/cm
2
 for 24 hours. Control slides containing un-sheared “static” endothelial 
cells were cultured in the same incubator.  Following experiments, both sheared 
and static slides were fixed and ready for immunocytochemical staining. 
 
 
 
Fig.2.4: Ibidi
®
 flow system used in laminar shear studies.  
A) Ibidi
®
 pressure pump connected to Ibidi
®
 flow unit and Y-shaped slide. 
B) Illustration of Y-shaped and straight Ibidi
®
 µ-slides, which allow different forms of shear stress to 
be investigated (http://www.biophysics.com/ibidi/Instruments/ibidiPUMP.html).  
 
 
2.2.2.3. Cyclic Strain 
 
For cyclic strain studies, HAECs were seeded into 6-well Bioflex plates (Dunn 
Labbortechnik GmBH – Asbach, Germany) at a density of 105 cells/cm2. Bioflex™ 
plates contained a pronectin-coated silicon membrane bottom which enabled precise 
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deformation of cultured cells by a microprocessor-controlled vacuum.  Once 
seeded, cells were then allowed to adhere and grow to confluence over a 24 hours 
period. Following this incubation period, Culture medium was removed, and 2 ml of 
fresh medium added to each well.  A Flexercell Tension Plus
™
 FX-4000T
™
 system 
(Flexcell International Corp., Hillsborough, NC) (Figure 2.5) was used to apply 
different cyclic strain regimen to each plate (0%, 5% and 10% strain, 60 
cycles/minute). Strain was applied for 24 hours.  Cyclic strain is described as the 
circumferential force/wall tension generated by blood pressure causing a physical 
stretch in the vessel wall. The relationship between cyclic strain and vessel 
simension can be defined by Laplace’s Law (Laplace, 1899).  
 
T=Pr/h 
 
  
Where: T = wall tension (force per unit length of the vessel),  P = blood pressure,   
r = vessel radius and h = thickness of the vascular wall. In this thesis 5% cyclic 
strain is defined as physiological condition while 10% is defined as pathological 
condition.  
 
Cells were also acutely stretched to 20% and induced at 1 minute, 5 minutes and 10 
minutes intervals. Following strain experiments, cells were either: (i) harvested for 
Real-Time PCR measurement of mRNA expression levels; (ii) harvested for Western 
blotting to determine protein expression levels; (iii) transplanted either into 96 well 
cell culture plates, or E-plates for adhesion assays; or into CIM-plates for migration 
assays. 
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Figure 2.5: Illustration of the computer-controlled Flexercell Tension Plus™ 
FX-4000T™ system apparatus, and its mechanism of operation in vascular cyclic 
strain simulation (this figure is adapted from:  
http://webpages.dcu.ie/~vhrc/Novel_Technologies.htm). 
 
 
2.2.3 Immunodetection techniques 
 
2.2.3.1 Western blotting studies 
 
2.2.3.1.1 Preparation of whole cell lysates 
 
To prepare cell lysate for Western blotting, cells were harvested at 4°C; culture 
medium removed and cells gently washed three times in ice-cold PBS solution.  
Following complete aspiration of PBS, 50 µl of 1X radioimmunoprecipitation assay 
(RIPA) lysis buffer (20 mM Tris, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 
1% Triton X-100 (v/v), 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 
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1 mM sodium orthovanadate, 1µg/ml leupeptin) was added into each well of the 
6-well cell culture plate, then harvested using a cell scraper.  Lysate was transferred 
into an eppendorf tube and rotated at 4°C for 30-40 minutes.  After 30-40 minutes 
rotation, lysate was centrifuged at 10,000 rpm for 20 minutes at 4°C. Cell lysate 
samples were either stored at -80°C for later analysis, or used immediately in a 
Bicinchoninic acid (BCA) assay or Western blot. 
 
 
2.2.3.1.2 Bicinchoninic acid (BCA) protein microassay 
 
The BCA assay (also known as the Smith assay) is a biochemical assay used to 
determine total protein concentration in a solution.  The assay relies on two 
reactions; firstly, peptide bonds in protein reduce Cooper (Cu
2+
) ions to Cu
1+ 
which, 
in turn, reacts with bicinchoninic acid to form a complex (purple) which strongly 
absorbs light at 562 nm.  Two separate reagents were supplied in this commercially 
available assay kit (Pierce Chemicals, Cheshire, UK); (A) alkaline bicarbonate 
solution and (B) copper sulphate solution.  Reagent solution was freshly prepared 
as follows; solution B was mixed into solution A at a ratio of 1:50, with 200 µl of 
this mixture added to 10 µl of protein lysate and BSA standards (standard curve in 
the range 0-2 mg/ml) in a 96-well plate.  Each protein lysate sample and BSA 
standard were assayed in triplicate. Following 30minutes incubation at 37°C, 
absorbance was read at 560 nm using an ELx800 microplate reader (BioTek, VT, 
USA). 
 
 
2.2.3.1.3 SDS-polyacrylamide gel electrophoresis of proteins 
 
SDS-polyacrylamide gel electrophoresis (PAGE) is a technique used to separate 
proteins based on their charge. 10% (v/v) acrylamide resolving gels and 4% (v/v) 
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stacking polyacrylamide gels were used throughout all experiments.  Individual 
volumes of each component required to make gel is shown in the following tables: 
 
 
Table 2.1: 10% SDS-PAGE resolving gel and (4%) SDS-PAGE Stacking gel 
composition 
 
        (10%) SDS-PAGE resolving gel                   
Distilled H2O 4.00 ml 
1.5 M Tris-HCl, pH 8.8  2.50 ml 
Acrylamide/Bis-acrylamide (30%) 3.33 ml 
10% SDS 100 µl 
10% Ammonium persulfate 50 µl 
TEMED 5 µl 
Total volume 10 ml 
 
 
 
         (4%) SDS-PAGE Stacking gel  
Distilled H2O 6.10 ml 
1.5 M Tris-HCl, pH 6.8 2.5 ml 
Acrylamide/Bis-acrylamide (30%) 1.30 ml 
10% SDS 100 µl 
10% Ammonium persulfate 100 µl 
TEMED 10 µl 
Total volume 10 ml 
 
Approximately 6-8 ml of resolving gel mixture was poured gently between two glass 
plates, with care taken to avoid bubbles. 1 ml of 70% (v/v) ethanol was then poured 
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on top (forming alayer) to remove any surface air bubbles and to give an even, 
isolated surface to the gel.  Following 30-45 minute incubation at room 
temperature, ethanol was poured off and the top of the resolving gel carefully 
washed using tap-water to remove all remaining ethanol traces.  The space between 
plates was then dried using filter paper.  Approximately 1-2 ml of 4% stacking gel 
mixture was then added on top of the acrylamide stacking gel and the comb 
carefully inserted.  Stacking gel was allowed to polymerise for 15 minutes at room 
temperature. 
 
Protein samples were prepared as follows; 4X sample buffer  (8% SDS (w/v), 
20%-mercaptoethanol (v/v), 40% glycerol (v/v), Brilliant Blue R in 0.32 M Tris pH 
6.8) was added to the appropriate quantity of protein samples (the ratio was 
determined by BCA assay).  Protein mixtures were boiled at 95°C for 5 minutes to 
denature.  Prior to loading, samples were placed on ice for 5 minutes 20 µl samples 
were loaded into appropriate lanes along with 3 μl of PageRuler™ Plus Pre-stained 
Protein Ladder (Fermantas).  Protein ladder and samples were electrophoretically 
separated for 120 minutes at 100V. 
 
2.2.3.1.4 Electrotransfer  
 
To transfer proteins from gel to a membrane, a Mini PROTEAN
®
 Trans Blot Module 
(BioRad, CA, USA) was employed. Following SDS-PAGE electrophoresis, gels 
were removed from glass plates and the stacking gel discarded. The resolved gel, 
membrane and filter paper were then soaked for 10 minutes in ice-cold transfer 
buffer (25 mM Tris, 192 mM Glycine, 20% methanol) to remove any SDS 
complexes bound to the gel. Following gel and membrane pre-soakings, the transfer 
cassette was assembled and sealed tightly, avoiding any air bubbles (as shown in 
Figure 2.6 below): 
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Figure 2.6: Wet transfer cassette assembly 
The cassette was inserted into the Trans Blot Module with the black side facing to the same colour.  
Proteins were transferred at 100 V for 2 hours or overnight at 4°C in a cold room at 50V while 
stirring.  
 
 
2.2.3.1.5 Ponceau S staining 
 
Ponceau S solution (Sigma-Aldrich, Dorset, UK) was used to visually confirm 
transfer of protein to membrane. In brief, mitrocellulose membrane was soaked in 20 
ml Ponceau S solution and incubated for 3 minutes with constant agitation.  The 
membrane was then visualised using G-box analysis and washed with PBS several 
times until the red stain was completely removed.  
 
2.2.3.1.6 Immunoblotting and chemiluminescence band detection 
 
Following protein transfer, membranes probed phos-Merlin protein were blocked for 
60 minutes at room temperature or overnight at 4°C in blocking solution (5% (w/v) 
BSA in Tris Buffered Saline (TBS), 10 mM Tris pH 8.0, 150 mM NaCl).  
Membranes probed Merlin protein were blocked for 60 minutes at room temperature 
or overnight at 4°C in blocking solution (5% (w/v) Milk in Tris Buffered Saline 
  
114 
 
(TBS), 10 mM Tris pH 8.0, 150 mM NaCl). After blocking, membranes were 
incubated for 2 hours at room temperature or overnight at 4°C with primary antibody 
(Table 2.2) whilst rocking. 
 
Table 2.2:  Antibody dilutions for Western blot analysis. 
Primary 
Antibody 
Primary 
Dilution 
Secondary 
Antibody 
Secondary 
Dilution 
Merlin/NF2  
(Santa Cruz) 
1:500 
Goat 
(Cell Signalling) 
1:1000 
Phos-Merlin 
(Cell 
Signalling) 
1:1000 
Goat 
(Cell Signalling) 1:1000 
GAPDH 
(Santa Cruz) 
1:1000 
Goat 
(CellSignalling) 
1: 3000 
 
Following primary incubation, membranes were washed 3 times for 5 minutes in 
wash buffer (0. 1% Tween-TBS). Membranes were subsequently incubated with 
appropriate horseradish peroxidase (HRP) conjugated secondary antibody in TBST 
(1% BSA (w/v)) for 1 hour with gentle rocking at room temperature.  Membranes 
were washed an additional three times using the same conditions as described above. 
 
Supersignal
®
 West Pico (Pierce, Cheshire, UK) was used to detect HRP-conjugated 
secondary antibodies.  The membrane was incubated with 0.5-1 ml of West Pico 
for 3-5 minutes, where upon completion of the incubation, excess substrate was 
removed and chemilluminescent signal were detected by G-Box fluorescence and 
chemi-luminescence gel documentation and analysis system (Syngene, Cambridge, 
UK).  The results were then saved as jpg format pictures which can be further 
analyzed by imagine J software for band intensity change.   
 
 
  
115 
 
 
2.2.3.1.7 Coomassie gel staining 
 
 
To visualize protein bands on SDS-PAGE gels, Coomassie gel staining was used.  
This is a useful technique used to ensure that transfer was executed as expected.  
The technique includes two steps; firstly, SDS-PAGE gel was immersed with filtered 
(0.25 μm) coomassie solution whilst rocking for approximately 4 hours.  The gel 
was then de-stained with methanol:acetic acid (50:50) solution until the protein 
bands were distinctly clear from background.  De-stain solution required frequent 
changing. 
 
 
 
2.2.4. Immunocytochemistry 
 
 
In order to determine the localization of Merlin and its association with actin, 
HAECs were prepared for immunocytochemical analysis on Ibidi
®
 y-shaped slides 
(Ibidi
®
, Germany). HAECs were washed 3 times in PBS and fixed with 3% (v/v) 
formaldehyde for 15 minutes. Permeabilised cells were subsequently washed in PBS 
3 times; with 0.2% (v/v) Triton X-100 for 15 minutes, following which, cells were 
again washed 3 times.  Cells were blocked for 30 minutes in PBS containing 5% 
(w/v) BSA solution.  After blocking, cells were incubated with primary Merlin 
antibody (Santa Cruz, USA) diluted 1:50 in the blocking buffer for 2 hours at room 
temperature whilst rocking.  This was followed by 3 washes in PBS and 1 hour 
incubation with 1:00 Alexa Fluor 488 anti-Rabbit secondary antibody.  Again, cells 
were washed 3 times in PBS, after which, nuclear DAPI staining was performed by 
incubating cells with 500 ng/ml DAPI for 3 minutes. HAECs were also co-stained 
with F-actin by adding 1 in 40 diluted Rhodamine Phalliodin (Invetrogen) for 20 
minutes.  Samples were then washed for a final time and were visualised by 
standard fluorescent microscopy (Nikon Eclipse Ti, Tokyo, Japan). 
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2.2.5 mRNA preparation and analysis 
 
 
2.2.5.1 RNA preparation 
 
Total RNA isolation was carried out using the Trizol
®
 method, developed by 
Chomczynski and Sacchi (Chomczynski and Sacchi 1987). Following 
haemodynamic stimulus, cells were lysed directly in culture plates by addition of 1 
ml of Trizol
®
 per 10 cm
2
.  Total RNA was harvested by physical removal from the 
plate using a cell scraper. Samples were then incubated for 5 minutes at room 
temperature to allow complete dissociation of nucleoprotein complexes.  Following 
incubation, 0.2 ml of chloroform was added per 1 ml of Trizol
®
 reagent used, shaken 
vigorously for 15 seconds and then centrifuged at 7,000 x g for 15 minutes at 4°C.  
The clear top layer containing RNA was carefully collected and transferred to a fresh, 
sterile tube.  RNA was then precipitated out of solution by addition of 0.5 ml 
isopropanol per 1 ml Trizol
®
 used.  Samples were inverted 5-8 times and incubated 
for 10 minutes at room temperature and centrifuged at 7,000 x g for 10 minutes at 
4°C.  Supernatant was carefully removed and pellet washed with 1 ml 75% ethanol 
per 1 ml of Trizol
®
 used.  Upon completion of centrifugation at 7,000 x g for 5 
minutes at 4°C, the resultant pellet was air-dried for 5-10 minutes, before being 
re-suspended in DEPC-treated water.  This was then incubated for 10 minutes at 
60°C. Following examination of RNA concentration by NanoDrop
®
, samples were 
stored at –80°C. 
 
 
 
2.2.5.2 NanoDrop
®
 ND-1000 Spectrophotometer 
 
 
To determine the amount of total RNA in each sample, a NanoDrop
®
 ND-1000 
Spectrophotometer (Thermo Scientific) was used.  After the instrument was 
blanked with RNase-free water, an undiluted 1.2 μl sample was pipetted onto the end 
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of a fiber optic cable (Receiving fibre).  (The gap is computer-controlled to both 1 
mm and 0.2 mm paths).  Samples were read at wavelengths of 260 nm and 280 nm 
and analysed by determining the ratio between the two (ABS 260/ABS 280).  A 
ratio of 1.9 to 2.0 was regarded as highly purified RNA.  Purification of RNA 
samples was achieved using a DNase treatment kit (Sigma-Aldrich, Dorset, UK). 
 
 
 
2.2.5.3 Reverse transcription Polymerase Chain Reaction (RT-PCR) 
 
 
To reverse transcribe mRNA into cDNA, a high capacity cDNA reverse transcription 
kit (Applied Biosystems, CA, USA) was used.  The volume of each component is 
shown below (20 μl was required for each reaction): 
 
RT Buffer (10X)               2 μl 
dNTP mix (100 mM)                 0.8 μl 
Random Primers (10X)        2 μl 
MultiScribe Reverse Transcriptase    1 μl 
Nuclease-free H2O                  4.2 μl 
 
 
Reagents were mixed with 1000 ng RNA, and were diluted in 10 µl nuclease-free 
water.  Samples were then transferred into 0.2 ml PCR tubes and placed into a 
desktop PCR instrument and run at 25°C for 10 minutes, 37°C for 120 minutes and 
finally 85°C for 5 minutes.  Total concentration of cDNA product was measured by 
NanoDrop
®
. 
 
 
2.2.5.4 Design of PCR primer set 
 
Merlin/NF2 DNA primers were designed using the online software programme, 
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Primer3 (http://frodo.wi.mit.edu/).  Briefly, the full sequence of Merlin/NF2 on 
NCBI/BLAST website was chosen.  From this sequence, highly conserved areas 
were copied to Primer3.  The primers were designed using this software.  Primers 
which contained 50% GC content or higher and an annealing temperature between 
55-60°C were then chosen.  House-keeping genes used were 18s (purchased from 
Ambion). The primer sequences, lengths and annealing temperatures are shown in 
the table below: 
 
 
 
Table 2.3:  Primer sequences, product size and annealing temperature used for 
PCR and qPCR 
 
Gene Primer Sequence (5’….3’) 
Product 
Length 
(bp) 
Annealing 
Temperature 
(°C) 
Merlin 
Forward 
ACC GTT GCC TCC 
TGA CAT AC 
234 
59.4 
Reverse 
TCG GAG TTC TCA 
TTG TGC AG 
57.3 
     
18s 
Forward 
CAG CCA CCC GAG 
ATT GAG CA 
324 
60.0 
Reverse 
TAG TAG CGA CGG 
GCG GTG TG 
60.0 
 
 
 
2.2.5.5 Polymerase chain reaction (PCR) 
 
 
Desktop PCR was used to check if newly designed primers were operational before 
use on Quantitative real-time polymerase chain reaction (QRT-PCR).  Each PCR 
reaction required 25 µl of total final volume, with mixtures prepared as follows: 
 
Forward primer (10 µM)------------------------------1-µl 
 
Reverse primer (10 µM)-------------------------------1-µl 
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cDNA sample--------------------------------------------1-μl 
 
Reaction buffer (10X)--------------------------------2.5-µl 
 
dNTP (10 mM)------------------------------------------2-µl   
 
MgCl2 (25 mM)---------------------------------------1.5-µl 
 
Taq Polymerase---------------------------------------0.25-µl 
 
RNase free water------------------------------------15.75-µl 
This mixture was then placed into an MJ Mini thermal cycler with hot-lid (Bio-Rad, 
CA, USA). Samples were then subjected to the following cycling conditions: 
 
Table 2.4:  Desktop PCR cycling conditions 
Steps  Temperature (°C) Time 
Denaturation  95 5 minutes 
Cycling Denaturation 95 15 seconds 
 Annealing 55-60 30 seconds 
(40 cycles) 
 Extension 72 15 seconds 
 Extension 72 5 minutes 
 Hold 4 Infinite 
 
PCR products were examined by agarose gel electrophoresis, described below. 
 
 
 
 
2.2.5.6 Quantitative real-time polymerase chain reaction (qPCR) 
 
 
Newly designed primers could be used in qPCR after they were optimized.  
Quantitative PCR is a technique used to amplify and simultaneously quantify a 
targeted DNA sequence.  This technique follows the general principle of RT-PCR, 
with amplified DNA quantified in real-time as it accumulates during the reaction.  
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This quantification was facilitated using SYBR Green, a dye that fluoresces only 
when bound to double strand DNA.  Therefore, an increase in DNA product during 
PCR leads to a quantifiable increase in fluorescence intensity. Quantitative PCR is 
more precise and accurate then desktop PCR as the amplification fluorescence is 
read at the end of every cycle, and the amount of cDNA product formed during the 
PCR cycles can be quantified in real time and graphed.  
Quantitative PCR was carried out using an Applied Biosystems 7900HT Fast 
real-time PCR instrument.  Each reaction was set up in triplicate as follows: 
 
Table 2.5:  Components of Quantitative real-time polymerase chain reaction 
(qPCR) 
Component Volume (µl) Final concentration 
Forward primer 1.0 300 nM 
Reverse primer 1.0 300 nM 
cDNA 2.0 10 ng 
SYBR Green 12.5 1X 
RNase-free water 8.5  
Fianl volume 25.0  
 
Samples were subjected to an initial denaturation step of 95°C for 10 minutes, 
followed by 40 cycles at 95°C for 15 seconds and a primer-specific temperature of 
between 55-60°C for 1 minute. 
 
 
 
2.2.5.7 Agarose gel electrophoresis 
 
 
All DNA gel electrophoresis was carried out using GibcoBRL Horizon 20.25 Gel 
Electrophoresis Apparatus in accordance with the manufacturer’s instructions.  
Briefly, agarose gels were prepared by boiling 1 g of agarose in 100 ml of 1X TAE 
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buffer (40 mM Tris-Acetate pH 8.2, 1 mM EDTA) using a microwave oven (700 
mHz) at full power for 5 minutes to make a 1% gel.  Following sufficient cooling 
(to approximately 60°C), 10 µl of SYBR Safe (Invitrogen, The Netherlands) was 
added to the gel, mixed by swirling and poured into a casting rig.  A comb was then 
inserted in order to form wells.  The gel was allowed to cool and polymerise before 
filling the chamber with 1X TAE and comb removal. 
 
As the 10X buffer in the RT-PCR reaction already contained a loading and tracking 
dye, 15 µl of PCR product was loaded directly into the wells of the gel. A 1 Kb DNA 
ladder was also added to one well as a molecular weight marker for reference.  The 
gel was run at constant voltage (5 V/cm, usually 100 V), for 1 to 2 hours.  Samples 
were then visualized using the transilluminator settings on GBOX (Syngene, UK). 
Images were saved for later densitometric analysis. 
 
 
 
2.2.6 Transfection methods 
 
For the purposes of experiments involving siRNA, the predesigned and validated 
Melin (NF2) siRNA (Cat: s194647) and Moesin siRNA (Cat: s8984) were purchased 
form Ambion USA, while the scambled control siRNA is commercially available 
from Applied Biosystems, USA.  
 
 
2.2.6.1 TransIT-siQUEST
®
 transfection reagent 
 
 
TransIT-siQUEST
®
 (Mirus) is a highly efficient transfection reagent which allows 
siRNA delivery into cells and knock-down of the target gene.  Transfection was 
performed following manufacturer’s instructions. 
 
HAECs were seeded in 6-well plates prior to transfection, and allowed sufficient 
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time to adhere, and come to 60-80% confluency.  Once achieved, both full growth 
and serum-free medium were warmed to 37°C and TransIT-siQUEST
®
 warmed to 
room temperature. 250 µl of the pre-warmed serum-free medium was then added 
into a sterile 1.5 ml micro-centrifuge tube. 7 μl of TransIT-siQUEST® reagent and 
the required concentration of siRNA were added to the medium and gently mixed by 
pipetting up and down.  This mixture was incubated at room temperature for 20 
minutes.  Meanwhile, fresh medium was added to cells (2 ml per well) and up to 
the completion of incubation, transfection suspension was added to each well.  
Cells were placed into a 37°C incubator for 48 hours, with experiments carried out 
after this time. 
 
 
 
2.2.6.2 Microporation 
 
Microporation is an efficient technique for facilitating transfection, creating 
effective channels which allow delivery of numerous nucleic acid types (cDNAs, 
siRNAs e.g.) into mammalian cells.  The microporator unit consisted of a control 
unit and gold-tip electroporation chamber which allowed generation of a uniform 
electric field, with minimal heat generation, metal ion dissolution, pH variation and 
oxide formation (consistent difficulties encountered with conventional 
electrophoration protocols). Microporation was carried out using a microporation 
solution kit in accordance with the manufacturer’s instructions. 
 
The HAECs were centrifuged at 100 g for 2 minutes at room temperature following 
washing and trypsinising steps.  The remaining pellet was washed using PBS 
(Mg2+, Ca2+ free).  Cells were then counted, re-suspended and divided into 
aliquots containing a final density of 500,000 cells/100 μl.  Aliquots of cell 
suspension were centrifuged at 100 g for 5 minutes at room temperature.  The 
appropriate number of wells in a 6-well plate was prepared by pre-incubating 2 ml 
of culture media, containing serum without antibiotics, in a humidified 37°C/5% 
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CO
2
 tissue culture incubator. Aliquoted cell pellets were re-suspended in 110 
μl/transfection of Buffer R.  Re-suspended cells were transferred to a 1.5 ml 
eppendorf tube and 1-100 nM siRNA/500,000 cells were added.  Upon addition of 
3 ml Buffer E, the microporation tube was inserted into the pipette station to form 
the microporation unit (Labtech, East Sussex, UK) (Figure 2.9).  The suspension 
was then pipetted into a 100 μl gold-tip using the microporator pipette.  Desired 
pulse conditions were set; 1000 V, 30 pulse width (ms) and 3 pulse number.  
Following microporation, each 100 μl sample was transferred to an individual well 
of the 6-well plate, each containing 2 ml pre-incubated culture medium.  Cells were 
allowed to recover overnight, after which period, the culture medium was changed. 
 
 
 
Figure 2.9: Microporator apparatus 
A) The base unit generates electrical parameters necessary for transfection of DNA and siRNA into 
cells. 
B) The apparatus utilises a tube (containing the electroporation buffer) and custom pipette used to 
deliver the electroporation parameters to the cells suspended within a gold-plated pipette tip. 
C) The microporation kit containing the necessary microporation solutions, tips and microporation 
tubes. (www.microporator.com)  
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2.2.7 Migration and Adhesion Assay 
2.2.7.1 Cell-Matrix Adhesion 
 
2.2.7.1.1 Coating Cell Adhesion Plates 
 
 
To investigate cell-matrix adhesion, 96-well plates were coated with either 
extracellular matrix (ECM) of fibronectin, vitronectin, laminin and fibrinogen.  The 
matrices were made up to a concentration of 10 μg/ml with Ca2+ and Mg2+ free PBS 
and sterilised by filtration (0.25μm).  Briefly, following washing and moistening by 
addition of 100 µl PBS, 100 μl of the appropriate matrix was added to wells of the 
96-well plate ensuring the well surface was fully covered with no air bubbles present.  
The plate was then incubated overnight at 4
o
C.  The following day, 5% BSA was 
freshly prepared using PBS, denaturation by boiling at 60
o
C for 30 minutes, and 
filtration (0.25 μm) to remove insoluble material.  The matrix was then carefully 
aspirated and the wells washed twice with 200 μl PBS before the addition of 500 μl 
BSA to each well, ensuring no air bubbles were present.  The wells were then 
incubated for 1 hour at room temperature, or overnight at 4
o
C. 
 
 
2.2.7.1.2 Cell Adhesion Protocol. 
 
 
Adhesion assay preparation required pre-coating of 96-well plates, with an 
additional wash using 200 μl PBS.  Serum-starved HAECs were washed with 5 ml 
PBS and detached using 1 ml of versene (Invitrogen) at 37 
o
C.  The versene 
reaction was halted by the addition of 3 ml full culture media.  Cells were then 
counted and re-suspended at a density of 300,000 cells/ml in serum-free media.  
Cells were then allowed to recover by incubation at 37
o
C for 30 minutes. 100 µl of 
cells were plated onto the appropriate matrix after incubation, and allowed to adhere 
for 0-90 minutes at 37
o
C.  At the end of each time point, unattached cells were 
removed by aspiration and adhered cells washed twice with 200 μl PBS and fixed 
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with 3.75% (v/v) paraformaldehyde in PBS for 15 minutes at room temperature.  
The fixed cells were then rinsed twice with PBS and stained with 0.5% (w/v) crystal 
violet in 20% methanol for 10 minutes at room temperature.  Once stained, wells 
were washed three times with 500 μl PBS. Crystal violet was then released by 
addition of 50 µl 2% SDS for 30 minutes at room temperature whilst rocking.  The 
absorbance of each well was measured using a spectrophotometer at 562 nm.  
Samples were run in triplicate, and background staining measured by plating no 
cells and continuing the protocol as normal. 
 
 
2.2.7.2 xCELLigence
®
 adhesion assay 
 
The xCELLigence
®
 system (Roche, Basal, Switzerland) is a novel system that 
allows monitoring of cell migration, adhesion and proliferation in real time without 
any labeling (Figure2.7).  The system measures electrical impedance across 
micro-electrodes integrated on the bottom of tissue culture E-Plates. The attachment 
of the cells with the electrodes affects the local ionic environment at the 
electrode/solution interface, leading to an increase in the electrode impedance. The 
more cells present the higher increases in electrode impedance. Briefly, for Merlin 
knock-down adhesion assays, each 16-well E-plate was pre-coated with fibronectin, 
fibrinogen, laminin and vitronectin at a concentration of 10 µg/ml (plate coating 
procedures as described on 2.2.7.3.1); while for adhesion studies, plain 16-well 
E-plates were used. 100 µl of medium was added into each well to wet the surface 
and the plate allowed incubating for 30 minutes at room temperature.  During this 
time, cells were trypsinised and counted. Upon completion of incubation, E-plate 
background was scanned and 30,000 cells per condition were then added per well in 
a 16-well E-Plate.  This was then incubated for another 30 minutes at room 
temperature.  Initial adhesion of cells was then measured at 5 minutes intervals 
from 0-24 hours.  
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2.2.7.3 xCELLigence
®
 migration assay 
 
For migration assays, CIM-plates were disassembled according the manufacturer’s 
instructions.  160 µl of serum-free medium was added into the lower chamber, and 
the upper chamber then placed onto it.  Another 50 µl of serum-free medium was 
added into each well ensuring the surface of the well was fully covered and no air 
bubbles were present.  The plate was then allowed to incubate for 30 minutes. 
Meanwhile, cells were trypsinised and counted.  Upon completion of incubation, 
the CIM-plate background was scanned. 30,000 cells per condition were then added 
per well into the upper chamber of CIM-Plate.  The CIM-plate was then incubated 
for another 30 minutes at room temperature. Initial migration of cells was then 
measured at 5 minute intervals from 0-24 hour. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.7  xCELLigence
®
 system 
The xCELLigence
®
 system (Roche, Basal, Switzerland) is a novel system that allows monitoring of 
cell migration, adhesion and proliferation in real time without any labeling  
A)  xCELLigence
®
 system used for cell adhesion and migration assays. 
B)  CIM- plate for migration assay. 
C)  E-plate for adhesion and proliferation assay. 
(ww.medgadget.com/2010/06/roche_xcelligence_system_reduces_the_need_for_animal_testing_lab_rats_rejoice.html) 
  
127 
 
2.2.8 Co-immunoprecipitation (Co-IP) 
 
2.2.8.1 Lysate Preparation  
 
CO-IP is a technique used to isolate target protein complexes out of solution using 
specific binding antibodies by means of precipitation or pull-out.  Complexes of 
target proteins were then examined by mass spectrometry to monitor possible 
binding partners.  Our studies focused on Merlin and were carried out using a 
Pierce CO-Immunoprecipitation kit (Thermo UK) in accordance with the 
manufacturer’s instructions.  To begin with, HAECs were washed once with 
ice-cold 1X Modified Dulbecco’s PBS and then lysed using ice-cold IP Lysis/Wash 
Buffer provided in the kit at a ratio of 500 μl per 10 cm2 growth areas.  The mixture 
was incubated on ice for 5 minutes, with periodic mixing.  Upon completion of 
incubation, lysate was transferred into a 1.5 ml eppendorf tube and centrifuged at 
13,000 × g for 10 minutes.  The clear supernatant was transferred into a new tube 
and stored at – 80oC for further analysis.  
 
 
 
2.2.8.2 Resin Preparation  
 
This process was used for coupling affinity-purified antibody to a coupling resin, 
allowing precipitation of the target protein out of lysate.  To begin with, the 
AminoLink Plus Coupling Resin and reagents were equilibrated to room 
temperature, with 50 µl of the resin slurry added into a Pierce Spin Column.  This 
was then placed into a microcentrifuge tube and centrifuged at 1000 g for 1 minute.  
Following two washes (200μL of 1X coupling buffer), centrifugation and discarding 
of flow-through, approximately 20 μg of affinity-purified Merlin antibody diluted in 
200 µl of 1X coupling buffer was added directly onto the resin in the spin column.  
In a fume hood, 3μl of the Sodium Cyanoborohydride Solution was added for every 
200 μl of reaction volume.  The screw cap was attached to the column and 
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incubated on a rotator or mixer at room temperature for 90-120 minutes, ensuring 
that the slurry remained suspended during incubation.  The Merlin-antibody 
coupled resin was again washed twice using 200 μl of 1X coupling buffer following 
incubation.  Following two more washes using 200 μl of quenching buffer, 3μl of 
Sodium Cyanoborohydride Solution was added in a fume hood and incubated for 15 
minutes with end-over-end mixing.  The resin was then washed twice with 200 μl 
of 1X coupling buffer and followed by six more washes with 150 μl of wash 
solution. At this piont, the resin was ready to proceed with CO-IP step or it could be 
washed twice with 200 μl of 1X coupling buffer and filled with 200 μl of 1X 
coupling buffer for short term storage at 4°C.  For long-term storage, sodium azide 
was added to obtain a final concentration of 0.02%. For control studies, the resin 
was coupled with 80 μl control quenching buffer or using the control resin which 
was supplied within the kit.  
 
 
2.2.8.3 Protein precipitation  
 
Protein precipitation steps were performed at 4°C unless otherwise indicated.  
Following preparation of whole-cell lysate as described in section above, briefly, 
lysate containing 200 µg of protein was pre-cleared using the control agarose resin 
slurry coupled resin in accordance with the manufacturer’s introductions.  
Pre-cleared protein mixture was diluted in IP lysis/wash buffer to make a final 
concentration of 200 µg/500 μl.  Prior to adding the protein mixture, resins were 
washed twice by adding 200 μl of IP lysis/wash buffer.  Resin that contained 
protein mixture was incubated with gentle mixing overnight at 4ºC.  The following 
day, resins were washed three times with 200 μl of IP lysis/wash buffer.  The 
CO-IP samples were eluted by the addition of 10 μl elution buffer.  Samples were 
stored at - 80ºC for further Mass spectrometric analysis or subsequent Western blot 
analysis.  
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2.2.9 Transformations 
 
 
2.2.9.1 Transformation of competent cells 
 
Transformation is a technique that allows introduction of foreign cDNA into 
competent cells by combining it into a plasmid vector used to facilitate rapid 
replication and subsequent purification of high quantities of the plasmid DNA.  
The Merlin-GFP plasmid was purchased from Origen and DH5α competent cells 
purchased from Invitrogen.  The transformation protocol was carried out in the 
following manner: 
 
Approximately 50 ng of purified DNA plasmid was added to 50 μl of competent 
bacterial cells.  This DNA-bacterial mix was incubated on ice for 30 minutes. 
Competent cells were then heat shocked by incubation at 42
o
C for 30 seconds, 
followed by subsequent incubation on ice for 2 minutes.  Following this step, 500 
μl of room temperature SOC media which contains 20% tryptone, 5% yeast extract, 
0.5% NaCl, 1% 0.25M KCl, 2% 1 M glucose was added and cells were incubated 
once again for 30 minutes at 37
o
C while shaking at 150 rpm.  Transformant cells 
were spread on two L.B. agar plates containing the appropriate selective antibiotic in 
volumes of 50 μl and 500 μl.  Spread plates were then inverted and incubated at 
37
o
C overnight, with transformed colonies selected the next day.  Non-transformed 
competent cells were also plated out as a negative control. Only transformed 
colonies contained the selective antibiotic resistance gene, and therefore were able to 
grow on the selective antibiotic -containing agar plates.  A single colony, therefore, 
was transferred to a 50 ml sterile tube containing 5 ml of LB broth (1% tryptone, 
0.5% yeast extract, 1.0% NaCl).  This primary culture was then incubated at 37
o
C 
with agitation of 200 rpm for 8 hours. 400 µl of culture was transferred to a 250 ml 
sterile conical flask containing 50 ml broth and incubated overnight at 37
o
C with 
agitation of 200 rpm.  DNA mini-preparation was then carried out on this 
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secondary culture as described below.  The remainder of the 5 ml primary culture 
was used for glycerol stocks. 
 
2.2.9.2 Plasmid purification protocol 
 
Plasmid DNA was purified using the QIAGEN-tip HiSpeed
®
 system from Qiagen, 
according to the manufacturer’s instructions.  In brief, the bacterial cells were 
pelleted at 6000 x g for 15 minutes at 4
0
C and the supernatant discarded by inverting 
the tube.  The bacterial pellet was re-suspended by vortexing in 6 ml chilled P1 
buffer.  As recommended, 6 ml P2 buffer was then added to lyse re-suspended cells 
and this mixture was vigorously mixed by shaking for 30 seconds, and subsequently 
incubated at room temperature for 5 minutes.  A further 6 ml of chilled P3 buffer 
was added to neutralise the lysis activity of P2 and once again the tube was shaken 
vigorously for 30 seconds.  This cell lysate was poured into the barrel of a QIA 
midi-cartridge and incubated at room temperature for 10 minutes in order to allow 
settling of cell debris.  Using the QIA filter, cell lysate was filtered into a 
previously equilibrated hispeed midi-prep tip where the DNA was allowed to bind to 
the resin column.  Bacterial cell proteins were removed by washing the column 
with 20 ml of QC buffer.  The DNA was eluted from the column with 5 ml of QF 
buffer and precipitated by the addition of 3.5 ml room temperature isopropanol. The 
tube was gently mixed by inversion a few times.  DNA was allowed to precipitate 
at room temperature for 5 minutes.  The isopropanol mixture was then added to the 
QIA-precipitator and filtered through.  Plasmid bound to the precipitator was then 
washed with 2 ml, 70% (v/v) ethanol, air dried by flushing air through and eluted 
into a 1.5 ml micro-centrifuge tube by the addition of 700 μl sterile TE-buffer.  
Finally, eluted DNA was flushed through the precipitator once again to remove any 
unbound DNA and quantified by spectrometric analysis. 
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2.2.9.3 DNA Quantitation and Storage 
 
In order to determine the concentration of DNA in a sample obtained from the 
Qiagen plasmid midi kit, the sample was analyzed using a NanoDrop
®
 ND-1000 
Spectrophotometer (Thermo Scientific) using TE to blank the instrument.  Samples 
were read at wavelengths of 260 and 280 nm, and the concentration of the DNA 
calculated out as follows;  
 
 
 
 
 
DNA purity was determined by calculating the ratio of absorbance at 260 nm to 280 
nm, the value of which should be greater than 1.6.  All samples were tested in 
triplicate and kept on ice at all times during the experiment. DNA samples were then 
stored at −20oC for use in transient transfections. 
 
 
 
2.2.10. Treatment with Pharmacological inhibitors. 
 
 
RGD inhibitors allow elucidating the effect of vaiorus RGD peptides, each with 
specificity for different classes of integrins, on HAEC adhesion. RGD inhibitors 
were purchased from Bachem Swizland; the details of each inhibitor are listed 
below:  
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Table 2.6 The details of RGD inhibitors 
 Sequences Targets References 
RGD1 
(H7630) 
H-Gly-Arg-Gly-Asp-Ser-P
ro-OH 
FN 
 and VN 
R.Pytela et al, 1986.  
M.Leptin,1986. 
F.D.Yelian et al, 1993. 
RGD2 
(H3164) 
H-Gly-Arg-Gly-Asp-D-Ser
-Pro-OH 
FN J.V.Jester et al, 1999. 
M.H.Wu et al, 2001. 
GRD3 
(H3964) 
H-Gly-Pen-Gly-Arg-Gly-A
sp-Ser-Pro-Cys-Ala-OH 
VN J.E.Mogford et al, 1996. 
K.J.Bayless et al, 2000. 
 
 
D2A and SRSRY peptides allow us investigate the interacting partner of urokinase 
receptor. D2A was first synthesized by Bernard Degryse and his collegues (Bernard 
Degryse, et al 2005). Derived from the sequence of Domain 2, D2A peptides 
(H-Lle-Gln-Glu-Gly-Glu-Glu-Gly-Arg-Pro-Lys-Asp-Asp-Arg-OH) have been 
shown to interact laterally with αvβ3 integrin and induce cell migration, via 
outside-in signalling. SRSRY (Ser-Arg-Ser-Arg-Tyr) is another chemotactic peptide, 
derived form an uPAR sequence, which localized in the D1-D2 linker region. 
SRSRY peptides bind specifically to fMLP- a seven-transmembrane domain 
G-coupled receptor, and promote cell migration in this manner (Lucia Gargiulo, et al, 
2005). 
 
To study the effect of D2A and SRSRY on Merlin phosphorylation, HAECs on 
6-well plates were grown to confluency, after which the culture media was removed 
and cells washed twice with sterile PBS. D2A and SRSRY were diluted in 
serum-free culture media supplemented with antibiotics.  The concentrations were 
optimised by Dr. Bernard Degryse in our laboratory and are shown below: 
 
 
  
133 
 
SRSRY 100 nM 
D2A 1 nM 
            
HAECs were exposed to D2A and SRSRY acutely for time intervals of 1, 3, 5, 15 
and 30 minutes.  Cells were lysed and stored at -80
o
C for further Western blot 
studies. 
 
 
In order to study migration and adhesion, HAECs were grown to confluency, after 
which growth media was removed and cells washed twice in PBS.  Cells were then 
trypsinised and counted as normal.  Inhibitors were diluted in serum-free medium 
supplemented with antibiotics.  The concentrations are given below: 
 
 
  
  
For migration assays, inhibitors were added into the lower chamber of CIM plates 
and 30,000 cells then added into the upper chamber.  For adhesion assays, 30,000 
cells and inhibitors were mixed together to make a final volume of 200 µl. The 
migration and adhesion of HAECs were monitored using the xCELLigence
®
 System. 
  
uPA 100 nM 
SRSRY 100 nM 
D2A 1 nM 
VN 1μg/ml 
RGD1 inhibitors 0.5mM 
RGD2 inhibitors 0.5mM 
RGD3 inhibitors 0.5mM 
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2.2.11. FACS analysis 
 
 
Following transfection of HAEC’s with GFP-encoding plasmid constructs, cells 
were monitored by fluorescent activating cell sorting (FACS, GUAVA, Millipore) to 
detect GFP and assess transfection efficiency.  Approximately 24 hours after GFP 
transfection, HAEC monolayers were washed twice with sterile PBS and harvested 
by trypsinisation.  Cells were pelleted by centrifugation at 700 rpm for 5 minutes at 
room temperature and the resulting supernatant removed.  Cell pellets were then 
washed with 1 ml of ice-cold PBS supplemented with 0.1% w/v bovine serum 
albumin (BSA) and centrifuged once again.  Following removal of the supernatant, 
the cell pellets were re-suspended with 1 ml of ice-cold PBS (0.1% w/v BSA) and 
placed on ice.  Samples were analysed by flow cytometry, following the 
instructions of the manufacturer.  
 
 
2.2.12. Statisticla Analysis 
 
 
Results are expressed as mean ±SEM and experiments were performed at least in 
triplicate (n=3) unless otherwise stated. Statistical comparisons between controls and 
treated groups were assessed using two-way ANOVA. P-values≤0.05were 
considered statistically significant. All results were analysed using the GraphPad 
Prism software. 
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Chapter Three: 
 
 
 
Investigation of Haemodynamic 
Regulation of Merlin Expression and 
Co-localisation. 
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3.1: Introduction 
 
It has long been known that physical levels of hemodynamic force are important in 
maintaining normal endothelial function. Nearly two hundred years ago, the 
pathologist, Virchow, pointed out that atherosclerotic lesions emerging at regions 
within large arteries might relate to the different pattern of blood flow occurring 
with them (Virchow 1989). In 1969, Caro further illustrated the role of blood flow in 
atherogenesis (Aoki, et al. 1969). Recent studies have also provided a further 
substantial evidence of this relationship between atherosclerosis and hemodynamic 
force.  Due to their functional nature, blood vessels are constantly and directly 
subject to various stimuli, including haemodynamic forces manifested in the form of 
cyclic strain and shear stress.  Endothelial cells sense and convert these mechanical 
forces into biochemical signals which, in turn, alter EC fate and functions (Orr, et al. 
2006a).  Thus, within the inner layer of blood vessels, vascular endothelial cells 
undergo acute and prolonged adaptations in order to maintain vascular health 
(Furchgott and Zawadzki 1980). These adaptations include morphological change 
and increased secretion of both cytokines and growth factors (Gimbrone, M., Kume, 
N. and Cybulsky, M.I. 1993).  These, in turn, alter EC functions such as 
permeability, migration, adhesion and proliferation (De Caterina, Massaro and 
Libby 2007). Haemodynamic forces achieve these alterations through 
re-organization of actin in stress fibres, establishments and turnover of focal contacts, 
redistribution of focal adhesion and re-assembly of cell-cell junctional complexes 
(McCue, et al. 2006a).  Endothelial cells elongate in the direction of blood flow 
(McCue, et al. 2006b) which is critical to maintaining endothelial integrity, 
disruption of which, may lead to dysfunction of ECs and initiation of atherosclerosis. 
Previous in vitro studies have also demonstrated that haemodynamic forces can 
change expression of genes involved in several actin polymerization functions.  
This further highlights the importance of hemodynamic forces in regulation of EC 
functions (Kris, Kamm and Sieminski 2008).  
  
137 
 
EC motility is a complex process, which requires the recruitment of many proteins. 
These proteins include both extra-cellular (eg. ECMs) and cytosolic proteins (eg. 
filamentous proteins).  During the last three decades, studies (including those 
carried out within our laboratory) have highlighted the importance of ERM proteins 
in the regulation of cytoskeleton organisation.  They appear to function widely as 
linker proteins that serve to connect microfilaments to the plasma membrane.  The 
C-terminal domain attaches to the actin filaments, and the N-terminal FERM domain 
attaches to the cytosolic face of trans-membrane proteins, including CD44, CD43, 
ICAM2 (McClatchey and Fehon 2009) and integrins (Bretscher, Edwards and Fehon 
2002b).  ERM is known to be involved in development (Saotome, Curto and 
McClatchey 2004b), differentiation (Doi, et al. 1999b), mitosis (Kunda, et al. 2008), 
epithelial morphogenesis (Pilot, et al. 2006) and metastasis (Christofori 2006).  
Previous works performed in our laboratory have also indicated that the protein, 
Moesin, is critically involved in EC functions such as migration, angiogenesis, and 
barrier integrity. 
 
3.1.1. Hypothesis 
This study will focus on a relatively new family member of ERM, Merlin.  
Although the functions of Merlin have been intensively studied since it was 
discovered 20 years ago, its role in the regulation of actin cytoskeleton organisation 
in endothelium remains unknown.  Therefore, this study will investigate whether 
Merlin, a pivotal tumour suppressor protein of the ERM family, is a 
mechanically-induced actin-binding protein essential to cellular adaptation or if it is 
a reinforcement response to continuous haemodynamic assault. We believe that 
haemodynamic forces such as laminar shear stress altering HAECs morphology and 
HAEC modify its morphology through promoting actin polymerisation which 
requires regulate the expression of many actin adapter proteins including merlin.  
We deduce that merlin is a hemodynamically regulated protein, which plays a 
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crucial role in cytoskeletal dynamic in Human Aortic Endothelial Cells and localise 
at many functional structures such as focal adhesion, stress fibre and the leading 
edge of migrating cells.  
 
3.1.2 Study Aims: 
In conclusion, maintenance of endothelial integrity is critical to normal blood 
homeostasis, and as an actin skeleton and cell membrane linker, the role of Merlin in 
maintaining endothelial integrity is unknown.  We therefore look to examine:  
 
 If physiologically relevant levels of laminar and disturbed shear affect the 
morphology of HAECs;  
 If Merlin is a mechanically-regulated protein in the vasculature;  
 Localization of Merlin in HAECs under mechanical stimulation;  
 Examination of the effect of shear stress on action polymerization and 
co-localisation of Merlin protein with F-actin.  
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3.2 Results 
3.2.1 Characterisation of Human Aortic Endothelial Cell 
3.2.1.1 Human Aortic Endothelial cell morphology 
 
In this study, we initially investigated the morphology of HAECs and the effect of 
laminar shear stress on HAECs’ morphological alteration.  Under physiological 
static conditions, HAECs present a smooth “cobblestone” morphology that realigns 
in the direction of laminar shear stress (Cines et al, 1998; Gimbrone, 1987).  For 
these initial studies, HAECs were seeded into Y-shaped micro-slides (Ibidi
®
), and 
were grown to confluency. After exposure to LSS (10 dyne/cm
2
, 24 hours), the cells 
were then fixed and monitored by phase-contrast microscopy for characteristic 
growth patterns and this typical “cobblestone”-shaped morphology.  Results clearly 
showed the realignment of HAECs in the direction of flow in comparison with static 
controls under LSS, in which no uniform realignment was observed under DSS at 
regions of bifurcations and curvature. 
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Figure 3.1: Human Aortic Endothelial cell (HAECs) morphological alterations 
in response to LSS and DSS compared to static control cells.  
HAECs were sheared at 10 dynes for 24 hours. using the Ibidi
®
 system.  B) Compared with 
the static control (A), HAECs realigned in the direction of LSS. White arrows indicate the 
direction of flow.  No uniform HAEC realignment was observed under DSS conditions.  
Images are representative.  C) Site of curvature.  D) Site of bifurcation.  
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3.2.1.2 F-actin realignment in response of laminar shear stress 
 
F-actins, a major component of the cytoskeleton, are involved in many functional 
cellular substructures, including stress fibres, focal adhesions and adherens junctions.  
Polymerisation of F-actins is the initial step in HAEC response to haemodynamic 
forces. Therefore, we investigated the effect of LSS on F-actin realignment in 
HAECs. As before, HAECs were seeded into µ-slides (Ibidi
®
), and grown to 
confluency. Following exposure to LSS (10 dyne/cm
2
, 24 hours), cells were then 
fixed and stained with phalloidin stain for F-actin. Cells were monitored by confocal 
microscopy for F-actin realignment. From the fluorescent images obtained, we 
observed that F-actin realigned in the direction of flow compared with static controls 
under LSS. 
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            STATIC                      SHEARED                                   
 
 
Figure 3.2: F-actin staining of HAEC’s, with and without shear.  
 
Confluent HAECs were exposed to LSS (10 dynes/cm
2
, 24 hours), and monitored for 
F-actin realignment using confocal microscopy (Alexa Fluor 488® phalloidin (Invetrogen)  
stain for F-actin).  Results indicated that HAEC F-actin filaments realigned in the direction 
of flow under shear stress.  White arrows show direction of LSS.  
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3.2.2 The effect of haemodynamic forces on Merlin expression 
3.2.2.1 The effect of shear stress on Merlin protein expression 
 
It has been previously shown from work carried out in this laboratory by Mishan 
Britto (publication in preparation) that Moesin protein expression in HAECs is 
down-regulated by LSS (10 dyne/cm
2
, 24 hours).  Therefore, the same protocol 
was carried out to investigate the effect of shear stress on Merlin protein expression.  
HAECs were seeded into 6-well plates at a density of 10
5
cells/cm
2
 for confluent 
studies and 10
4
cells/cm
2
 for sub-confluent studies and subsequently permitted to 
adhere for 24 hours in order to reach confluency and 80% confluency respectively. 
HAECs were then sheared at 10 dyne/cm
2 
for 24 hours using an orbital rotator. 
Control plates containing un-sheared “static” endothelial cells were cultured in the 
same incubator, but on a different shelf in order to avoid vibrations produced by the 
orbital rotator in operation.  Following shearing experiments, cells were lysed and 
Merlin protein expression changes were monitored by Western blot analysis. 20µg 
of each sample was loaded into each lane of 10% SDS-PAGE polyacrylamide gel.  
From the results, it was observed that Merlin protein expression in sub-confluent 
HAECs decreased by approximately 34% relative to the static control, while only 
13% decrease was observed in confluent HAECs (Figure 3.3). 
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Figure 3.3:  The effect of shear stress on Merlin protein expression  
Following exposure of 10 dyne/10cm
2 
of physiological, laminar, shear stress over a 24 hours 
time period using the orbital rotator, cell lysates were analysed by Western blot.
 
A) were 
conducted on sub-confluent cells seeded at 10
4 
cells/cm
2
.  B) were conducted on 
fully-confluent cells seeded at a density of 10
5 
cells/cm
2
.  C) Histograms represent fold 
change in band intensity relative to un-sheared controls.  All values were controlled for 
equal loading by equalising for corresponding GAPDH protein. Results are averaged from 
three independent experiments ±SEM and each experiment was performed in triplicate; *P
≤0.05 vs control.  
(B) 
(A) 
(C) 
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3.2.2.2 The effect of shear stress on Phosphorylation state of Merlin  
 
The same protocol was carried out in order to investigate the effect of shear stress on 
phosphorylation state of Merlin.  HAECs were seeded into 6-well plates at a 
density of 10
5 
cells per cm
2
 for confluent studies and 10
4 
cells per cm
2
 for 
sub-confluent studies and then allowed to adhere for 24 hours before reaching 
confluency and 80% confluency separately.  HAECs were then sheared at 10 
dyne/cm
2 
for 24 hours using an orbital rotator.  Control plates containing 
un-sheared “static” endothelial cells were cultured in the same incubator, but on a 
different shelf to avoid vibrations caused by the orbital rotator.  Following shearing 
experiments, cells were lysed and phosphorylation state of Merlin was monitored by 
Western-blot.  Phosphorylation state of Merlin in sub-confluent HAECs was found 
to increase by approximately 2.37 fold relative to total merlin protein, while only 
1.44 fold increase in confluent HAECs (Figure 3.4). 
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Figure 3.4: The effect of shear stress on Phosphorylation state of Merlin  
Following exposure of to 10 dyne/10cm
2 
of laminar shear stress over a 24 hour time period 
using an orbital rotator, both sub-confluent cells (seeded at 10
4 
cells/cm
2
) and 
fully-confluent cells (seeded at 10
5 
cells/cm
2
) were lysed and analysed by Western blotting.  
A) Western blot analysis to generate phosphorylated merlin protein band.
 
B) Histograms 
represent fold change in band intensity relative to total merlin protein.  All values were 
controlled for equal loading by equalising for corresponding GAPDH protein. Results are 
averaged from three independent experiments ±SEM and each experiment was performed 
in triplicate; *P≤0.005 vs control.  
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3.2.2.3 The effect of cyclic strain on Merlin protein expression 
 
For cyclical strain studies, HAECs were seeded into 6-well Bioflex plates (Dunn 
Labbortechnik GmBH – Asbach, Germany) at a density of 105 cells per cm2. 
Bioflex
™
 plates contained a pronectin-coated silicon membrane bottoms, enabling 
precise deformation of cultured cells by microprocessor-controlled vacuum. Once 
seeded, cells were allowed to adhere and grow to confluence over a 24 hour period.  
Following this incubation period, culture medium was removed, and 2 ml of fresh 
medium added to each well. A Flexercell Tension Plus
™
 FX-4000T
™
 system 
(Flexcell International Corp., Hillsborough, NC) was employed to apply different 
cyclic strains.  Following exposure of HAECs to cyclic strain at static (0%), 
physiological (5%) and pathogenic (10%) levels over a 24 hour time period, Merlin 
protein expression was monitored by Western blotting. Protein expression of Merlin 
was found to have decreased by approximately 25% in HAECs at 5% cyclic strain 
relative to the static control. Reaching pathogenic levels of cyclic strain, Merlin was 
observed to have decreased by approximately 34% in HAECs (Fig 3.5). 
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Figure 3.5:    The effect of cyclic strain on Merlin protein expression  
Following exposure of to 5% and 10% cyclic strain over a 24 hour time period using the 
Flexercell Tension Plus
™
 FX-4000T
™
 system, cell lysates were analysed by Western 
blotting.
   
Histograms represent fold change in band intensity relative to un-strained 
controls. Western blot band analysis Merlin protein (75KD) expression change in HAECs 
following 24 hours cyclic strain.  All values were controlled for equal loading by 
equalising for corresponding GAPDH. Results are averaged from three independent 
experiments ±SEM and each experiment was performed in triplicate; *P≤0.05 vs control.  
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3.2.2.4 The effect of cyclic strain on phosphorylation state of Merlin  
 
Again, HAECs were seeded into 6-well Bioflex plates (Dunn Labbortechnik GmBH 
– Asbach, Germany) at a density of 105 cells per cm2.  Cells were then allowed to 
adhere and grow to confluence over a 24 hour period.  After this incubation period, 
culture medium was removed, and 2 ml of fresh medium added to each well.  
Following exposure of HAECs to cyclic strain at static (0%), physiological (5%) and 
pathogenic (10%) levels over a 24 hour time period, phosphorylation state of Merlin 
was monitored by Western blotting. Phosphorylation state of Merlin was found to 
have increased by approximately 1.85 fold in HAECs at 5% cyclic strain relative to 
the total merlin protein.  Reaching pathogenic levels of cyclic strain, Merlin was 
observed to have increased by 2.51 fold in HAECs (Fig 3.6) relative to the total 
merlin protein. 
 
 
 
 
 
 
 
 
 
  
150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6:    The effect of cyclic strain on Phosphorylation state of Merlin  
Following exposure of to 5% and 10% cyclic strain over a 24 hour time period using a 
Flexercell Tension Plus
™
 FX-4000T
™
 system, cell lysates were analysed by Western blot. 
Western blot band analysis phosphorylated merlin protein after expose to cyclic strain for 24 
hours. Histograms represent fold change in band intensity relative to total merlin protein.  
All values were controlled for equal loading by equalising for corresponding GAPDH 
protein. Results are averaged from three independent experiments ±SEM and each 
experiment was performed in triplicate; *P≤ 0.05 vs control.  
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3.2.2.5 The effect of acute stretch on phosphorylation state of Merlin  
 
HAECs were also exposed to 20% stretch for various time periods (1 minute, 5 
minute and 10 minute) in order to investigate acute Merlin phosphorylation state.  
HAECs were seeded into 6-well Bioflex plates (Dunn Labbortechnik GmBH – 
Asbach, Germany) at a density of 10
5
 cells per cm
2
.  Cells were then allowed to 
adhere and grow to confluence over a 24 hour period.  Following this incubation 
period, culture medium was removed, and 2 ml of fresh medium added to each well.  
Cells were then acutely stretched to 20% and induced at 1 minute, 5 minute and 10 
minute intervals using the Flexercell Tension Plus
™
 FX-4000T
™
 system.  
Phosphorylation states of Merlin was significantly decreased by 56% at 1 minute of 
stretch, 52% decrease at 5 minute of stretch and 60% at 10 mintes of stretch 
respectively compare to un-stretched control (Figure.3.6).
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Figure 3.7: The effect of 20% cyclic stretch on Phosphorylation state of Merlin  
Following exposure of 20% cyclic stretch at time point of 1 minute, 5 minute and 10 minute 
using the Flexercell Tension Plus
™
 FX-4000T
™ 
system, cell lysates were analysed by 
Western blot.  Western blot analysis of Phosphorylation state of Merlin (75KD) in HAECs 
after exposure to 20% cyclic strain at different time points.  Histograms represent fold 
change in band intensity relative to un-stretched controls.  All values were controlled for 
equal loading by equalising for corresponding GAPDH. Results are averaged from three 
independent experiments ±SEM and each experiment was performed in triplicate; *P≤ 
0.05 vs control. 
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3.2.2.6 The effect of haemodynamic forces on Merlin mRNA 
expression 
 
Previous results show that Merlin protein expression and phosphorylation state are 
regulated by haemodynamic forces.  Therefore, we commenced an investigation to 
further examine mRNA levels which reflect Merlin gene expression under various 
haemodynamic forces.  Briefly, following exposure of HAECs to cyclic strain at 
static (0%), physiological (5%) and pathogenic (10%) levels over a 24 hour time 
period, and exposure of both fully-confluent and sub-confluent HAECs to laminar 
shear stress (10 dynes/cm
2
; 24 hour), total RNA isolation was carried out using the 
Trizol
®
 method, developed by Chomczynski and Sacchi (Chomczynski and Sacchi, 
1987).   Messenger RNA was then reverse transcribed into complimentary DNA 
(cDNA) using a high capacity cDNA reverse transcription kit (Applied Biosystems, 
CA, USA).  Merlin primers were designed using the online software programme, 
Primer3 (http://frodo.wi.mit.edu/) and Desktop PCR used to ensure that newly 
designed primers were operational before use in Quantitative real-time polymerase 
chain reaction (QRT-PCR) experiments.  QRT-PCR products were tested on a 1% 
agarose gel to ensure that only one clear band at the expected product size was 
visualised.  Merlin mRNA changes were examined using an Applied Biosystems 
7900HT Fast real-time PCR instrument following Quantitative real-time PCR 
Experiment (MIQE) guidelines (Bustin, et al., 2009).  The house keeping gene, 18s, 
was used for all qPCR normalisation.  
 
Messenger RNA levels were reflective of these protein quantities, with Merlin 
increasing expression significantly by 71% relative to the static control in 
sub-confluent HAECs exposed to laminar shear stress at 10 dyne/cm
2
 for 24 hours  
In contrast, only a 24% increase in confluent HAECs was determined under the 
  
154 
 
same conditions (Figure 3.8 (A)).  Under 5% cyclic strain for 24 hours, Merlin 
mRNA levels only increased by approximately 15%, while a significant increase 
(approximately 89%) was found under 10% strain for 24 hours (Figure 3.8 (B)). 
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Figure 3.8: Merlin mRNA expression change under haemodynamic stimulus. 
A) Following exposure of 10 dyne/10cm
2 
of laminar shear stress over a 24 hour time period 
using the orbital rotator, and B) following exposure of 5% and 10% cyclic strain over a 24 
hour time period using the Flexercell Tension Plus
™
 FX-4000T
™
 system, Merlin mRNA 
was extracted and a two-step QRT-PCR carried out using specific primer sets for the 
measurement of Merlin gene expression.  Results were normalised to the housekeeping 
gene, 18s, and histograms represent normalised values relative to the un-sheared control. 
Results are averaged from three independent experiments ±SEM and each experiment was 
performed in triplicate; *P ≤ 0.05 vs control.  
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3.2.2.7 Immunocytochemical analysis of Merlin co-localisation 
under shear 
 
In order to study Merlin co-localisation under shear, HAECs were diluted to a 
density of 1x10
6
 cells/ml, with 200 μl of this dilution introduced into an Ibidi® 
Y-shape µ slide. HAECs were permitted time to adhere and grow to confluency, and 
then sheared using the Ibidi
®
 pump system.  Merlin co-localization with F-actin 
after 10 dyne/cm
2
 shear stress for 24 hours was examined by staining cells with 
rhodamine phalloidin (Figure 3.9).  In comparison with static controls, HAECs 
re-aligned in the direction of shear stress and the co-stain with F-actin revealed 
Merlin association with dynamic actin at the site of stress fibres (Figure 3.10(A)), 
focal adhesions (Figure 3.10(B)), at sites of cell-cell contact (Figure 3.10(C)) and at 
the leading cell edge, lamellipodial regions in particular (Figure 3.10(D)). 
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Figure 3.9:  The effect of shear stress on vascular endothelial cells and Merlin 
co-localisation with F-actin 
HAECs were exposed to static and 10 dyne/cm
2
 laminar shear stress for 24 hours.  
Cellular localisation of Merlin was analysed by immunofluorescent imaging, 
co-staining for F-actin and monitoring of Merlin (green) with F-actin (yellow) by 
standard fluorescent microscopy.  HAEC F-actin filaments realigned in the 
direction of flow under LSS while and no F-actin filaments realignments were 
observed under static conditions.  (Arrow showing the direction of blood flow) 
 
M
erlin
 
 
 
 
 
 
 
 
 
 
 
 
F
-actin
 
 
 
 
 
 
 
 
 
 
 
 
M
erg
ed
 
  
158 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Merlin localisation by immunofluorescence microscopy. 
Cellular localisation of Merlin was analysed by immunofluorescent imaging.  Images show 
the association of merlin with dynamic actin strictures within the cells. Arrows indicate 
Merlin localisation at the site of stress fibres (A), focal adhesions (B), cell-cell junction (C), 
and lamellipodia leading edges (D). Imagine A has taken from static control sample and 
imagine B-D have taken from sheared samples.  
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3.3 Discussion  
According to the World Health Organisation (WHO), CVD is the leading cause of   
death across the world, including America, Europe and Asia.  The lesions of 
atherosclerosis contribute enormously to this large death toll.  It is now well known 
that endothelium is critical in maintaining vascular homeostasis, the dysfunction of 
which contributes many different CVD, including atherosclerosis.  As a direct 
stimulus, blood flow alters many EC functions, including morphology (Nerem, 
Levesque and Cornhill 1981), protein and gene expression, permeability 
(Förstermann and Münzel 2006) (Vita and Keaney 2002), adhesion and migration 
(Figure 3.11).  The alignment in direction of blood flow and formation of long 
spindle morphology is the first adaptation of endothelium under shear stress.  This 
is achieved by alteration of its actin polymerisation.  However, this uniform 
alignment does not appear at sites of bifurcations and curvature (Langille and 
Adamson 1981). At such sites more complicate forms of shear stresses such as 
oscillated and disturbed shear stress are formed which contribute the initiation and 
progression of atherosclerosis.  
  
Under physiological conditions, the value of shear stress is 10-15 dynes/cm
2
 
(Lehoux and Tedgui, 2003) and the value of cyclic strain is 5-7.5% (Fujiwara 
K.2003. Debes JC, Fung YC. 1995). The level of health shear stress in this thesis is 
chosen a protocol of 10 dynes/cm
2
.  The level of health cyclic strain is chosen a 
protocol of 5%. 10% and 20% of cyclic strain were also used to mimic the state of 
hypertension. 10% cyclic strain was used for chronic studies while 20% stretch was 
only used for acute studies as HAECs cannot withstand for 20% stretch more than 
few hours. These values were also optimised by previous works in our laboratory 
using biomarkers which particularly represent the pathological and physiological 
ranges of haemodynamic forces for HAECs (unpublished data).  
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In this study, we first examined if haemodynamic forces affect HAECs morphology. 
We compared the effect of both patterns of laminar and disturbed shear stress on 
HAECs morphologies, particularly at sites of bifurcations and curvature, where there 
exists a high risk of developing atherosclerosis. From the results obtained, we have 
successfully demonstrated that HAECs realign in the direction of flow compared 
with static control under LSS, but no uniform realignment was observed under DSS 
at regions of bifurcations and curvature.  These results indicated that shear stress 
plays a critical role in regulation of HAEC morphology; consequently, the primary 
questions which must be answered are through which mechanism haemodynamic 
forces achieve regulation of HAEC functions, and whether or not Merlin plays a role 
in this mechanism. 
 
Many studies show that in response to shear stress, endothelial cells change their 
morphology through reorganisation of its cytoskeleton.  In the process, actin 
filament re-polymerises and forms different functional structures such as stress fibre 
bundles which provide an internal structural frame work for EC themselves (Wong, 
Pollard and Herman 1983) (Wechezak, Viggers and Sauvage 1985). As a 
cytoskeleton adaptor protein, Merlin is responsible for regulation of cell morphology, 
in addition to such functions as adhesion and migration (Reed and Gutmann 2001). 
Lallemand, et al have discovered that both merlin protein expression level and 
phosphorylation states are regulated by cell density, growth factor withdraw and 
cell-ECM detachment (Lallemand, et al. 2003). Their studies demonstrated that 
deficiency of merlin lost the ability of cellular contact-dependent inhibition of 
growth. Increased merlin protein expression was observed in primary rat Schwann 
cells (Morrison, et al. 2001). Many studies have also illustrated that merlin is 
activated or phosphorylated in cell-cell contact manner (Shaw, McClatchey and 
Jacks 1998) (Morrison, et al. 2001b) (Herrlich, et al. 2000). Furthermore our 
laboratory demonstrated the persistent increase of moesin with cyclic strain in 
sub-confluent HAECs. Meanwhile, the comparison of confluent and sub-confluent 
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cell culture conditions allow us to mimic the endothelial injury models which may 
indicates the role of merlin in control of cell migration and growth.   
 
Figure 3.11: The application of haemodynamic force to endothelial cell 
HAECs expose to multiple haemodynamic forces in the vasculature including the shear 
stress of blood flow and generate myosin-dependent contractile and actin polymerisation 
mediated tensile forces through ECM. The close-up of a FA showing the actin stress fibre 
binding into focal adhesion complex which anchored to the ECM through integrins. 
Diagram modified from (Hoffman, Grashoff and Schwartz 2011). 
 
 
  
162 
 
We, therefore firstly, focused on the effects of physiological shear stress levels on 
Merlin protein in both confluent and sub-confluent HAEC cultures.  We found that 
after continuous exposure to 10 dynes; 24 hours shear, only a slight decrease in 
Merlin protein expression in confluent HAECs was observed.  In contrast, however, 
a dramatic decrease in sub-confluent HAECs compared with static control occurred. 
We also discover the similar results in a comparison study between static and 
physiological (5%) levels and pathological (10%) levels of cyclic strain.  Merlin 
protein expression underwent only subtle decreases while significant decreases were 
observed following pathogenic levels.  
 
Activation of Merlin is inhibited by the phosphorylation of Ser518, located on the 
C-terminal, preventing its ability to bind to actin (Sherman, et al. 1997). We can see 
that after 10 dyne/cm
2
; 24 hours shear, only a slight increase in phosphorylated 
Merlin protein expression in confluent HAECs occurred.  In contrast, however, a 
dramatic increase in sub-confluent HAECs compared with total merlin protein was 
observed.  Again, similar results were found in a comparison between static and 
physiological (5%) levels and pathological (10%) levels of cyclic strain.  
Phosphorylated Merlin protein expression underwent only subtle increases while 
significant increases were observed following exposure to pathogenic levels.  
Results suggested that Merlin activation is inhibited under physiological conditions 
that allow ECs to undergo active modulation. 
 
The above results have confirmed that Merlin protein expression and 
phosphorylation states are indeed regulated by haemodynamic forces.  Therefore, 
further examination of the mRNA levels that reflect Merlin quantities under 
haemodynamic forces was carried out.  In brief, experiments under the same 
haemodynamic force conditions in HAECs were repeated for Merlin mRNA 
expression.  Interestingly, it was found that mRNA levels increased with both shear 
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stress and cyclic strain, and did not correspond to Merlin protein expression.  This 
phenomenon was also observed by previous works in our laboratory while studying 
the other ERM family protein, Moesin, under the same conditions. This may 
indicate the regulation of haemodynamic forces on merlin protein functions. There 
are generally three ways to regulate merlin activity. First, HAECs can alter merlin 
protein expression rate. The rate of merlin protein synthesis is controlled by the rate 
at which the merlin DNA encoding the protein is converted to mRNA. This process 
may involve microRNA mediated transcript degradation and translational 
suppression of which decrease the synthesis of merlin protein. MicroRNA (miRNA) 
are short non-coding single stranded RNA molecules usually 19-25 nucleotides in 
length.  MicroRNA was discovered by Lee et al in 1993 on the nematode 
Caenorhabditis elegans (Lee, Feinbaum and Ambros 1993). It functions in many 
different biological processes, such as gene silencing (Bartel 2009). Intensive studies 
have shown that microRNA are involved in cardiac development and cardiovascular 
functions that are well described in Eric M. Small and Eric N. Olson’s review (Small 
and Olson 2011). Saydam O, et al., have also demonstrated the role of miR-7’s 
tumour suppressor function in schwannomas (Saydam, et al. 2011).  Second, 
HAECs can change the activity of protein such as affinity of substrate binding. Last, 
HAECs may transport merlin proteins into different locations thus alter the 
cytoplasmic protein concentration.  However, the exact way that HAECs control 
merlin functions is still poorly understood, and will be investigated in depth in future 
studies. 
 
Our previous works have shown that cyclic strain increase HAECs motility both at 
adhesion and migration. As I mentioned before, cell adhesion and migration are two 
related processes. This process requires involvement of many actin adaptor proteins. 
The migrating cell first form distinct functional structures at its leading edge which 
then attach the cell to the ECM. Response to haemodynamic forces, cell can start 
adhesion as quick as few minutes. Therefore we want to investigate if merlin is 
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required in cyclic strain induced both HACEs adhesion and migration at molecular 
levels.  The phosphorylation of merlin disable it form inhibition of cell adhesion 
and migration. In consequence, investigation of phosphorylation state of merlin will 
reflect its function during the process. The acute impact of cyclic stretch on Merlin 
phosphorylation states in HAECs was examined by exposure to 20% stretch for 
various time periods (1 minute, 5 minute and 10 minute) using the Flexercell 
Tension Plus™ FX-4000T™ system. Phosphorylation states of Merlin were 
monitored by Western blot analysis. We observed that phosphorylation states of 
Merlin were significantly decreased by 56% at 1 minute of stretch, 52% decrease at 
5 minute of stretch and 60% at 10 minutes of stretch respectively compare to 
un-stretched control (Figure.3.6). Dephosphorylation of merlin is an important acute 
adaptive response mechanism to haemodynamic force. Phosphorylation of merlin is 
the other important regulatory mechanism of its function.  Merlin inactivation 
occurs by phosphorylation at serine 518 in the C-terminal by either p21-activated 
kinase (PAK) or cAMP dependent protein kinase A (PKA) resulting in  
disassociation of the C-terminal from FERM (Kissil, et al. 2002). 
 
Figure 3.12: Merlin phosphorylation.  
Merlin inactivation occurs by phosphorylation at serine 518 in the C-terminal by either 
p21-activated kinase (PAK) or cAMP dependent protein kinase A (PKA). The 
phosphorylation of merlin leads to de-association of its C-terminal from N-terminal which 
promote cell growth. (Scoles 2008). 
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Like other ERM proteins, Merlin is a critical component involved in regulating cell 
morphology and motility by binding to the actin cytoskeleton (Reed and Gutmann 
2001b). Studies show that Merlin is located at many dynamic functional regions, 
such as microspikes and membrane ruffles (Bretscher, Edwards and Fehon 2002a) 
(Gonzalez-Agosti, et al. 1996). In order to investigate Merlin co-localisation with 
F-actin, HAECs were exposed to 10 dynes shear stress for 24 h. and stained with 
rhodamine phalloidin.  In comparison with static controls, HAECs re-aligned in the 
direction of shear stress and the co-stain with F-actin revealed Merlin association 
with dynamic actin at the site of stress fibres, focal adhesions, at sites of cell-cell 
contact and, in particular, the leading cell edge in lamellipodial regions.  
Importantly, this indicated its involvement with actin polymerisation. 
 
From the above studies, we can conclude that Merlin, an endogenous protein in 
HAECs, is highly responsive to mechanical stimuli.  Merlin was also observed in 
numerous functional sites of dynamic action activity such as cell-cell 
communication, cell adhesion, cell migration and actin polymerization. 
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Chapter Four: 
 
 
 
The Role of Mechano-Regulated  
Merlin in Cell-Matrix Adhesion and 
Migration. 
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4.1 Introduction 
 
Cell adhesion and migration are two related processes which are crucial in 
maintaining cell morphogenesis; indeed, abnormal cell migration contributes many 
human diseases, including cancer, immunodeficiency disorders and cardiovascular 
disease. Cell movement has traditionally classified by four steps: 1) formation of 
functional region on the leading edge of the migrating cell, 2) protrusion and 
adhesion of the leading edge to ECM, 3) cell body translocation, 4) detachment of 
rear adhesion (Huttenlocher, Sandborg and Horwitz 1995) (Ridley, et al. 2003).  
 
Cellular migration is driven by a number of factors; the gradient of growth factors or 
chemokines, ECM proteins (e.g. collogen and fibronectin), and electrochemical 
gradients (Parsons, Horwitz and Schwartz 2010b). It is now well known that the 
mechanical forces is the other crucial factor that maintaining the organisation of 
focal adhesion and cytoskeleton polymerisation that in turn regulate endothelial cell 
adhesion and adhesion. In response to extracellular stimuli, protrusive cells form 
distinct functional regions (e.g. lamellipodia, filopodia) at their leading edge by actin 
polymerization (Katoh and Negishi 2003). This functional leading edge then stretch 
out towards to the cues, and then stabilised by adhesion. Cellular adherence to ECM 
is therefore also considered as the first step of cell migration (Parsons, Horwitz and 
Schwartz 2010a). Many cell surface receptors such as integrins, cadherins, 
proteoglycans and cell adhesion molecules are involved in cell motility, among 
which integrins are the best characterized. Integrin mediated cell adhesion adheres 
specifically to ECM proteins which is determined by extracellular ECM binding 
domains (Figure 4.1).  For example αvβ3 specifically binding fibronectin while 
α2β1 only bind to laminin. In turn, the variety of these different integrin mediated 
adhesion affect the dynamic of cell motility and activation of different cell signalling 
pathway which regulates cell response to stimuli. For example, αvβ3 mediated 
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adhesion is more stable than α5β1 mediated adhesion (Huttenlocher and Horwitz 
2011).  
 
 
 
Figure 4.1: Cell–matrix adhesions and their downstream regulation.  
Cell-ECM adhesions mediated by numerous integrins and recruit many cytoplasmic proteins.  
The recruitment of different cytoplasmic proteins leads to various downstream signalling 
cascades which regulate diverse cell fates (Allison L. Berrier, and Kenneth M. yamada, 
2007).   
 
The nascent integrin mediated adhesions by binding to ECM are matured and form a 
“dot- like adhesions” termed as focal complex which can be further stabilised to 
focal adhesion by associate with many actin binding scaffolding proteins.  Over 
150 proteins have been identified to involve in focal adhesion and this number is 
still expending (Zaidel-Bar and Geiger 2010). Among these proteins, vinculin, talin, 
kindlins and α-actinin have been intensively studied. Both talin and α-actinin 
promote the maturation of focal complex.  Calderwood has shown the ability of 
talin interact with β-integrin cytoplasmic domains to increase its binding affinity to 
ECM (Calderwood 2004), and absent of talin or α-actinin significant effect on cell 
  
169 
 
adhesion (Zhang, et al. 2008) (Choi, et al. 2008). Both talin and α-actinin can 
interact with vinculin (Ziegler, Liddington and Critchley 2006), but Xu et al have 
shown that vinculin does not play critical role in adhesion formation (Xu, Baribault 
and Adamson 1998).  
 
Many studies have revealed that Merlin interaction occurs with β1-integrin 
(Obremski, Hall and Fernandez‐ Valle 1998a), actin (Bashour, et al. 2002) and 
microtubules (Muranen, et al. 2007) and L.Hemmings et al have also demonstrated 
that talin contains a N-terminal binding site of ERM that indicating that Merlin may 
play an important role in regulation of endothelium cell functions such as adhesion 
and migration (Hemmings, et al. 1996).   
 
 
4.1.1. Hypothesis 
 
The investigation of merlin interacting proteins will reveal potential therapeutic 
targets and help us understand by which mechanism merlin involved in regulate 
vascular functions. The previous results have shown that merlin present at many 
functional structures in HAECs. Therefore we expect to see that merlin will binding 
to cytoskeleton proteins such as actin and microtubulin. We also believe that merlin, 
as a member of the ERM family, plays an important role in regulation of HACE 
motility through αvβ3 integrins mediated pathway. The knock-down of merlin will 
affect HACEs motilities under haemodynamic forces.   
 
 
4.1.2. Study Aims: 
 
From the previous studies, we concluded that Merlin is endogenously expressed in 
HAECs and is highly responsive to mechanical stimuli.  Merlin is also involved in 
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numerous cell functions such as cell-cell communication, cell adhesion, cell 
migration and actin polymerization.  In order to further confirm these conclusions 
and to investigate if Merlin affects cell-matrix adhesion and cell migration he 
following studies were carried out: 
 
 The investigation of the binding proteins of Merlin using Proteomics Mass 
Spectrometric analyse. 
 The investigation of the effect of siRNA mediated merlin knock-down 
HAECs on cell adhesion using the real time cell analysis system 
xCelligence.  
 The investigation of the effect of haemodynamic forces on Merlin 
knock-down HAEC motility using xCELLigence system.  
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4.2 Results. 
4.2.1 Mass Spectrometric analyse of Merlin binding proteins 
 
From chapter 3, we observed that Merlin localise at numerous functional sites of 
dynamic action activity such as cell-cell communication, cell adhesion, cell 
migration and actin polymerization.  The results implicate Merlin play an important 
role in regulation of haemodynamic regulated actin polymerisation.  This 
regulation may involve in many Merlin binding partner proteins which we will first 
investigate at this chapter.   
 
CO-IP is carried out using Pierce Co-Immunoprecipitation Kit (Thermo Scientific). 
In brief, the HAECs were lysed according the manufacturer’s instructions.  Lysate 
was then immunoprecipitated using a purified Merlin antibody coupled resin.  Two 
control studies were performed along the experiments.  One is the Quenched Resin 
Control is prepared by adding a 200 µl of quenching buffer to the resin column, 
which stops the resin from binding.  Another inactivated Resin control is supplied 
within the kit which is composed of the same support material as the co-IP resin, but 
it is not activated.  The elution sample of CO-IP was analysed both western blot 
and Mass Spectrometric methods (the elutions were sent and analysed by Dr Paul 
Dowling’ laboratory in National Institute for Cellular Biotechnology, DCU). 
 
Before analysis using the Mass Spectrometer, the CO-IP elution samples were 
validated by Western blot.  From Fig 4.1, we can observe a clear band in the eluted 
Merlin protein sample, while no band is visible in either control resin samples.  
Samples were then examined using Mass Spectrometry.  Results were interesting, 
and pointed to the fact that compared with controls, Merlin protein bound to many 
functional proteins including tubulin, myosin light chain 6B, annexin and actin.  
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This result verified our last co-localisation study that Merlin is present at numerous 
functional sites of stress fibres, focal adhesion, at sites of cell-cell contact and the 
leading cell edge in lamellipodial regions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Validation of Immunoprecipitated Merlin by Western blot.  
Following the immunoprecipitation of Merlin from Human Aortic Endothelial Cell lysate, a 
portion of the precipitated sample was tested on a Western blot to verify the elution 
contained Merlin.  A clear band is observed in the eluted Merlin protein sample, while no 
band can be seen in either control resin samples.  
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Table 4.1 Mass Spectrometry results of control CO-IP elution samples from 
HAECs. 
sp|P62158|CALM_HUMAN Calmodulin OS=Homo sapiens GN=CALM1 PE=1 SV=2 
[MASS=16838] 
sp|P11142|HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens 
GN=HSPA8 PE=1 SV=1 [MASS=70898] 
sp|P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Homo sapiens 
GN=EEF1A1 PE=1 SV=1 [MASS=50141] 
sp|P08670|VIME_HUMAN Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4 
[MASS=53651] 
sp|P51991|ROA3_HUMAN Heterogeneous nuclear ribonucleoprotein A3 OS=Homo 
sapiens GN=HNRNPA3 PE=1 SV=2 [MASS=39595] 
sp|P35268|RL22_HUMAN 60S ribosomal protein L22 OS=Homo sapiens GN=RPL22 
PE=1 SV=2 [MASS=14787] 
sp|P11021|GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens 
GN=HSPA5 PE=1 SV=2 [MASS=72332] 
sp|P62258|1433E_HUMAN 14-3-3 protein epsilon OS=Homo sapiens GN=YWHAE 
PE=1 SV=1 [MASS=29174] 
sp|P62805|H4_HUMAN Histone H4 OS=Homo sapiens GN=HIST1H4A PE=1 SV=2 
[MASS=11367] 
sp|P14618|KPYM_HUMAN Pyruvate kinase isozymes M1/M2 OS=Homo sapiens 
GN=PKM2 PE=1 SV=4 [MASS=57937] 
 
This table displays the results of non-specific binding proteins in the inactivated Resin 
control CO-IP elution sample.  
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Table 4.2 Mass Spectrometry results of Immunoprecipitation of Merlin from 
HAECs 
sp|Q8NBS9|TXND5_HUMAN Thioredoxin domain-containing protein 5 
OS=Homo sapiens GN=TXNDC5 PE=1 SV=2 [MASS=47629] 
sp|P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Homo sapiens 
GN=EEF1A1 PE=1 SV=1 [MASS=50141] 
sp|P62736|ACTA_HUMAN Actin, aortic smooth muscle OS=Homo sapiens 
GN=ACTA2 PE=1 SV=1 [MASS=42009] 
sp|P02786|TFR1_HUMAN Transferrin receptor protein 1 OS=Homo sapiens 
GN=TFRC PE=1 SV=2 [MASS=84871] 
sp|P07355|ANXA2_HUMAN Annexin A2 OS=Homo sapiens GN=ANXA2 PE=1 
SV=2 [MASS=38604] 
sp|P21980|TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 
OS=Homo sapiens GN=TGM2 PE=1 SV=2 [MASS=77328] 
sp|P14649|MYL6B_HUMAN Myosin light chain 6B OS=Homo sapiens GN=MYL6B 
PE=1 SV=1 [MASS=22764] 
sp|P62269|RS18_HUMAN 40S ribosomal protein S18 OS=Homo sapiens 
GN=RPS18 PE=1 SV=3 [MASS=17719] 
sp|P68371|TBB2C_HUMAN Tubulin beta-2C chain OS=Homo sapiens 
GN=TUBB2C PE=1 SV=1 [MASS=49831] 
sp|P11021|GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens 
GN=HSPA5 PE=1 SV=2 [MASS=72332] 
sp|P50454|SERPH_HUMAN Serpin H1 OS=Homo sapiens GN=SERPINH1 PE=1 
SV=2 [MASS=46440] 
sp|Q13885|TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens 
GN=TUBB2A PE=1 SV=1 [MASS=49907] 
 
This table displays the results of Merlin CO-IP elution sampled. The results pointed that 
compared with controls, Merlin protein binding to many proteins include tubulin, myosin 
light chain 6B, annexin and actin.  This result future confirmed our last co-localisation 
study that Merlin present at numerous functional sites of stress fibres, focal adhesion, at 
sites of cell-cell contact and the leading cell edge in lamellipodial regions. 
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4.2.2. Merlin siRNA optimisation 
 
Merlin knock-down HAECs allowed us to further evaluate the role of Merlin in 
HAECs motility.  In order to achieve this goal, Merlin was knocked-down by 
introducing Merlin siRNA into HAECs.  HAECS were transfected by two different 
methods: Microporation (Digital Bio) and TransIT-siQUEST® (Mirus) to determine 
the most appropriate method of siRNA delivery.  
Initial optimization of each system required fine tuning of electrical parameters and 
cell numbers.  Once achieved, both systems were compared for cell viability and 
transfection efficiency.  HAECs were monitored by phase contrast microscopy.  
Analysis 48 hour post transfection revealed noticeably better cell viability (and 
morphology) with Microporation compared to siQUEST.  HAECs were then 
transfected with different concentrations of Merlin siRNA (10-40 nM), to determine 
the optimum amount of siRNA with highest transfection efficiency and lowest 
toxicity.  Same amount of scrambled siRNA was used as a control.  After 
transfection, cells were allowed to recovery for 48 hours and transfection efficiency 
monitored by Western blot.  Results of these experiments showed that Merlin 
protein expression is down-regulated by 77% after HAECs were transfected with 40 
nM of Merlin siRNA at 48 hour time point. As a result, all subsequent transfections 
were performed using microporation at the same concentration of siRNA and the 
same incubation times. 
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(A) 
 
 
(B) 
 
 
 
 
 
 
 
Figure 4.3:  Optimisation of Merlin siRNA concentrations. 
HAECs were transfected with Merlin siRNA at different concentrations using a 
Microporator (Digital Bio).  Cells were then incubated at 37
o
C for 48 hour.  Cell lysates 
were analysed by Western blot.  A) Western blot analysis of Merlin (75 KD) expression 
change after transfected with siRNA.  B) Histograms represent fold change in band 
intensity relative to scrambled controls.  All values were controlled for equal loading by 
equalising for corresponding GAPDH. Results are averaged from three independent 
experiments ±SEM and each experiment was performed in triplicate; *P≤ 0.05 vs 
control.  
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4.2.3. The effect of Merlin knock-down on HAECs adhesion to 
various ECM. 
 
In the previous studies highlighted in chapter 3, we discovered that Merlin was 
present at sites focal adhesion, stress fibres and the leading edges of lamellipodia 
using immune fluorescent images (figure 3.10), and in addition, using a proteomic 
approach we illustrated that Merlin binding occurs to the cytoskeleton proteins, actin 
and tubulin (Table 4.2). We hypothesised that Merlin is critical in regulation of 
HACEs adhesion and migration.  In order to investigate the effect of Merlin in 
HAEC adhesion, and to evaluate by which mechanism Merlin is involved, several 
different ECM were introduced.  Merlin knock-down HAECs were subsequently 
plated into E-plates pre-coated with various extracellular matrices, consisting of 
fibronectin, vitronectin, fibrinogen or laminin.  Cell-matrix adhesion was 
monitored by xCelligence
®
.  Results indicated that relative to none coating controls, 
in Merlin knock-down HAECs, cell-matrix adhesion was greatly increased (figure 
4.4).  Also in the Merlin knock-down, increased levels of attachment of vitronectin 
was approximately 1.9-fold, while an approximate 1.66-fold increase to fibronectin 
compared to laminin (0.1%) and fibrinogen (8%) was observed (figure 4.3). 
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Fig 4.4 the effect of Merlin knock-down on HAEC adhesion to various ECMs 
 
The effect of Merlin knock-down on HAEC adhesion was studied using the xCELLigence
®
 
system.  Merlin knock-down HAECs were seeded into E-plates pre-coated with fibronectin 
(Green), fibrinogen (Blue), Laminin (Pink) and Vitronectin (Cyan), at a concentration of 
30,000 cells per well.  Plates with none coating (Red) were set as controls.  Results 
appear to indicate that Merlin-absent HAECs exhibited preferential adhesion to VN and FN.  
Histograms represent slope changes according with CI value of ECMs related to no-coating 
controls. Results are averaged from three independent experiments ±SEM and each 
experiment was performed in triplicate; *P≤ 0.05 vs control.  
 
*  * 
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Fig 4.5 The role of Merlin knock-down on HAEC–ECM adhesion. 
 
The role of Merlin knock-down on HAEC –ECM adhesion was studied using the 
xCELLigence® system.  Merlin knock-down HAECs were seeded into E-plates which 
were pre-coated with fibronectin (A), fibrinogen (B), Laminin (C) and Vitronectin (D), at a 
concentration of 30,000 cells per well.  Graphs illustrate that the absence of Merlin (Red) 
increased HAEC adhesion to all ECM compared with the scrambled control (Green). 
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4.2.4. The role of Merlin knock-down on HAEC migration 
 
Again, to investigate the role of Merlin in HAEC migration, the same protocol was 
followed.  Following knock down by transfecting Merlin siRNA, HAECs were 
subsequently plated into the upper chambers of CIM-plates at a concentration of 
30,000 cells per well.  Cell migration was then monitored by Real Time Cell 
Analysis System xCELLigence®.  Results indicate that the knock-down of Merlin 
(Green) increased HAEC migration (approximately 1.76 fold) compared with 
scrambled controls. 
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Fig 4.6 The role of Merlin knock-down on HAEC migration. 
 
The role of Merlin absence on HAECs migration was studied using xCELLigence system. 
Merlin knock-down HAECs were seeded into CIM-plate at a concentration of 30,000 cells 
per well. Graphs illustrate that absent of Merlin (Green) increase HAECs migration 
compared with scrambled control (Blue). Histograms represent slope change according with 
CI values related to scrambled control. Results are averaged from three independent 
experiments ±SEM and each experiment was performed in triplicate. 
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4.2.5 The effect of laminar shear stress on Merlin knock-down 
HAECs’ adhesion. 
As mentioned previously, under physiological conditions, ECs realign in the 
direction of blood flow in order to maintain healthy hemostasis.  The previous 
chapter showed that Merlin is highly responsive to mechanical stimuli, and also 
from section 4.2.3 and section 4.2.4, it was observed that the Merlin knock-down 
greatly affects HAEC motility. Therefore, we wanted to further elucidate the effect 
of laminar shear stress on Merlin-absent HAEC motility.  
 
We first investigated the effect of laminar shear stress on Merlin knock-down HAEC 
adhesion.  HAECs were transfected with Merlin siRNA.  Cells were then 
incubated for 48 hours at 37
o
C.  Cells were harvested after incubation and 
transfection efficiency monitored by Western blot to ensure an approximate 80% 
knock-down of Merlin was achieved.  Both Merlin knock-down HAECs and 
scrambled control cells were exposed to LSS (10 dyne/cm
2
 for 24 hours).  Cells 
were then trypsinised and seeded into E-plates at a concentration of 30,000 
cells/well. The cell adhesions were monitored by the Real Time Cell Analysis 
System xCELLigence
®
. 
 
Results indicated that relative to static controls, the level of adherance of HAECs 
was significantly increased by 1.4-fold after exposure to LSS.  In the Merlin 
knock-down, the level of adherence was further increased to 1.69-fold over wild 
type cells, after exposure to LSS compared with static controls.  
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Figure 4.7 The role of laminar shear stress on Merlin knock-down HAEC 
adhesion. 
The role of laminar shear stress on HAEC adhesion was studied using xCELLigence system. 
Following 10 dyne/cm
2
 24 hours shear, both scrambled and Merlin knock-down cells were 
seeded into E-plates at a concentration of 30,000 cells per well. Graphs illustrate the effect 
of LSS on merlin knock-down HAEC adhesion. Green: scrambled control; Blue: Merlin 
knock-down; Pink: sheared; Cyan: Merlin knock-down+sheared.  Histograms represent 
slope change according with CI values. Results are averaged from three independent 
experiments ±SEM and each experiment was performed in triplicate; *P≤ 0.05 vs 
control. 
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4.2.6 The effect of laminar shear stress on Merlin knock-down 
HAEC migration. 
 
In order to investigate the effect of laminar shear stress on Merlin-absent HAEC 
migration, HAECs were transfected with Merlin siRNA.  Cells were then incubated 
for 48 hours, at 37
o
C.  Cells were then harvested following incubation, and 
transfection efficiency was monitored by Western blot to ensure about 80% 
knock-down of Merlin was achieved.  Both Merlin knock-down HAECs and 
scrambled control cells were exposed to LSS (10 dyne/cm
2
 for 24 hours).  Cells 
were then trypsinised and seeded into CIM-plates at concentration of 30,000 cells 
per well.  Cell migration was monitored by Real Time Cell Analysis System 
xCELLigence
®
. 
 
Results indicate that relative to static controls, the level of HAEC migration was 
non-significantly increased by 1.7-fold after exposure to LSS.  In the Merlin 
knock-down, the level of migration further increased to 3.4-fold after exposure to 
LSS compared with static controls. 
  
185 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8  The role of laminar shear stress on Merlin knock-down HAEC 
migration. 
The role of laminar shear stress on HAEC adhesion was studied using xCELLigence
®
 
system.  Following 10 dyne/cm
2
 24 hours shear, both scrambled and Merlin knock-down 
cells were seeded into E-plates at concentration of 30,000 cells per well. Graphs illustrate 
the effect of LSS on HAEC migration in the absence of Merlin.  Cyan: scrambled control; 
Pink: sheared; Green: Merlin knock-down; Blue: Merlin knock-down+sheared. Histograms 
represent slope change according with CI values. Results are averaged from three 
independent experiments ±SEM and each experiment was performed in triplicate and each 
experiment was performed in triplicate; *P≤ 0.05 vs control. 
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4.2.7 The effect of cyclic strain on Merlin knock-down HAEC 
adhesion. 
 
To investigate the effect of cyclic strain on Merlin knock-down HAEC adhesion, 
HAECs were transfected with Merlin siRNA.  Cells were then incubated for 48 
hours at 37
o
C.  The cells were harvested after incubation and transfection 
efficiency was monitored by Western blot to ensure that approximately 80% 
knock-down of Merlin was achieved. Both Merlin knock-down HAECs and 
scrambled control cells were then exposed to cyclic strain (10% for 24 hours).  
Cells were then trypsinised and seeded into E-plates at a concentration of 30,000 
cells per well. HAEC adhesion was monitored using the Real Time Cell Analysis 
System xCELLigence
®
. 
 
Results indicate that relative to static controls, the level of adherence of HAECs was 
increased by 1.38-fold after exposure to 10% cyclic strain.  Significantly, in the 
Merlin knock-down, the level of adherence significantly increased to 2.25-fold after 
exposure to 10% cyclic strain compared with static controls. 
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Figure 4.9 The role of cyclic strain on Merlin knock-down HAEC adhesion. 
The role of cyclic strain on HAEC adhesion was studied using the xCELLigence
®
 system.  
Following 10% 24 hours strain, both scrambled and Merlin knock-down cells were seeded 
into E-plates at a concentration of 30,000 cells per well. The above graphs illustrate the 
effect of cyclic strain on Merlin absent HAEC adhesion: Green: scrambled control; Blue: 
Merlin knock-down; Pink: strained; Cyan: Merlin knock-down+sheared. Histograms 
represent the slope change according to the CI value. Results are averaged from three 
independent experiments ±SEM and each experiment was performed in triplicate; P≤ 
0.05 vs control. 
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4.2.8 The effect of cyclic strain on Merlin knock-down HAEC 
migration. 
In order to investigate the effect of cyclic strain on Merlin knock-down HAEC 
migration, HAECs were transfected with Merlin siRNA.  Cells were then incubated 
for 48 hours at 37
o
C.  Cells were harvested following incubation, and transfection 
efficiency was monitored by Western blot to make sure that about 80% knock-down 
of Merlin was achieved.  Both Merlin knock-down HAECs and scrambled control 
cells were exposed to cyclic strain (10% for 24 hours). The cells were then 
trypsinised using EDTA and then seeded into CIM-plates at concentration of 30,000 
cells per well.  Cell adhesions were monitored by the Real Time Cell Analysis 
System xCELLigence
®
. 
 
Results indicate that relative to static controls, the level of migration of HAECs was 
increased by 1.25-fold after expose to 10% cyclic strain.  When Merlin was 
knocked-down, migration levels was significantly increased to 2.17-fold after 
exposure to 10% cyclic strain compared with static controls.  
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Figure 4.10 The role of cyclic strain on Merlin knock-down HAEC migration. 
The role of cyclic strain on HAEC adhesion was studied using the xCELLigence
®
 system.  
Following 10% 24 hours strain, both scrambled and Merlin knock-down cells were seeded 
into E-plates at a concentration of 30,000 cells per well.  Graphs illustrate the effect of 
cyclic strain on Merlin-absent HAEC migration: Green: scrambled control; Blue: Merlin 
knock-down; Pink: strained; Cyan: Merlin knock-down+sheared.  Histograms represent the 
slope change according to the CI value. Results are averaged from three independent 
experiments ±SEM and each experiment was performed in triplicate; *P≤ 0.05 vs 
control. 
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4.3. Discussion 
Intensive studies have been carried out since the discovery of Merlin in 1993, due to 
its tumour suppressor function and its close structural similarity to ERM proteins.  
It has been widely reported that Merlin affects the stabilization of 
membrane-cytoskeleton interaction.  Over 30 proteins so far have been known to 
interact with Merlin (Table 4.3) (Scoles 2008c). All these interacting proteins 
critically regulate Merlin structure and function.  For example, Merlin may be 
phosphorylated at serine 518 by interacting with p21-activated kinases (PAKs) 
(Kissil, et al. 2002b). Merlin is well known as a linker protein between the 
membrane and cytoskeleton.  However, unlike other ERM family members, Merlin 
contains both an F-actin binding domain and FERM domain in the N-terminal 
(Sainio, et al. 1997) (Xu and Gutmann 1998b) which may indicate the merlin exists 
for different functions. Interestingly, our IP results discovered the interaction of 
merlin with microtubules. Xu HM has also demonstrated that Merlin contains a 
microtubule-binding domain in the N-terminal, which can be closed by 
self-association form (Figure 4.11) (Xu and Gutmann 1998b). Xu demonstrated that 
merlin binding to polymerized actin at its N-terminal domain mapping to residues 
178–367. This interaction is not affected folding of merlin which is considered as 
“close conformation”. The “closed conformation” may serve as a docking site that 
allows merlin interacts with its critical effector proteins. In contrast, interaction of 
merlin with microtubules exists in an ‘‘open conformation”. Merlin is unable to 
associate with microtubules in the ‘‘closed conformation”, due to the losses of the 
correct conformation necessary for this association. The interaction of merlin with 
microtubules may also implicate the cross talk between tubulin and actin (Figure 
4.12). As one of the major component of cytoskeleton, microtubule has long been 
known to be essential for cell polarization, vesicle transport and cell division. It is 
also play a critical role in cell migration (Scliwa and Höner 1993) (Small, et al. 2002). 
Vasiliev et al were first reported that microtubules were required during cell 
migration in 1970 (Vasiliev, et al. 1970). Concentrated microtubules were observed 
  
191 
 
at the leading edge of lamellipodia (Rinnerthaler, Geiger and Small 1988). 
Furthermore, Kaverina demonstrated the presence of microtubules at FA in 
fibroblast (Kaverina, Rottner and Small 1998). Stabilization of plus end enable 
microtubules re-orient towards the leading edge and constitute a highly dynamic 
cytoskeleton filament system. Microtubules are considered to control disassemble of 
FA (Rid, et al. 2005). The polymerization of microtubule filament requires helps of 
many scaffolding proteins, such as paxillin (Efimov, et al. 2008). However, the role 
of merlin plays in microtubule polymerization is poorly understood and requires a 
further investigation. 
 
 
Figure 4.11 The model of merlin “open and close conformation”.  
Xu demonstrated that merlin binding to polymerized actin at its N-terminal domain mapping 
to residues 178–367. This interaction is not affected folding of merlin which is considered 
as “close conformation”. The “closed conformation” may serve as a docking site that allows 
merlin interacts with its critical effector proteins that fail of merlin growth suppressor 
function. In contrast, interaction of merlin with microtubules exists in an ‘‘open 
conformation”. Merlin is unable to associate with microtubules in the “closed 
conformation”, due to the losses of the correct conformation necessary for this association.   
(Xu, Huamei 1998) 
  
192 
 
The CO-IP results indicated that Merlin protein bound to many functional proteins 
including tubulin, myosin light chain 6B, annexin and actin.  This result verified 
our last co-localisation study that Merlin is present at numerous functional sites of 
stress fibres, focal adhesion, at sites of cell-cell contact and the leading cell edge in 
lamellipodial regions. However, our CO-IP results also unveiled some other Merlin 
interacting proteins, including transferrin receptor protein 1, annexin A2 and myosin 
light chain 6B. Transferrin receptor protein is involved in regulate the intaking of 
irons into cell (Qian ZM, Li H, Sun H, Ho K,. 2002), while annexin is cellular 
protein that is involved in control cellular processes including cell motility. The 
diversity of merlin binding protein may indicate its broad cellular functions. As 
these proteins have not been reported as interacting with Merlin in other studies, a 
further investigation will carried out to determine if these proteins are directly 
interact with Merlin. 
 
 
Figure 4.12 Crosstalk between actin filaments and microtubule, and their 
interaction with focal adhesion.  
Microtubules are stabilized at the plus ends and oriented towards to the leading edge of 
migrating cell where it interacts with FA. Several proteins are involved in the processes, 
including cross-linker proteins which possess both actin- and microtubule-binding domains 
and actin-based motor protein myosins. The local targeting of microtubules modulates the 
activities of Rho family GTPases, resulting in the regulation of focal adhesion turnover. 
(Watanabe, Noritake and Kaibuchi 2005) 
  
193 
 
 
As Merlin was originally identified as a tumour suppressor, mutations to NF2 gene 
related to many cancers, including schwannomas, meningiomas, melanoma and 
thyroid cancer (Evans, et al. 1992) (Gutmann, et al. 1997) (Xiao, Chernoff and Testa 
2003) (Bianchi, et al. 1994). Many studies have shown that Merlin is critical in 
regulating in cell growth and motility (LaJeunesse, McCartney and Fehon 1998) 
(Sherman, et al. 1997b) (Ikeda, et al. 1999).  Absence of Merlin interrupts 
embryonic development and also initiates tumour metastasis (McClatchey, et al. 
1997) (McClatchey, et al. 1998). Our studies have also revealed that merlin 
knock-down significantly increases HACE motility in terms of both adhesion and 
migration.  In order to investigate what role Merlin plays in cell-matrix and 
cell-cell adhesion and how this might be regulated, a series of cell adhesion 
experiments were performed using a variety of ECMs, including fibronection, 
fibrinogen, laminin and vitronectin.  Results indicated that relative to scrambled 
controls, Merlin-absent cells bound preferentially to vitronectin (VN) and 
fibronectin (FN). It is well documented that both of VN and FN contain the adhesive 
sequence: Argenine-Glycine-Aspartic acid (RGD) which selectively binds to αvβ3 
and β1 integrin (Redick, et al. 2000). High expression of these ECMs is related to 
endothelial injury or inflammation.  Apart from these RGD sequences, FN also 
contains two other actin-binding domains: Pro-His-Ser-Arg-Asn (PHSRN) and 
Ile-Asp-Ala-Pro-Ser (IDAPS).  It is documented in literature that the PHSRN 
domain is recognised by α5β1 while the IDAPS domain activates α4β1 (Vogel 2006) 
(Pierschbacher and Ruoslahti 1984) (Mould and Humphries 1991). As mentioned 
previously, Obremski, Hall and Fernandez have revealed that Merlin also interacts 
with β1-integrin (Obremski, Hall and Fernandez‐Valle 1998b). From the attachment 
data, we can speculate on the important role played by Merlin in control of HAEC 
adhesion and migration. Furthermore, it may act to regulate HAEC motility by 
interacting with αvβ3 and β1 integrin.  
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Our previous data also show down-regulation of Merlin protein expression by 
various hemodynamic forces including shear stress and cyclic strain (figure 3.3 and 
figure 3.5).  The effects of hemodynamic force on EC functions have long been 
investigated and the one of the historical discoveries is the realignment of ECs in the 
direction of a steady shear flow (Davies and Tripathi 1993). The process is then 
followed by EC migration.  Both steps involved in cytoskeleton reorganization and 
formation of focal adhesion require the recruitment of many proteins. Many 
laboratories, including those of our colleagues in DCU, have shown the effects of 
cyclic strain and shear stress on EC migration (Von Offenberg Sweeney, et al. 2005). 
In this regard, we proposed that prolonged exposure of hemodynamic force would 
change HAEC functions, such as motility through the down-regulation of Merlin 
protein.  Figure 4.6 to figure 4.9 elegantly illustrates how both shear stress and 
cyclic strain increased HAEC adhesion and migration, and how these increases were 
even more enhanced when Merlin was knocked-down.  These results clearly 
implicate the negative role of Merlin in regulation of HAEC motility. However, we 
observed that merlin knock-down increased adhesion in Figure 4.5 but no effect in 
Figure 4.7. The effect of merlin knock-down on HAEC adhesion in figure 4.5 was 
performed on ECM coated plate while the experiments on figure 4.7 were performed 
on none-coating plate. This may alter the HAEC’s attachment.  
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Table 4.3 Merlin interacting proteins 
(Scoles 2008e) 
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Chapter Five 
 
 
The role of Merlin in the regulation of 
the uPAR-integrin signalling nexus 
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5.1 Introduction 
 
The extracellular matrix (ECM), not only provides physical support for tissue, but is 
also pivotal in both interaction with and activation of cell plasma membrane 
receptors, and thus cytoplasmic signal transduction. Some of the cell fate and 
functions that are regulated by such processes include cell adhesion and migration.  
Interaction between ECM and cell membrane receptors plays an important role in 
vascular remodelling and EC repair.  Alteration of the physical property or 
composition of ECM results in hypertensive heart disease (HHD) which is one of 
the major causes of stroke and heart failure (Berk, Fujiwara and Lehoux 2007). The 
deposition of fibronectin and fibrinogen into the subendothelial ECM is the early 
sign of progression of atherosclerosis. A. Wayne Orr et al have showed the 
interaction of subendothelial ECM with flow activates endothelial cell integrins, 
which in turn trigger nuclear factor-κB activation (Tzima, et al. 2001).  
 
The urokinase type plasminogen activator receptor, uPAR, is one of the cell 
membrane adhesive receptors that play a crucial role in a number of cellular 
processes, including proteolysis and fibrinolysis.  uPAR is an essential component 
of the activation machinery that converts and activates plasminogen into the protease 
plasmin.  It also facilitates the pro-urokinase into urokinase (uPA).  Both of these 
enzymes are essential in proteolysis and fibrinolysis.  uPAR is anchored to cell 
membrane by its GPI domain (peripheral glycosyl-phosphatydil-insositol) which can 
also be cleaved and release the soluble uPAR (Figure 1.12). The GPI tail located at 
the Gly 283 residue which does not span the membrane. Due to its lack of a 
cytoplasmic domain, uPAR must interact with other trans-membrane receptors, such 
as integrin and G-coupled receptors, for outside-in signal transduction (figure 5.1) 
(Blasi and Carmeliet 2002b). Among these receptors, integrins are the most well 
studied and characterised.  Previous studies have shown that uPAR interacts with a 
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number of the integrin family, specifically the heterodimers containing the β1, β2, 
β3 and β5 integrin subunits (Ragno 2006). Most recently, attention has focused on a 
less well characterised member of the integrin family-αvβ6, and its interaction with 
uPAR (Saldanha, et al. 2007). αvβ6 is thought to play a pivotal role in the metastasis 
and intra/extravasion of cancer cells via its interaction with uPAR (Ahmed, et al. 
2002). It is also thought to play a role in the activation of Latency Associated 
Peptide (LAT or pro-TGF-β) and in epithelial-Mesenchymal Transition (EMT) (Wei, 
et al. 1996). 
 
Integrins have been the focus of intense study due to their role in a multitude of 
cellular functions and their ability to “integrate” signals into and out of the cell in a 
bi-directional manner (Schwartz and Assoian 2001b) (Harris, Wild and Stopak 
1980). They have been well studied for their ability to transduce these “inside-out” 
and “outside-in” signals which are capable of influencing cytoskeletal dynamics and 
subsequent, cell adhesion and migration. Although the direct binding of uPA with 
integrins is controversial, accumulating evidence demonstrated the requirement of 
integrins in uPAR signalling. The interaction of uPAR with its agonists promotes 
integrin-mediated cell motility as well as cell proliferation (Blasi 1997) (Chapman 
1997) (Degryse, et al. 1999). α5β1 was demonstrated to be involved in 
uPA-uPAR-mediated migration in chinese hamster ovary cells. The vitronectin 
binding receptors, αvβ3, αvβ5, are other integrins that are associated with uPAR 
(Montuori, et al. 2001).  
 
Urokinase is a single chain enzyme, with a molecular weight of 54 kDa.  The 
inactive state of urokinase is referred to as pro-uPA which can be activated by 
binding to uPAR (Prager, et al. 2004). Activated urokinase is comprised of two 
chains and is referred to as high molecular weight urokinase.  The association of 
urokinase to uPAR result in plasminogen activation, which then promotes cell 
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migration by enhanced ECM proteolysis (Estreicher, et al. 1990). Many studies have 
also demonstrated that uPAR promotes cell migration and proliferation through the 
activation of FAK and Rho families signalling pathways (JA 2002) (Vial, Sahai and 
Marshall 2003) (Kjøller and Hall 2001a).  
 
Wei, et al. were the first to describe the binding interaction between uPAR and 
vitronectin (Wei, et al. 1996). It is now well established that vitronectin interacts 
with many integrin family members, including αvβ1, αvβ3, αvβ5 and αIIβ3, which 
all contain a RGD motif (Hynes 1992) (Pytela, Pierschbacher and Ruoslahti 1985a) 
(Pytela, Pierschbacher and Ruoslahti 1985b) (Preissner and Jenne 1991). The 
vitronectin binding site on uPAR is located on the D1 and the D1-D2 linker regions 
(Gårdsvoll and Ploug 2007). Sidenius, N. et al. demonstrated that the interaction 
between urokinase and uPAR enhance the binding ability of vitronectin with uPAR 
(Alfano, et al. 2002). Vitronectin can also be observed at the sites of focal adhesions 
(Ciambrone and McKeown-Longo 1992) (Kjøller and Hall 2001b) and specifically at 
the site of interaction between vitronectin and FA which is involved in 
re-arrangement of FA components (Kjøller and Hall 2001b).  
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Figure 5.1:  uPA-uPAR and their interacting receptors 
(Binder, Mihaly and Prager 2007) 
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5.1.1 Study Aims 
5.1.1.1 Background 
Previous work in our laboratory has demonstrated that uPAR to be found involved 
in strain-induced tube formation, and that uPA is critical in cyclic strain regulated 
cell migration and tube formation in ECs (Von Offenberg Sweeney et al., 2005).  
Intensive studies in our laboratory have also indicated that Moesin, another ERM 
family member, is critically involved in chemotaxis, angiogenesis and endothelial 
barrier integrity.  Therefore, the work undertaken set out to investigate if uPAR is 
involved in EC adhesion and migration, and by which mechanisms these uPAR 
mediated functions are controlled.   
 
5.1.1.2 Hypothesis  
We postulated that merlin regulates HACE adhesion and migration through a 
specific integrin-αvβ3, and the interaction of αvβ3 with uPAR is required in this 
cellular mechanism. 
 
5.1.1.3 Specific Aims 
The overall aims of this chapter include: 
 Based on the results of the cell-ECM adhesion and migration assays, 
investigate integrin inhibition (i.e. integrins that bind to RGD-containing ECM) 
alter cell migration.  
 Using urokinase (uPA) to activate of uPAR, and using integrin (αvβ3)  
and G-coupled receptor (fMLly) activating peptides (e.g. D2A and 
SRSRY) to investigate the role of uPAR on endothelial cell migration, 
and to identify which membrane receptor is the principle play in this 
process i.e. migration.   
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 Using siRNA mediated knock-down techniques, investigate if Merlin is 
involved in uPAR- integrin mediated cell-matrix adhesion and migration. 
 To investigate whether Merlin phosphorylation is modulated by uPAR using 
signalling. 
 
5.2 Results 
 
5.2.1 The effect of various RGDs inhibitory peptides on integrin mediated 
HAECs adhesion. 
From the previous chapter, it can be seen that knock-down of merlin in HAECs 
preferentially promote adhesion to both VN and FN.  Both of these ECM contain a 
RGD sequence which selectively activates specific integrins, such as αvβ3 (table 
5.2). To elucidate the effect of various specific RGD peptides on integrin-mediated 
HAECs’ adhesion, real time adhesion assays were carried out in the presence of 
three well characterised RGD inhibitors.  RGD1 inhibitor blocks both vitronectin 
and fibronectin mediated integrin interactions, RGD2 inhibitor is specific for 
fibronectin mediated integrin adhesion, while RGD3 blocks vitronectin mediated 
integrin activation.  In brief, the role of three RGDs on integrin mediated adhesion, 
in wild type HAEC was studied using the real time impedance based xCELLigence
®
 
system (Roche Diagnostics, Basal, Switzerland), HAECs were seeded into E-plates 
at a concentration of 30,000 cells per well, with the same number of untreated cells 
used for controls. The wells of which, had been treated with either RGD1, RGD2, or 
RGD3 prior to beginning the experiment.  Results illustrate that compared with 
untreated controls, RGD1 inhibitor significant decreased wild type HAECs’ 
adhesion (62%), while incurring a non-significant 20% reduction in HAEC adhesion 
was observed with RGD2 and a non-significant 38% reduction in HACE adhesion 
was observed with RGD3 mediated inhibition. Furthermore, the maximal 
attachments of HAEC on both control and RGD inhibitors treated cells were reached 
at the 3 hour time point. 
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Fig 5.2:  The effect of specific RGDs inhibitors on integrin mediated HAECs’ 
adhesion 
 
The role of RGD-mediated integrin inhibition on wild type HAEC adhesion was studied 
using the real-time xCELLigence
®
 system. HAECs were seeded into E-plates at a 
concentration of 30,000 cells per well, with the same number of untreated cells used for 
controls. The wells of which, had been treated with either RGD1, RGD2, or RGD3 prior to 
beginning the experiment. Graphs illustrate that compared with untreated controls; RGD 
inhibitors significantly decreased HAEC adhesion as expected.  The histogram represents 
slope changes, i.e. rate of adhesion, according with CI value change of RGD-treated HACE 
related to un-treated control. Results are averaged from three independent experiments ±
SEM; *P≤ 0.05 vs control. 
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5.2.2 Specific of RGD inhibitors and their effect on uPA mediated HAECs’ 
adhesion. 
 
As uPAR only contains an extracellular domain, it has to transduce extracellular 
signals through the interaction and synergistic association with other cell membrane 
receptors. Many studies have shown that integrins play important roles in uPAR 
mediated cell signaling.  Therefore, in this section, we investigate if integrins are 
involved in the uPAR mediated signaling. To study the effects of RGD inhibitors on 
uPA stimulated HAEC adhesion, again, the xCELLigence
®
 system was employed.  
Wild type HAECs were seeded into E-plates at a concentration of 30,000 cells per 
well. The wells of which, had been treated with uPA and either RGD1, RGD2, or 
RGD3 prior to beginning the experiment. For controls, untreated cells were used.  
The results illustrated that in comparison with untreated controls, uPA-mediated 
activation of uPAR increased HAEC adhesion by approximately 23% 
(non-significant). This increase was abrogated, significantly with treatment of RGD1 
(54% decrease) and RGD3 (52% decrease).  Only a non significant 24% reduction 
on HAEC adhesion was observed upon treatment with RGD2.  Furthermore, 
maximal adhesion of HAECs in both control and treated cells was reached at the 3 
hour time point. 
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Fig 5.3:  The effect of specific RGD inhibitors on uPA mediated HAECs 
adhesion 
 
The effect of the three specific RGD inhibitors on uPA-mediated wild type HAECs 
adhesion was studied using the xCELLigence
®
 system. HAECs were seeded into E-plates at 
a concentration of 30,000 cells per well. The wells of which, had been treated with uPA and 
either RGD1, RGD2, or RGD3 prior to beginning the experiment (the concentrations are 
described in chapter 2). Untreated cells were used as controls. Graphs illustrate that 
compared with untreated controls; uPA increased HAEC adhesion, the effect of which was 
significantly inhibited by the addition of the RGD inhibitors.  The histogram represents 
slope changes according with CI value change. (Red: control, Green: UPA, Blue: 
RGD1+UPA, Pink: RGD2+UPA, Cyan: RGD3+UPA). Results are averaged from three 
independent experiments ±SEM; *P≤ 0.05 vs control. 
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5.2.3 The effect of specific RGD inhibitors on D2A mediated HAEC adhesion. 
 
Due to less of cytoplasmic domain, uPAR has to interact with the other 
transmembrane proteins such as αvβ3 and fMLP for signaling transduction. To 
investigate which transmembrane protein is involved in uPAR regulated HAECs 
motility two peptides D2A and SRSRY were employed. D2A was first synthesized 
by Bernard Degryse and his collegues (Bernard Degryse, et al 2005). The details of 
this peptide please see section 1.6.2.  D2A has been shown to interact laterally with 
αvβ3 integrin and induce cell migration, via outside-in signalling. SRSRY 
(Ser-Arg-Ser-Arg-Tyr) is another chemotactic peptide, bind specifically to fMLP- a 
seven-transmembrane domain G-coupled receptor, and promote cell migration in 
this manner (Lucia Gargiulo, et al, 2005). 
 
In order to study the effect of the RGD inhibitors on D2A mediated HAECs 
adhesion (i.e. αvβ3 integrin mediated), the xCELLigence® system was employed.  
Wild type HAECs were seeded into E-plates at a concentration of 30,000 cells per 
well. The wells of which, had been treated with D2A and either RGD1, RGD2, or 
RGD3 prior to beginning the experiment. Untreated cells were used as controls. The 
results illustrate that compared with untreated controls, D2A-mediated activation of 
αvβ3 significantly increased HAEC adhesion by approximate 23%, and was 
significantly decreased by treatment with RGD1 (69% decrease) and RGD3 (40% 
decrease), while only a 24% reduction on HAEC adhesion was observed upon 
treatment with RGD2. Furthermore, the maximal attachments of HAEC on both 
control and treated cells were reached at 3 hour time point. 
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Fig 5.4:  The effect of specific RGD inhibitors on D2A mediated wild type 
HAEC adhesion 
 
The effect of specific RGD inhibitors on D2A mediated wild type HAEC adhesion was 
studied using the xCELLigence system
®
. Wild type HAECs were seeded into E-plates at a 
concentration of 30,000 cells per well. The wells of which, had been treated with D2A and 
either RGD1, RGD2, or RGD3 prior to beginning the experiment. Untreated cells were used 
as controls. Graphs illustrate that compared with untreated controls D2A increased HAEC 
adhesion, and that this increase was significantly inhibited by the addition of RGD inhibitors.  
The histogram represents slope changes according with CI value change.  (Cyan: control, 
Pink: D2A, Red: RGD1+D2A, Green: RGD2+D2A, Blue: RGD3+D2A). Results are 
averaged from three independent experiments ±SEM; *P≤ 0.05 vs control. 
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5.2.4 The effect of specific RGD inhibitors on SRSRY mediated HAEC 
adhesion. 
 
To study the effect of the three RGD inhibitors on SRSRY mediated HAECs 
adhesion (i.e. fMLP mediated adhesion), the xCELLigence
®
 system was employed.  
Wild type HAECs were seeded into E-plates at a concentration of 30,000 cells per 
well. The wells of which, had been treated with SRSRY and either RGD1, RGD2, or 
RGD3 prior to beginning the experiment.  Results indicate that compared with 
untreated controls, SRSRY mediated activation of fMLP increased HAEC adhesion 
by approximately 10% (non-significant), the effect of which was significantly 
decreased by treatment with RGD1 (67% decrease) and RGD3 (53% decrease), 
while only a 20% reduction on HAEC adhesion was observed upon treatment with 
RGD2.  Furthermore, maximal adhesion of HAECs, with both control and treated 
cells was reached at the 3 hour time point. 
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Fig 5.5:  The effect of specific RGD inhibitors on SRSRY peptide mediated 
HAEC adhesion.  
 
The effect of specific RGD inhibitors on SRSRY mediated adhesion in wild type HAECs, as 
studied using the xCELLigence
®
 system.  Wild type HAECs were seeded into E-plates at a 
concentration of 30,000 cells per well. The wells of which, had been treated with SRSRY 
and either RGD1, RGD2, or RGD3 prior to beginning the experiment. Untreated cells were 
used as controls.  Graphs illustrate that compared to untreated controls; SRSRY increased 
HAEC adhesion, which was significantly inhibited by the addition of RGD inhibitors.  The 
histogram represents slope changes according with CI value change. (Red: control, Green: 
SRSRY, Blue: RGD1+SRSRY, Pink: RGD2+SRSRY, Cyan: RGD3+SRSRY). Results are 
averaged from three independent experiments ±SEM; *P≤ 0.05 vs control. 
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5.2.5 The effect of the integrin inhibitor, RGD1 on HAEC adhesion in siRNA 
mediated merlin knockdown HAECs 
 
From the previous studies, we concluded that uPAR transduced cell signals through 
the integrin mediated pathways.  We then sought to investigate whether Merlin was 
involved in this molecular mechanism.  The role of RGD1 mediated integrin 
inhibition on Merlin knock-down HAEC adhesion was studied using the 
xCELLigence
®
 system.  HAECs were first transfected with Merlin siRNA to 
knock-down Merlin protein expression.  HAECs were also transfected with 
scrambled siRNA for the control study. The transfection and subsequent 
knock-down efficiency was monitored using western blot, to ensure a minimum of 
70 to 80% knock-down of Merlin in HAECs was achieved before analysis could 
proceed. Both scrambled control and Merlin knock-down HAECs were seeded into 
E-plates at a concentration of 30,000 cells per well. The wells of which, had been 
treated with RGD1 prior to beginning the experiment.  Untreated cells were used as 
controls.  The results indicate that compared with scrambled controls, Merlin 
knock-down significantly increased HAEC adhesion by 73%.  This then decreased 
by 63% when treated with RGD 1 inhibitors.  Maximal attachments of HAECs on 
both control and treated cells were reached at the 4 hour time point. 
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Fig 5.6:  The effect of RGD1 mediated integrin inhibition on HAEC adhesion 
in siRNA mediated merlin knock-down cells 
 
The effect of RGD1 mediated integrin inhibition on Merlin knock-down HAEC adhesion 
was studied using the xCELLigence
®
 system.  Both Merlin knock-down (i.e. siRNA 
treated) and scrambled siRNA treated control HAECs were seeded into E-plates at a 
concentration of 30,000 cells per well. The wells of which, had been treated with RGD1 
prior to beginning the experiment. Scrambled siRNA transfected HAECs were used as 
controls.  Graphs illustrate that compared with untreated controls, the treatment of RGD1 
inhibitor significantly reduced the effect of Merlin absence on HAEC adhesion. The 
histogram represents slope changes according with CI value change. Results are averaged 
from three independent experiments ±SEM; *P≤ 0.05 vs control. 
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5.2.6 The effect of the integrin inhibitor, RGD2 on HAEC adhesion in siRNA 
mediated merlin knockdown cells 
 
The effect of RGD2 mediated integrin inhibition on the Merlin knock-down HAEC 
adhesion profile was studied in real-time, using the xCELLigence
®
 system.  
HAECs were first transfected with Merlin siRNA to knock-down Merlin protein 
expression. HAECs were also transfected with scrambled siRNA for control studies.  
The transfection and subsequent knock-down efficiency was monitored using 
Western blot, to ensure a minimum 70 to 80% knock-down of Merlin in HAECs was 
achieved before analysis could proceed. Both scrambled control and Merlin 
knock-down HAECs were seeded into E-plates at a concentration of 30,000 cells per 
well. The wells of which, had been treated with RGD2 prior to beginning the 
experiment. Untreated cells were used as controls. Results showed that in 
comparison with scrambled control, Merlin knock-down significantly increased 
HAEC adhesion by 73%, the effect of which was decreased by 27% upon treatment 
by RGD2 inhibitors.  Furthermore, the maximal adhesion of HAECs with both 
control and treated cells was reached at the 4 hour time point. 
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Fig 5.7:  The effect of the integrin inhibitor, RGD2 on HAEC adhesion in 
siRNA mediated merlin knock-down cell 
 
The effect of RGD2 mediated integrin inhibition on Merlin knock-down HAEC adhesion 
was studied in real time using the xCELLigence
®
 system. Both scrambled control and 
Merlin knock-down HAECs were seeded into E-plates at a concentration of 30,000 cells per 
well. The wells of which, had been treated with RGD2 prior to beginning the experiment. 
Untreated scrambled control HAECs were used as controls. Graphs illustrate that compared 
with untreated controls, treatment of RGD2 inhibitor reduced the effect observed on Merlin 
knock-down on HAEC adhesion. The histogram represents slope changes according with CI 
value change. Results are averaged from three independent experiments ±SEM; *P≤ 
0.05 vs control. 
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5.2.7 The effect of the integrin inhibitor, RGD3 on HAEC adhesion in siRNA 
mediated merlin knock-down cells 
 
The effect of RGD3 mediated integrin inhibition on HAEC adhesion in merlin 
knock-down cells, was studied using real time cell analysis, the xCELLigence
®
 
system.  HAECs were transfected with Merlin siRNA to knock-down Merlin 
expression.  HAECs were transfected with scrambled siRNA for the purposes of 
control studies, as well as untransfected cell. The transfection and subsequent 
knock-down efficiency was monitored using western blot, to make sure a minimum 
of a 70 to 80% knock-down of Merlin in HAECs was achieved before analysis could 
proceed.  Both scrambled control and Merlin knock-down HAECs were seeded 
into E-plates at a concentration of 30,000 cells per well. The wells of which, had 
been treated with RGD3 prior to beginning the experiment.  Untreated cells were 
also used for controls.  The findings illustrated, that compared with scrambled 
controls, Merlin knock-down significantly increased HAEC adhesion by 73%, the 
effect of which was abrogated by 74% upon treatment with RGD3 inhibitory 
peptides.  Furthermore, maximal adhesion of HAECs on both control and treated 
cells were reached at the 4 hour time point. 
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Fig 5.8:  The effect of RGD3 mediated integrin inhibition on HAECs adhesion, 
in siRNA mediated merlin knock-down cells 
 
The effect of RGD3 mediated integrin inhibition on HAECs adhesion in merlin 
knock-down cell, was studied using the xCELLigence
®
 system. Both scrambled 
control and Merlin knock-down HAECs were seeded into E-plates at a concentration 
of 30,000 cells per well. The wells of which, had been treated with RGD3 prior to 
beginning the experiment. Untreated scrambled control HAECs were used as 
controls in this experiment.  Graphs illustrate that compared with untreated controls, 
treatment of RGD3 inhibitor significantly reduced the impact of Merlin absence on 
HAEC adhesion.  The histogram represents slope changes according with CI value 
change. Results are averaged from three independent experiments ±SEM; *P≤ 
0.05 vs control. 
 
 
 
  
216 
 
5.2.8 The effect of the integrin inhibitor, RGD1 on HAEC migration in siRNA 
mediated merlin knock-down cells 
 
The effect of RGD1 mediated integrin inhibition on Merlin knock-down HAEC 
migration profile was studied in real-time, using the xCELLigence
®
 system. HAECs 
were transfected with Merlin siRNA to knock down Merlin protein expression. 
HAECs were also transfected with scrambled siRNA for the control studies.  The 
transfection and subsequent knock-down efficiency was monitored using Western 
blot to ensure a minimum of 70 to 80% knock down of Merlin in HAECs was 
achieved before analysis could proceed. Both scrambled controls and Merlin 
knock-down HAECs were then seeded into the upper chambers of CIM-plates at a 
concentration of 30,000 cells per well.  The lower chambers of CIM plate of which, 
had been treated with RGD1 prior to beginning the experiment.  As before, 
untreated cells were used as controls.  The results illustrate that compared with 
scrambled controls, merlin knock-down significantly increased HAEC migration by 
71%, the effect of which was decrease by 24% upon treatment with RGD1 inhibitors. 
Furthermore, the maximal migration of HAEC with both control and treated cells 
was reached at the 4 hour time point.  
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Fig 5.9:  The effect of RGD1 mediated integrin inhibition on Merlin 
knock-down HAEC migration 
 
The effect of RGD1 mediated integrin inhibition on Merlin knock-down HAEC migration 
was studied in real time using the xCELLigence
®
 system.  Both Merlin knock-down and 
scrambled control HAECs were seeded into the upper chambers of CIM-plates at a 
concentration of 30,000 cells per well.  The lower chambers of CIM plate of which, had 
been treated with RGD1 prior to beginning the experiment. Graphs illustrate that compared 
with untreated controls, RGD1 inhibitor reduced the effect observed on Merlin knock-down 
HAEC migration by 24%.  The histogram represents slope changes according with CI 
value change. Results are averaged from three independent experiments ±SEM; *P≤ 
0.05 vs control. 
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5.2.9 The effect of the integrin inhibitor, RGD2 on HAEC migration in siRNA 
mediated merlin knock-down cells 
 
The effect of RGD2 mediated integrin inhibition on Merlin knock-down HAEC 
migration profile was studied in real-time, using the xCELLigence
®
 system. HAECs 
were transfected with Merlin siRNA to knock down Merlin protein expression. 
HAECs were also transfected with scrambled siRNA for the control studies.  The 
transfection and subsequent knock-down efficiency was monitored using Western 
blot to ensure a minimum of 70 to 80% knock down of Merlin in HAECs was 
achieved before analysis could proceed. Both scrambled controls and Merlin 
knock-down HAECs were then seeded into the upper chambers of CIM-plates at a 
concentration of 30,000 cells per well. The lower chambers of CIM plate of which, 
had been treated with RGD2 prior to beginning the experiment. As before, untreated 
cells were used as controls.  The results illustrate that compared with scrambled 
controls, merlin knock-down significantly increased HAEC migration by 71%, the 
effect of which was decrease by 5% upon treatment with RGD2 inhibitors. 
Furthermore, the maximal migration of HAEC with both control and treated cells 
was reached at the 4 hour time point.  
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Fig 5.10: The effect of RGD2 mediated integrin inhibition on Merlin 
knock-down HAEC migration 
 
The effect of RGD2 mediated integrin inhibition on Merlin knock-down HAEC migration 
was studied in real time using the xCELLigence
®
 system. Both Merlin knock-down and 
scrambled control HAECs were seeded into the upper chambers of CIM-plates at a 
concentration of 30,000 cells per well.  The lower chambers of CIM plate of which, had 
been treated with RGD2 prior to beginning the experiment. Graphs illustrate that compared 
with untreated controls, RGD2 inhibitor reduced the effect observed on Merlin knock-down 
HAEC migration by 5%.  The histogram represents slope changes according with CI value 
change. Results are averaged from three independent experiments ±SEM; *P≤ 0.05 vs 
control. 
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5.2.10 The effect of the integrin inhibitor, RGD3 on HAEC migration in siRNA 
mediated merlin knock-down cells 
 
The effect of RGD3 mediated integrin inhibition on Merlin knock-down HAEC 
migration profile was studied in real-time, using the xCELLigence
®
 system. HAECs 
were transfected with Merlin siRNA to knock down Merlin protein expression. 
HAECs were also transfected with scrambled siRNA for the control studies.  The 
transfection and subsequent knock-down efficiency was monitored using Western 
blot to ensure a minimum of 70 to 80% knock down of Merlin in HAECs was 
achieved before analysis could proceed. Both scrambled controls and Merlin 
knock-down HAECs were then seeded into the upper chambers of CIM-plates at a 
concentration of 30,000 cells per well. The lower chambers of CIM plate of which, 
had been treated with RGD3 prior to beginning the experiment. As before, untreated 
cells were used as controls.  The results illustrate that compared with scrambled 
controls, merlin knock-down significantly increased HAEC migration by 71%, the 
effect of which was decrease by 70% upon treatment with RGD3 inhibitors. 
Furthermore, the maximal migration of HAEC with both control and treated cells 
was reached at the 4 hour time point.  
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Fig 5.11: The effect of RGD3 mediated integrin inhibition on Merlin 
knock-down HAEC migration 
 
The effect of RGD3 mediated integrin inhibition on Merlin knock-down HAEC migration 
was studied in real time using the xCELLigence
®
 system. Both Merlin knock-down and 
scrambled control HAECs were seeded into the upper chambers of CIM-plates at a 
concentration of 30,000 cells per well.  The lower chambers of CIM plate of which, had 
been treated with RGD3 prior to beginning the experiment. Graphs illustrate that compared 
with untreated controls, RGD3 inhibitor reduced the effect observed on Merlin knock-down 
HAEC migration by 70%.  The histogram represents slope changes according with CI 
value change. Results are averaged from three independent experiments ±SEM; *P≤ 
0.05 vs control. 
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5.2.11 The comparison of RGD inhibitors on merlin knock-down HAEC 
motility.  
 
To compare the effect of RGD inhibitors on merlin knock-down HAEC motility 
HAECs were transfected with Merlin siRNA to knock down Merlin protein 
expression. HAECs were also transfected with scrambled siRNA for the control 
studies.  The transfection and subsequent knock-down efficiency was monitored 
using Western blot to ensure a minimum of 70 to 80% knock down of Merlin in 
HAECs was achieved before analysis could proceed. Both scrambled controls and 
Merlin knock-down HAECs were then seeded into E-plate for adhesion studies or 
CIM-plate for migration assay of which had been treated with RGD inhibitors prior 
to beginning the experiment. The HAECs motility was monitored in real-time, using 
the xCELLigence® system.    
 
The results demonstrate that compared with scrambled controls, merlin knock-down 
significantly increased HAEC motility, including adhesion (30%) and migration 
(88%). RGD1 inhibitors decreased the HAEC motility about 81% on adhesion and 
52% on migration compared with scrambled control. RGD2 inhibitors decreased the 
HAEC motility about 71% on adhesion and 2% on migration compared with 
scrambled control. RGD3 inhibitors decreased the HAEC motility about 83% on 
adhesion and 75% on migration compared with scrambled control. RGD inhibitors 
have also shown the ability to decrease HAECs motility when merlin was 
knocked-down. The treatment of RGD1 decreased merlin knocked-down HAEC 
adhesion by 58% and migration 47% respectively. The treatment of RGD2 
decreased merlin knocked-down HAEC adhesion by 24% and migration 16% 
respectively. The treatment of RGD3 decreased merlin knocked-down HAEC 
adhesion by 70% and migration 67% respectively.  
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Fig 5.12:  The comparison of RGD inhibitors on merlin knock-down HAEC 
motility. 
To compare of RGD inhibitors on merlin knock-down HAEC motility, the real time and 
label-free monitoring system, the xCELLigence
®
 system was employed. Both Merlin 
knock-down and scrambled control HAECs were seeded into E-plate for adhesion studies or 
CIM-plate for migration assay of which had been treated with RGD inhibitors prior to 
beginning the experiment at a concentration of 30,000 cells per well. The figure A represents 
adhesion assay and the figure B represents migration assay. Results are averaged from three 
independent experiments ±SEM; *P≤ 0.05 vs control. 
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5.2.12. The effect of D2A peptides on Merlin phosphorylation. 
 
In summary, we have demonstrated that uPAR plays a critical role in regulation of 
HAEC adhesion and migration, a process mediated via integrins. Moreover we have 
illustrated that Merlin is involved in this integrin-mediated cellular process.  In this 
section, we endeavored to further investigate if the activation of αvβ3 integrin by 
D2A directly modulates merlin phosphorylation state.  To study the effect of D2A 
peptides on merlin phosphorylation state, HAECs were seeded into 6-well plates at a 
density of 10
5 
cells per cm
2
 and allowed to adhere and grow to confluence over a 24 
hour period.  Cells were then exposed to 1 nM D2A acutely for time points of 1, 3, 
5, 10, 30 minute.  Untreated HACEs were used as control. Cells were then lysed, 
and analyzed by Western blotting.  Results demonstrate that merlin 
phosphorylation is increased within a short time-frame, starting at the 3 minutes 
(eliciting 0.25-fold increase in merlin phosphorylation approximately) and this 
transient phosphorylation of Merlin gradually increases until in a linear fashion until 
it reaches peak phosphorylation at 30 minutes approximately 2.2 fold increases.
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Fig 5.13:  The effect of D2A peptides on Phospho-Merlin expression. 
 
HAECs were seeded into 6-well plates at a density of105 cells per cm2, and allowed 
to adhere and grow to confluence over a 24 hour time frame.  The cells were then 
exposed to 1 nM D2A for the times stated above.  The effect of D2A peptides on 
phospho-merlin state was then monitored by Western blot.  Histograms represent 
fold change in band intensity relative to untreated control. Results are averaged from 
three independent experiments ±SEM; *P≤0.05 vs control.  
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5.2.13 The effect of SRSRY peptides on merlin phosphorylation. 
 
Again, to study the effect of SRSRY peptides on merlin phosphorylation, HAECs 
were seeded into 6-well plates at a density of 10
5 
cells per cm
2
 and allowed to adhere 
and grow to confluence over 24 hour time frame. The cells were then exposed to 
100nM SRSRY at time intervals of 1, 3, 5, 10, 30 minute. Untreated HACEs were 
used as control.  The cells were then lysed and analyzed by Western blot.  Results 
indicate that Merlin phosphorylation is increased; starting at the 1 minute time point 
(approximately 0.2-fold increase) and this phosphorylation of Merlin gradually 
increases, reaching a maximum at the 10 minutes (approximately 1.65-fold increase). 
Then decrease slightly at the 30 minute time point (about 1.6 fold increase). 
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Fig 5.14:  The effect of SRSRY peptides on merlin phosphorylation. 
 
HAECs were seeded into 6-well plates at a density of 10
5 
cells per cm
2
 and allowed 
to adhere and grow to confluence over 24 hours.  Cells were then treated with 100 
nM SRSRY for the times outlined. The effect of SRSRY peptides on merlin 
phosphorylation state was then monitored by Western blot.  Histograms represent 
fold change in band intensity relative to untreated control. Results are averaged from 
three independent experiments ±SEM; *P≤ 0.05 vs control.  
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5.3 Discussion 
 
From the previous chapter, it can be seen that Merlin knock-down HAECs 
preferentially adhered to VN and FN.  Both of these ECM contain a RGD sequence, 
which selectively interacts with specific integrins heterodimers, such as αvβ3 (for 
the comprehensive list of FN and VN binding integrins please check table 5.2). To 
elucidate the effect of various RGD peptides, each with specificity for different 
classes of integrins, on HAEC adhesion, a real time cell monitoring system, based 
on electrical impedance-xCELLigence system- was established. This allowed the 
dynamic monitoring of both cell adhesion and migrations over time, without the 
need for end-/fixed-point analysis. This allowed us to precisely monitor the rate and 
extent of adhesion and migration, something with is difficult to analyses with static 
standard assays. By investigating these cellular functions in real-time with three 
different, well characterized RGD peptide (for details please check Table 2.6), we 
were able to decipher the class of integrins involved and their overall contribution to 
the cellular dynamic.  RGD1 inhibitor prevents both vitronectin and fibronectin 
mediated integrin adhesion and outside-in signaling (Pytela, et al. 1986) (Leptin 
1986) (Yelian, et al. 1993), RGD2 inhibitor prevents fibronectin mediated integrin 
activation (Jester, et al. 1999) (Wu, Ustinova and Granger 2001), while RGD3 
blocks vitronectin mediated integrin activation (J.E.Mogford et al, 1996. K.J.Bayless 
et al, 2000).   
 
 
Results illustrated that in comparison with untreated controls; RGD1and RGD3 
inhibitors significantly decreased wild type HAEC adhesion, while only a slight 
reduction of HAECs adhesion was observed with the use of RGD2 mediated 
inhibition. This finding leads to the conclusion that integrin-mediated signaling is 
crucial for the regulation of EC motility.  The role of integrin in cell migration is 
well characterized elsewhere in literature (Moissoglu and Schwartz 2006). Cell 
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migration requires the attachment of cell surface to ECM which is mediated by 
many cell surface adhesion receptors including integrins, adhererins, cell adhesion 
molecules, syndecans and other proteoglycans. Among these receptors, integrins are 
is the most well studied and best characterized due to their importance in a multitude 
of cellular functions. Integrins contribute to cell adhesion and migration in multiple 
ways. The interaction between integrins and ECM can be modulated by intracellular 
signal which is termed “in-side out” and in turn activated integrins alter focal 
adhesion complex and induce intracellular signaling cascade which is called 
“out-side in” integrin signal. Integrins also serve as linkers that connect cytoskeleton 
to the ECM. Integrins are heterodimers which comprised of alpha (α) subunits and 
beta (β) subunits. Up to date, 24 integrins have been identified in human. Expression 
of integrins is in tissue specific manner. Many integrins such as αvβ3, β1, α5β1 and 
α6β4, play a center role in regulating endothelial integrity as well as vasculogenesis 
and angiogenesis (Weis 2007). Vasculogenesis is completely rely on FN mediated 
activation of α5β1 (Astrof and Hynes 2009). Studies also demonstrated that α5β1 is 
critical during vascular morphogenesis in mice with a FN dependent manner 
(Carlson, et al. 2008). Concentrated αvβ3 was observed at sites of wound healing and 
tumor growth which indicate its important role during pathologic vascularization 
(Brooks, Clark and Cheresh 1994b). 
 
 
Furthermore, these results have also shown that this integrin mediated HAEC cell 
adhesion and migration is principally through the interaction with vitronectin. Many 
integrins have been identified interact with vitronectin, list of these integrins can be 
found in Table 5.1. Among these integrins, αvβ3 is endogenously expressed in 
endothelial cells and is involved in pathologic vascularization as mentioned above. 
Vitronectin is found in many connective tissues, and is involved in many 
physiological and pathological processes such as angiogenesis (Brooks, Clark and 
Cheresh 1994a) (Brooks, et al. 1995), hemostasis (Mohri and Ohkubo 1991) 
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(Thiagarajan and Kelly 1988) and metastasis (Juliano and Varner 1993) (Nip, et al. 
1992). As a member of ECM family, vitronectin not only interacts with integrins, but 
also has an ability to bind uPAR (Madsen and Sidenius 2008).  Studies show that 
uPAR is not essential in Vitronectin (VN) induces cell migration but the interaction 
between uPAR and integrin promote its ability to bind Vitronectin (Wei, et al. 2011). 
It is well known that VN increase migration by interacting with integrin αvβ3, and 
many studies have illustrated that uPAR also regulate cell migration and adhesion 
through laterally interacting with αvβ3 (Waltz and Chapman 1994) (Wei, et al. 1994) 
(Ossowski and Aguirre-Ghiso 2000b).  
 
 
Table 5.1 The list of FN and VN binding integrins 
ECM Integrins 
FN αIIbβ3, α5β1, α8β1, αvβ1, αvβ3, αvβ6, 
α4β1, α4β7, αDβ2, αMβ2, αxβ2, 
VN αvβ3, αIIbβ3, α8β1, αvβ1, αvβ5, αvβ8 
(Lowell and Mayadas 2012) 
 
As uPAR only contains extracellular domains, it must transduce cellular signals 
across the cell membrane and into the cell through various, dynamic interactions 
with other cell membrane receptors. A wide range of cell membrane receptors have 
been identified to interact with uPAR, including integrin, G-protein coupled 
receptors and LDL-receptor related proteins (Resnati, et al. 1996) (Ossowski and 
Aguirre-Ghiso 2000a). The uPAR-integrin signaling nexus has been well studied and 
is well characterized. However, our picture and understanding of such interactions, 
and their subsequent role in cell fate decisions and functions is far from complete, 
warranting further expensive investigation. Indeed, these uPAR-integrin associations 
may be a novel therapeutic in various pathological states such as cancer, 
inflammation and vascular disease.  A wide range of integrins have been reported 
  
231 
 
to interact with uPAR, e.g. α3β1, αmβ2, αvβ3 and α5β1 (Wei, et al. 1996) (Wei, Y. et 
al 2001) (Simon, et al. 2000). uPAR is suggested as a modulator in integrin mediated 
pathway (Xue, et al. 1997). Wei, Y. et al, demonstrated the direct binding of uPAR 
and α5β1, rather than blocking or renders fibronectin (Fn) binding by α5β1 
Arg-Gly-Asp (RGD) resistant (Wei, et al. 2005). The binding sites of α5β1 and α3β1 
locate at D3 domain (Wei, et al. 2005) (Simon, et al. 2000), while D2 region is 
corresponding binding site for αvβ3 (Degryse, et al. 2005b). The affinity of α5β1 to 
FN was enhanced when uPAR was introduced (Leiss, et al. 2008). 
Co-immunoprecipitates reveal the interaction between αvβ3 integrin and uPAR in 
podocytes (Wei, et al. 2007a) and activation of uPAR leading to expression of αvβ3 
integrin at tumour cell surface (Schiller, et al. 2009). Similarly, uAPR expressions 
induced by treatment with lipopolysaccharide promote activation of αvβ3 in mouse 
kidney podocytes (Wei, et al. 2007b). All the evidences implicate the essential role 
of uPAR in integrins mediated cellular singling. 
 
 
In this chapter, we therefore focus on investigating whether integrins were involved 
in uPAR-mediated HAEC migration, and if so what classes of integrins were 
involved and what were their overall contribution to this important cellular function. 
In order to study the effect of specific RGD inhibitors on uPA mediated HAEC 
adhesion, urokinase, and two peptides; D2A and SRSRY were utilized. Sensitive and 
responsive to a plethora of enzymes, including uPA, plasmin, metalloproteases, and 
trypsin, uPAR can be truncated into soluble forms, for example; c-uPAR is a soluble 
form of uPAR (minus the D1 domain). C-uPAR possesses potent and immediate 
chemotactic properties, and Fazioli, F et al., discovered that the chemotactic activity 
attributed to the D2D3 domain did not require of uPA-uPAR interaction in uPA-/- 
mice (Fazioli, et al. 1997). Generation of shorter domain peptides facilitated the 
study of the specific binding properties of uPAR. D2A was first synthesized by 
Bernard Degryse and his collegues (Degryse, et al. 2005) (Kamikubo, Neels and 
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Degryse 2009). Derived from the sequence of Domain 2, D2A peptides have been 
shown to interact laterally with αvβ3 integrin and induce cell migration via 
outside-in signaling. SRSRY (Ser-Arg-Ser-Arg-Tyr) is another chemotactic peptide, 
derived from an uPAR sequence, which localized in the D1-D2 linker region. 
SRSRY peptides bind specifically to fMLP- a seven-transmembrane domain 
G-coupled receptor, and have been demonstrated to promote cell migration in this 
manner (Gargiulo, et al. 2005). From the results we can see that EC adhesion was 
increased with treatment of urokinase and D2A peptide but no significant increase 
was observed upon treatment with SRSRY peptide. This indicates that uPAR 
regulate HAEC migration through the interaction with integrins rather than fMLP. 
And again, αvβ3 has been demonstrated to play a major role in this process.  
 
 
From above studies, we conclude that uPAR transduce cell signals through integrin 
mediated pathways. We then wanted to investigate if merlin is involved in this 
mechanism. To illustrate the role of merlin in the regulation of HAEC migration, the 
adhesion and migration experiments highlighted at the beginning of this chapter 
were repeated, but this time using siRNA mediated merlin knock-down in HAEC 
cells. The transfection and knock-down efficiency was evaluated using western blot 
to ensure a minimum 70 to 80% reduction of merlin for each experiment. The 
HAECs transfected with scrambled control siRNA were used as control, as well as 
untransfected cells. Both merlin knock-down and scrambled control HAECs were 
then seeded into E-plates for adhesion assay or CIM-plates for migration assay 
which were pre-treated with either RGD inhibitors (RGD1, 2 and 3). From the 
results obtained, similar data were achieved as in chapter 4, i.e. HAEC adhesion and 
migration are significantly increased in the absence of merlin. The treatment use of 
RGD1 and RGD2 inhibits both HAEC’s adhesion and migration dramatically. The 
inhibitory effect of RGD peptides on HAEC-matrix interactions are significantly 
attenuated when merlin is knocked-down in the cell. This finding concludes that 
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merlin is critical component in regulation of HAECs adhesion and migration. And 
also merlin regulates HAECs adhesion and migration via vitronectin interacting 
integrins. The comprehensive list of the RGD binding integrins is shown below 
(table 5.2). Among these integrins, only αvβ3, αIIbβ3, α8β1, αvβ1, αvβ5, αvβ8 have 
demonstrated interact with vitronectin and furthermore, αvβ3 and αIIbβ3 are the 
only two endogenously express in endothelial cells. Combine with our previous 
results; we conclude that merlin regulates HAECs adhesion and migration via 
vitronectin interacting integrins-αvβ3. HAECs adhesion and migration are 
significantly increased when merlin was knocked-down. The use of RGD1 and 
RGD2 greatly inhibits both HAEC adhesion and migration dramatically. However 
the treatment of RGD2 only affects HAEC’s adhesion and no any inhibition on 
HAEC’s migration was observed. This may due to technical problem or degradation 
of RGD2 inhibitor after long term exposure to warm atmosphere. The inhibition of 
RGDs on HAECs motilities are significantly reduced when merlin was 
knocked-down. This finding concludes that merlin is critical component in 
regulation of HAECs adhesion and migration.  And also merlin regulates HAECs 
adhesion and migration via Fibronectin interacting integrin such as αvβ3. 
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Table 5.2 The RGD binding integrins 
Integrins  Ligands Primary sites of expression 
αIIbβ3 Fibrinogen, thromobospondin, 
fibronectin, vitronectin, vWF, 
Cyr61, ICAM-4, CD40L 
Platelets 
α5β1 Fibronectin, osteopontin, 
fibrillin, thrombospondin, 
ADAM, COMP 
Blood vessels (embryonic) 
α8β1 Tenascin, fibronectin, 
osteoponitin, vitronectin, latent 
TGFβ, nephronectin 
Kidney, inner ear 
αvβ1 Latent TGFβ, fibronectin, 
osteopontin, vitronectin 
Poorly defined 
αvβ3 Fibrinogen, vitronectin, 
fibronectin, vWF, 
thrombospondin, fibrillin, 
tenascin, PECAM-1, 
osteopontin, ADAM, Cyr61, 
MMP, uPAR, uPA, ICAM-4 
Osteoclasts, vascular 
endothelium 
αvβ5 Osteopontin, vitronectin, latent 
TGFβ 
Eye, bone 
αvβ6 Latent TGFβ, fibronectin, 
osteopontin, ADAM 
Skin, lung 
αvβ8 Latent TGFβ, vitronectin Vascular endothelium 
   (Lowell and Mayadas 2012) 
 
 
In this chapter, we have already demonstrated that uPAR is critical in regulation of 
HAEC adhesion and migration via integrins specifically αvβ3 mediated signaling. In 
addition, we have illustrated that merlin is involved in this integrin mediated cell 
signaling pathway. Moreover, in this study, we wanted to further investigate if the 
activation of αvβ3 and fMLP by uPA derived peptides will directly modulate merlin 
phosphorylation state. In this study, HAECs were treated with chemotactic peptides 
D2A and SRSRY (the details of these peptides are described above) respectively. 
These experiments need to be performed on 6 well plates which allow us achieve 
significant amount of cell lysate. Due to the very high molecular weight of uPA, the 
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investigation of effect of uPA on merlin phosphorylation state in HAEC requires 
large volume of uPA. We could not afford the cost and the uPA activate uPAR is well 
documented somewhere else. Therefore we did not exam the effect of uPA on merlin 
phosphorylation. In brief, at defined points over a time-course (1, 3, 5, 10, 30 
minutes), HAECs were lysed and merlin phosphorylation states were monitored 
using western blot. The results indicated that merlin was acutely phosphorylated 
when treated with D2A and SRSRY (the phosphorylation occurs as early as 
1-3minute), and this phosphorylation process was transit for it reach its peak time 
for 10 minute for SRSRY, and 30 minute for D2A.   
 
 
As I mentioned in section 1.6.2, uPAR can be activated by many extracellular 
matrices, such as vitronectin, which in turn promote cell motility and proliferation.  
As a protease, uPAR is responsible for converting pro-urokinase into urokinase and 
activate plasminogen to produce plasmin.  Both of these enzymes are required in 
proteolysis which is essential mechanisms to release the attachment of migrating cell 
from ECM. Many extracellular cues stimulate HAECs motility including 
haemodynamic forces and exposure to ECM. D2A and SRSRY peptide derived from 
uPAR which representing the binding site of αvβ3 and fMLP. The treatments of 
these peptides mimic the interaction of αvβ3 and fMLP to uPAR which in turn 
activate downstream signaling cascade and promote cell motility. Both activation of 
αvβ3 by either haemodynamic forces (see the results from chapter 3) or D2A, in turn 
increase the state of merlin phosphorylation which inactive its HAEC motility 
suppressor function.  We observed that the fMLP activating peptide SRSRY which 
has no significant effect on HAEC motility (this results were observed at 30 minutes 
upto 10 hours base) also increase merlin phosphorylation state. Compared with D2A 
induced merlin phosphorylation state (approximately 2.2 fold increase), SRSRY 
promote only 1.65 fold increase of merlin phosphorylation at 10 minute time point 
and the effect decreased to 1.6 fold when time reach 30 minute. Which may indicate 
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SRSRY activation may only transiently affect HAEC motility but has no effect on 
long term regulation.  
 
 
In summary, from our studies, we concluded that Merlin is endogenously expressed 
in HAECs, and is highly responsive to mechanical stimuli. As linker between actin 
cytoskeleton and the plasma membrane, Merlin regulates cell motilities through 
uPAR and integrin interaction signaling pathways. Merlin is localized predominantly 
at functional sites of stress fibers, filopodia, lamellipodia and focal adhesions. 
Through exposure to haemodynamic force or other activating factors, such as D2A 
and SRSRY, HAECs are able to sense environmental changes via cell surface 
receptors, including uPAR and integrin, and transduce the signal inside cell. This, in 
turn, serves to either suppress Merlin expression, or increase Merlin phosphorylation. 
Loss of Merlin activity results in the freeing of integrin binding sites that promote 
interaction between integrin and the integrin–actin linkage proteins (including talin, 
vinculin, Kindlins and α-actinin). This infers a role of merlin being a competitive 
inhibitor of integrin activation. Rac, CDC42 and Rho pathways are then activated 
following binding of the above proteins to integrins, which in turn leads to formation 
of various functional migration structures, such as filopodia, lamellipodia and stress 
fiber (figure 6.1). 
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Chapter 6: 
 
 
Summary and Future Direction 
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6.1 Final Summary 
Atherosclerosis is described as a slowly formation and progression of plaque within 
blood vessel which leading to narrowing and hardening the vessel wall. The causes 
of atherosclerosis are complicate. Hyperlipidaemia, especially high plasma 
concentrations of low-density lipoprotein (LDL) cholesterol, is one of the major 
causes of the disease.  However some scientist believe atherosclerosis is an 
inflammatory disease due to the improvement of new therapeutic approach and 
change in life style to lower plasma cholesterol seem have no effect on the death toll 
(Ross R. 1999).  
 
Atherosclerosis normally occur at large and medium-sized muscular elastic arteries; 
the aorta, coronary and cerebra, especially at the site of arterial bifurcation and 
regions of high curvature that results in complex blood flow patterns (Hahn and 
Schwartz, 2009; Lusis, 2000). At such sites, disturbed blood flow occurs and leads 
to formation of atherosclerotic plaques which in turn narrow the blood vessel and 
cause luminal occlusion or even wall rupture at advanced stages (Lusis, 2000; Orr et 
al., 2006). As the inner layer of blood vessel, endothelial cells play a crucial role in 
control vascular functions including the control of vascular tone, endothelium 
permeability, endothelial cell adhesion, migration and proliferation. Blood flow 
itself exist a strong biomechanical influence on the vessel wall. Sensing to these 
haemodynamic forces, endothelial cell constantly undergo adaptation to maintain 
homeostasis. Some paper described that EC elongate at the direction of blood flow 
(Cines et al, 1998: Gimbrone, 1987). EC morphology is maintained by actin 
cytoskeleton. Actin polymerization is a complex process that plays an important role 
in maintaining endothelial integrity. This process requires the recruitment of 
numerous actin adaptor proteins.   
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In this thesis, we examed the role of the actin adaptor protein merlin and its impact 
on endothelial cell-matrix adhesion and migration. We initially investigated the 
effect of shear stress on HAEC morphology, and ascertained if the expression and 
regulatory profile of Merlin is affected by hemodynamic forces, including shear 
stress and cyclic strain. The results clearly showed realignment of HAECs in the 
direction of flow when comparing static controls to LSS. Moreover, no uniform 
realignment was observed under DSS at regions of bifurcations and curvature. The 
results have also shown that Merlin was highly responsive to mechanical stimuli in 
HAECs. By using fluorescence microscopy, we observed Merlin association with 
dynamic actin at many functional sites, such as those at stress fibres, focal adhesions, 
and at sites of cell-cell contact. Merlin association was particularly apparent at the 
leading cell edge in lamellipodial regions, indicative of de novo integrin activation 
and attachment to the ECM. 
 
Studies then focused on the role, and possible regulatory mechanism, of Merlin on 
cell-matrix adhesion and migration. We first investigated Merlin binding partners 
using CO-IP and proteomic analysis. Our results unveiled a number of 
merlin-interacting proteins, including tubulin, annexin, actin transferrin receptor 
protein 1, annexin A2 and myosin light chain 6B. By using siRNA-mediated 
knock-down, several experiments were undertaken to evaluate the effects of 
knock-down merlin expression in HAEC cell-matrix adhesion. Results indicate that 
relative to scrambled controls, in merlin knock-down HAECs, cell-matrix adhesion 
was greatly increased and merlin knock-down HAECs preferentially adhered to 
vitronectin and fibronectin compared to laminin and fibrinogen. Parallel 
investigations for HAEC migration were carried out under identical conditions. 
Merlin knock-down results indicated that relative to scrambled controls, absence of 
merlin greatly increased HAEC migration. Merlin knock-down HAECs were also 
exposed to various haemodynamic forces, including shear stress and cyclic strain, to 
further elucidate the effect of these forces on merlin knock-down HAEC motility. 
  
240 
 
Results indicated that both forms of haemodynamic force significantly increased 
HAEC motility. Furthermore, these effects were greatly enhanced by knock-down of 
Merlin. In this regard, it was proposed that prolonged exposure to hemodynamic 
force would alter HAEC functions, such as motility, through down-regulating 
merlin. 
 
The above studies demonstrated that Merlin plays a pivotal role in cell motility - 
especially in cell-ECM adhesion and migration. Additionally, Merlin knock-down 
HAECs preferentially adhered to vitronectin and fibronectin. Both of these ECMs 
contain a RGD sequence that selectively activates specific integrins, such as αvβ3. 
In order to determine and elucidate the mechanism of integrin-mediated HAEC 
adhesion, and to identify the specific integrin involved, three well characterised 
RGD inhibitors were introduced. RGD1 inhibitor prevents both vitronectin and 
fibronectin-mediated integrin activation. RGD2 inhibitor prevents 
fibronectin-mediated integrin activation only, and RGD3 specifically blocks 
vitronectin-mediated integrin activation. Experimental results illustrated that 
compared with untreated controls, RGD1 and RGD3 inhibitors significantly 
decreased wild type HAEC adhesion, while only a slight reduction in 
RGD2-mediated inhibition of HAECs adhesion was noted. These findings led to the 
conclusion that integrin-mediated signalling is crucial for regulation of endothelial 
cell motility and the role of integrins in cell migration. 
 
Furthermore, results have also demonstrated that this integrin-mediated cell 
adhesion and migration is achieved through binding with vitronectin. As a member 
of the ECM family, vitronectin not only interacts with integrins, but also has the 
ability to bind with uPAR. As uPAR contains only extracellular domains, it must 
transduce cellular signals by interacting with other cell membrane receptors, such as 
αvβ3. In order to elucidate the effect of RGD inhibitors on uPA-mediated HAEC 
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adhesion, urokinase and two peptides (D2A and SRSRY) were introduced. Derived 
from the sequence of domain 2 of uPAR, D2A peptides interact laterally with αvβ3 
integrin and induce cell migration. SRSRY (Ser-Arg-Ser-Arg-Tyr) is another 
chemotactic uPAR derived sequence located in the D1-D2 linker region. SRSRY 
peptides bind specifically to fMLP, a seven transmembrane domain G-coupled 
receptor, and promote cell migration. Experimental data illustrated that endothelial 
motility increased with treatment of urokinase and D2A peptide. However, no 
significant increase was observed when treated with SRSRY peptide (figure 
5.2-figure 5.4). This indicated that uPAR serves to regulate HAEC motility through 
interaction with integrins, rather than fMLP. Additionally, data pointed to αvβ3 as 
the major integrin involved in this pathway.  
 
From above studies, we concluded that uPAR transduces cell signals through the 
integrin pathway. The investigation then turned to Merlin, to determine its 
involvement in the mechanism. In order to illustrate the role of Merlin in the 
regulation of HAEC motility, Merlin knock-down was achieved by transfection with 
siRNA. HAECs transfected with scrambled control siRNA were used as controls. 
Both Merlin-absent and scrambled control HAECs were then seeded into 
xCELLigence E-plates for adhesion assays or CIM-plates for migration assays, 
pre-treated with either RGD inhibitors (RGD1, 2 and 3). From the results, it was 
observed that HAEC motility- both adhesion and migration - were significantly 
increased after knock-down of Merlin. Treatment with RGD1 and RGD2 inhibited 
both HAEC adhesion and migration dramatically. However, treatment with RGD2 
only affected HAEC adhesion, with no inhibition of HAEC migration observed. 
Inhibition of HAEC motility, using specific RGD inhibitors, was significantly 
abrogated with knock-down of Merlin. Thus, the conclusion of these findings was 
that Merlin is critical component in regulation of HAEC adhesion and migration. 
Moreover, it was determined that Merlin serves to regulate HAEC adhesion and 
migration via vitronectin-interacting integrins. Integrins including αvβ3, αIIbβ3, 
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α8β1, αvβ1, αvβ5, αvβ8, have demonstrated interact with vitronectin and 
furthermore, αvβ3 and αIIbβ3 are the only two endogenously express in endothelial 
cells. Combine with our previous results; we conclude that merlin regulates HAECs 
adhesion and migration via vitronectin interacting integrins-αvβ3. 
 
In the last section, we demonstrated that Merlin was acutely phosphorylated when 
exposed to D2A and SRSRY (with phosphorylation beginning after 1-3 mins). This 
phosphorylation process was transit for it reaches its peak time for 10 min for 
SRSRY, and 30 mins for D2A. 
 
In summary, from our studies, we concluded that Merlin is endogenously expressed 
in HAECs, and is highly responsive to mechanical stimuli. As linker between actin 
cytoskeleton and the plasma membrane, Merlin regulates cell motilities through 
uPAR and integrin interaction signalling pathways. Merlin is localised 
predominantly at functional sites of stress fibres, filopodia, lamellipodia and focal 
adhesions. Through exposure to haemodynamic force or other activating factors, 
such as D2A and SRSRY, HAECs are able to sense environmental changes via cell 
surface receptors, including uPAR and integrin, and transduce the signal inside cell. 
This, in turn, serves to either suppress Merlin expression, or increase Merlin 
phosphorylation. Loss of Merlin activity results in the freeing of integrin binding 
sites that promote interaction between integrin and the integrin–actin linkage 
proteins (including talin, vinculin, Kindlins and α-actinin). This highlights the role 
of merlin being a competitive inhibitor of integrin activation. Rac, CDC42 and Rho 
pathways are then activated following binding of the above proteins to integrins, 
which in turn leads to formation of various functional migration structures, such as 
filopodia, lamellipodia and stress fibre (figure 6.1).  
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Figure 6.1 The critical role of merlin in uPAR mediated motility regulation 
Through exposure to haemodynamic force or other activating factors, such as D2A and 
SRSRY, HAECs are able to sense environmental changes via cell surface receptors, 
including uPAR, integrin, ions channel, G-coupled receptor, VEGFR, TKR and transduce 
the signal inside cell. This, in turn, serves to either suppress Merlin expression, or increase 
Merlin phosphorylation. Loss of Merlin activity results in the freeing of integrin binding 
sites that promote interaction between integrin and the integrin–actin linkage proteins 
(including talin, vinculin, Kindlins and α-actinin). Rac, CDC42 and Rho pathways are then 
activated following the binding of these proteins to integrin, which in turn leads to the 
formation of various functional migration structures, such as filopodia, lamellipodia and 
stress fibres.  
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6.2 Future Directions 
 
This thesis examined the role of the cell membrane and cytoskeleton linker protein, 
Merlin, on endothelial cell-matrix adhesion and migration within vasculature. We 
observed that Merlin expression, both at protein and mRNA levels, is altered by 
haemodynamic force, including cyclic strain and laminar shear stress. Interestingly, 
it was found that mRNA levels increased with both shear stress and cyclic strain, 
and did not correspond to Merlin protein expression. This phenomenon was also 
observed in previous studies in our lab while studying the protein, moesin, under the 
same conditions. This may, therefore, be indicative of the fact that Merlin mRNA is 
regulated by splicing, mediated through the RNA interference (RNAi) pathway. This 
pathway mainly involves microRNA. MicroRNA (short non-coding single strand 
RNA molecules, normally 19-25 nucleotides long), was discovered by Lee et al in 
1993 during studies on the nematode, Caenorhabditis elegans (C. elegans), (Lee, 
Feinbaum and Ambros 1993). It is involved in many different biological processes, 
such as gene silencing (Bartel 2009). Intensive studies have shown that microRNAs 
are involved in cardiac development and cardiovascular functions, well described in 
Eric M. Small and Eric N. Olson’s review (Small and Olson 2011). Saydam O, et al 
have also demonstrated the role of miR-7’s tumour suppressor function in 
schwannomas (Saydam, et al. 2011). However, the role of microRNA in controlling 
Merlin function in ECs remains poorly understood, and forms the basis of future 
investigations to be carried out. 
 
Currently, over 30 proteins have been identified that interact with Merlin (list of 
merlin binding proteins please see Table 4.3). Each of these interacting proteins 
critically regulates merlin structure and function. For example, merlin may be 
phosphorylated at serine 518 by interacting with p21-activated kinases (PAKs). 
Merlin has been identified as being involved in numerous signalling pathways, and 
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results in this thesis clearly demonstrate the important role of Merlin in HAEC 
motility regulation. In the future, more research based on CO-IP will be carried 
under different conditions, including under various haemodynamic conditions and 
knock-down and over-expression of Merlin. Interacting proteins may reveal 
potential pathways that regulate cell motility. 
 
Our studies have also clearly shown Merlin association with dynamic actin at many 
functional sites, such as stress fibres, focal adhesions, at sites of cell-cell contact and, 
in particular, the leading cell edge in lamellipodial regions. We have hypothesised 
that the loss of Merlin activity results in freeing of integrin-binding sites that 
promote interaction between integrin and the integrin–actin linker proteins. These 
include talin, vinculin, kindlins and α-actinin. Investigating the co-localisation of 
Merlin and these integrin-binding proteins using confocal microscopy, would greatly 
enhance our knowledge of the dynamics of integrin activation, particularly the 
events around the cytoplasmic tails. In this study, the Ibidi
®
 flow system would also 
be used to explore the effects of mechano-regulation on integrin-binding proteins 
under various conditions, such as over-express and knock-down of Merlin. 
Furthermore, the role of different ECMs on Merlin localisation will be investigated.  
 
 
 
 
 
 
 
 
  
246 
 
Bibliography 
 
  
Abercrombie, M. 1980. The Croonian lecture, 1978: the crawling movement of 
metazoan cells. Proceedings of the Royal Society of London.Series B, Biological 
Sciences, pp.129-147.  
Ahmed, N., Pansino, F., Clyde, R., Murthi, P., Quinn, M., Rice, G., Agrez, M., Mok, S. 
and Baker, M. 2002. Overexpression of αvβ6 integrin in serous epithelial ovarian cancer 
regulates extracellular matrix degradation via the plasminogen activation cascade. 
Carcinogenesis, 23(2), pp.237-244.  
Aird, W.C. 2007. Phenotypic heterogeneity of the endothelium I. Structure, function, 
and mechanisms. Circulation Research, 100(2), pp.158-173.  
Alfano, M., Sidenius, N., Panzeri, B., Blasi, F. and Poli, G. 2002. Urokinase–urokinase 
receptor interaction mediates an inhibitory signal for HIV-1 replication. Proceedings of 
the National Academy of Sciences, 99(13), pp.8862-8867.  
Allender, S., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernandez, R. and 
Gray, A. 2008. European cardiovascular disease statistics. European Heart Network, 
3pp.11-35.  
Allison L. Berrier, and Kenneth M. yamada, 2007. Cell–Matrix Adhesion. J. Cell. 
Physiol. 213: 565–573, 2007. 
Ambrose, J.A., Tannenbaum, M.A., Alexopoulos, D., Hjemdahl-Monsen, C.E., Leavy, 
J., Weiss, M., Borrico, S., Gorlin, R. and Fuster, V. 1988. Angiographic progression of 
coronary artery disease and the development of myocardial infarction. Journal of the 
American College of Cardiology, 12(1), pp.56-62.  
Aoki, T., Wood, H., Old, L. and Boyse, E. 1969. Arterial wall shear and distribution of 
early atheroma in man. Nature, 223(1), pp.159.  
Arroyo, L.H. and Lee, R.T. 1999. Mechanisms of plaque rupture mechanical and 
biologic interactions. Cardiovascular Research, 41(2), pp.369-375.  
Astrof, S. and Hynes, R.O. 2009. Fibronectins in vascular morphogenesis. Angiogenesis, 
12(2), pp.165-175.  
  
247 
 
Ballestrem, C., Hinz, B., Imhof, B.A. and Wehrle-Haller, B. 2001. Marching at the front 
and dragging behind differential αVβ3-integrin turnover regulates focal adhesion 
behavior. The Journal of Cell Biology, 155(7), pp.1319-1332.  
Barakat, A., Leaver, E., Pappone, P. and Davies, P. 1999. A flow-activated 
chloride-selective membrane current in vascular endothelial cells. Circulation Research, 
85(9), pp.820-828.  
Bartel, D.P. 2009. MicroRNAs: target recognition and regulatory functions. Cell, 136(2), 
pp.215-233.  
Bashour, A., Meng, J., Ip, W., MacCollin, M. and Ratner, N. 2002. The 
neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects 
in primary human Schwannoma cells. Molecular and Cellular Biology, 22(4), 
pp.1150-1157.  
Berk, B.C., Fujiwara, K. and Lehoux, S. 2007. ECM remodeling in hypertensive heart 
disease. Journal of Clinical Investigation, 117(3), pp.568-575.  
Berryman, M., Gary, R. and Bretscher, A. 1995. Ezrin oligomers are major cytoskeletal 
components of placental microvilli: a proposal for their involvement in cortical 
morphogenesis. The Journal of Cell Biology, 131(5), pp.1231-1242.  
Berthiaume, F. and Frangos, J.A. 1992. Flow-induced prostacyclin production is 
mediated by a pertussis toxin-sensitive G protein. FEBS Letters, 308(3), pp.277-279.  
Bianchi, A.B., Hara, T., Ramesh, V., Gao, J., Klein-Szanto, A.J., Morin, F., Menon, 
A.G., Trofatter, J.A., Gusella, J.F. and Seizinger, B.R. 1994. Mutations in transcript 
isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature 
Genetics, 6(2), pp.185-192.  
Binder, B.R., Mihaly, J. and Prager, G.W. 2007. uPAR-uPA-PAI-1 interactions and 
signaling: a vascular biologist's view. THROMBOSIS AND 
HAEMOSTASIS-STUTTGART-, 97(3), pp.336.  
Blasi, F. 1997. uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and 
chemotacfic highways? Immunology Today, 18(9), pp.415-417.  
Blasi, F. and Carmeliet, P. 2002. uPAR: a versatile signalling orchestrator. Nature 
Reviews Molecular Cell Biology, 3(12), pp.932-943.  
Blessing, C.A., Ugrinova, G.T. and Goodson, H.V. 2004. Actin and ARPs: action in the 
nucleus. Trends in Cell Biology, 14(8), pp.435-442.  
  
248 
 
Bonilha, V.L., Rayborn, M.E., Saotome, I., McClatchey, A.I. and Hollyfield, J.G. 2006. 
Microvilli defects in retinas of ezrin knockout mice. Experimental Eye Research, 82(4), 
pp.720-729.  
Brakebusch, C., Bouvard, D., Stanchi, F., Sakai, T. and Fässler, R. 2002. Integrins in 
invasive growth. Journal of Clinical Investigation, 109(8), pp.999-1006.  
Bretscher, A., Edwards, K. and Fehon, R.G. 2002. ERM proteins and merlin: integrators 
at the cell cortex. Nature Reviews Molecular Cell Biology, 3(8), pp.586-599.  
Brooks, P.C., Clark, R. and Cheresh, D.A. 1994. Requirement of vascular integrin alpha 
v beta 3 for angiogenesis. Science, 264(5158), pp.569-571.  
Brooks, P.C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F.H. and Cheresh, D.A. 
1995. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis 
in human skin. Journal of Clinical Investigation, 96(4), pp.1815.  
Burridge, K. and Chrzanowska-Wodnicka, M. 1996. Focal adhesions, contractility, and 
signaling. Annual Review of Cell and Developmental Biology, 12(1), pp.463-519.  
Burridge, K. and Wennerberg, K. 2004. Rho and Rac take center stage. Cell, 116(2), 
pp.167-179.  
Calderwood, D.A. 2004. Integrin activation. Journal of Cell Science, 117(5), 
pp.657-666.  
Carlier, M., Laurent, V., Santolini, J., Melki, R., Didry, D., Xia, G., Hong, Y., Chua, N. 
and Pantaloni, D. 1997. Actin depolymerizing factor (ADF/cofilin) enhances the rate of 
filament turnover: implication in actin-based motility. The Journal of Cell Biology, 
136(6), pp.1307-1322.  
Carlos, T.M. and Harlan, J.M. 1994. Leukocyte-endothelial adhesion molecules. Blood, 
84(7), pp.2068-2101.  
Carlson, T.R., Hu, H., Braren, R., Kim, Y.H. and Wang, R.A. 2008. Cell-autonomous 
requirement for β1 integrin in endothelial cell adhesion, migration and survival during 
angiogenesis in mice. Development, 135(12), pp.2193-2202.  
Chapman, H.A. 1997. Plasminogen activators, integrins, and the coordinated regulation 
of cell adhesion and migration. Current Opinion in Cell Biology, 9(5), pp.714-724.  
Chesarone, M.A. and Goode, B.L. 2009. Actin nucleation and elongation factors: 
mechanisms and interplay. Current Opinion in Cell Biology, 21(1), pp.28-37.  
  
249 
 
Chew, C.S., Chen, X., Parente, J.A., Tarrer, S., Okamoto, C. and Qin, H. 2002. Lasp-1 
binds to non-muscle F-actin in vitro and is localized within multiple sites of dynamic 
actin assembly in vivo. Journal of Cell Science, 115(24), pp.4787-4799.  
Chew, C.S., Parente, J., Chen, X., Chaponnier, C. and Cameron, R.S. 2000. The LIM 
and SH3 domain-containing protein, lasp-1, may link the cAMP signaling pathway with 
dynamic membrane restructuring activities in ion transporting epithelia. Journal of Cell 
Science, 113(11), pp.2035-2045.  
Chew, C., Parente, J., Zhou, C., Baranco, E. and Chen, X. 1998. Lasp-1 is a regulated 
phosphoprotein within the cAMP signaling pathway in the gastric parietal cell. 
American Journal of Physiology-Cell Physiology, 275(1), pp.C56-C67.  
Chien, S., Li, S. and Shyy, J.Y. 1998. Effects of mechanical forces on signal 
transduction and gene expression in endothelial cells. Hypertension, 31(1), pp.162-169.  
Choi, C.K., Vicente-Manzanares, M., Zareno, J., Whitmore, L.A., Mogilner, A. and 
Horwitz, A.R. 2008. Actin and α-actinin orchestrate the assembly and maturation of 
nascent adhesions in a myosin II motor-independent manner. Nature Cell Biology, 10(9), 
pp.1039-1050.  
Christofori, G. 2006. New signals from the invasive front. Nature, 441(7092), 
pp.444-450.  
Ciambrone, G. and McKeown-Longo, P. 1992. Vitronectin regulates the synthesis and 
localization of urokinase-type plasminogen activator in HT-1080 cells. Journal of 
Biological Chemistry, 267(19), pp.13617-13622.  
Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., 
Pober, J.S., Wick, T.M., Konkle, B.A. and Schwartz, B.S. 1998. Endothelial cells in 
physiology and in the pathophysiology of vascular disorders. Blood, 91(10), 
pp.3527-3561.  
Cook, N.R., Cutler, J.A., Obarzanek, E., Buring, J.E., Rexrode, K.M., Kumanyika, S.K., 
Appel, L.J. and Whelton, P.K. 2007. Long term effects of dietary sodium reduction on 
cardiovascular disease outcomes: observational follow-up of the trials of hypertension 
prevention (TOHP). Bmj, 334(7599), pp.885.  
Critchley, D.R. and Gingras, A.R. 2008. Talin at a glance. Journal of Cell Science, 
121(9), pp.1345-1347.  
Davies, P.F. and Tripathi, S. 1993. Mechanical stress mechanisms and the cell. An 
endothelial paradigm. Circulation Research, 72(2), pp.239-245.  
  
250 
 
Davignon, J. and Ganz, P. 2004. Role of endothelial dysfunction in atherosclerosis. 
Circulation, 109(23 suppl 1), pp.III-27-III-32.  
De Caterina, R., Massaro, M. and Libby, P. 2007. Endothelial functions and 
dysfunctions. Endothelial Dysfunctions in Vascular Disease, pp.1-25.  
Degryse, B., Resnati, M., Czekay, R., Loskutoff, D.J. and Blasi, F. 2005. Domain 2 of 
the urokinase receptor contains an Integrin-interacting epitope with intrinsic signaling 
activity generation of a new integrin inhibitor. Journal of Biological Chemistry, 280(26), 
pp.24792-24803.  
Degryse, B., Resnati, M., Rabbani, S.A., Villa, A., Fazioli, F. and Blasi, F. 1999. 
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent 
chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood, 94(2), 
pp.649-662.  
Doi, Y., Itoh, M., Yonemura, S., Ishihara, S., Takano, H., Noda, T., Tsukita, S. and 
Tsukita, S. 1999. Normal development of mice and unimpaired cell adhesion/cell 
motility/actin-based cytoskeleton without compensatory up-regulation of ezrin or 
radixin in moesin gene knockout. Journal of Biological Chemistry, 274(4), 
pp.2315-2321.  
Dyche Mullins, R. and Pollard, T.D. 1999. Structure and function of the Arp2/3 
complex. Current Opinion in Structural Biology, 9(2), pp.244-249.  
Efimov, A., Schiefermeier, N., Grigoriev, I., Brown, M.C., Turner, C.E., Small, J.V. 
and Kaverina, I. 2008. Paxillin-dependent stimulation of microtubule catastrophes at 
focal adhesion sites. Journal of Cell Science, 121(2), pp.196-204.  
Endemann, D.H. and Schiffrin, E.L. 2004. Endothelial dysfunction. Journal of the 
American Society of Nephrology, 15(8), pp.1983-1992.  
Estreicher, A., Mühlhauser, J., Carpentier, J., Orci, L. and Vassalli, J. 1990. The 
receptor for urokinase type plasminogen activator polarizes expression of the protease 
to the leading edge of migrating monocytes and promotes degradation of enzyme 
inhibitor complexes. The Journal of Cell Biology, 111(2), pp.783-792.  
Etienne-Manneville, S. and Hall, A. 2002. Rho GTPases in cell biology. Nature, 
420(6916), pp.629-635.  
Evans, D.G.R., Huson, S., Donnai, D., Neary, W., Blair, V., Newton, V. and Harris, R. 
1992. A clinical study of type 2 neurofibromatosis. QJM, 84(1), pp.603-618.  
  
251 
 
Fazioli, F., Resnati, M., Sidenius, N., Higashimoto, Y., Appella, E. and Blasi, F. 1997. 
A urokinase-sensitive region of the human urokinase receptor is responsible for its 
chemotactic activity. The EMBO Journal, 16(24), pp.7279-7286.  
Fishman, A.P. 1982. Endothelium: a distributed organ of diverse capabilities. Annals of 
the New York Academy of Sciences, 401(1), pp.1-8.  
Folkow, B. 1993. Early structural changes in hypertension: pathophysiology and clinical 
consequences. Journal of Cardiovascular Pharmacology, 22pp.S1.  
Förstermann, U. and Münzel, T. 2006. Endothelial nitric oxide synthase in vascular 
disease from marvel to menace. Circulation, 113(13), pp.1708-1714.  
Furchgott, R.F. and Zawadzki, J.V. 1980. The obligatory role of endothelial cells in the 
relaxation of arterial smooth muscle by acetylcholine.  
Gårdsvoll, H. and Ploug, M. 2007. Mapping of the Vitronectin-binding Site on the 
urokinase receptor involvement of a coherent receptor interface consisting of residues 
from both domain I and the flanking interdomain linker region. Journal of Biological 
Chemistry, 282(18), pp.13561-13572.  
Gargiulo, L., Longanesi-Cattani, I., Bifulco, K., Franco, P., Raiola, R., Campiglia, P., 
Grieco, P., Peluso, G., Stoppelli, M.P. and Carriero, M.V. 2005. Cross-talk between 
fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide. 
Journal of Biological Chemistry, 280(26), pp.25225-25232.  
Goldman, R. D., Chou, Y. H., Prahlad, V. and Yoon, M. (1999). Intermediate filaments: 
dynamic processes regulating their assembly, motility, and interactions with other 
cytoskeletal systems. FASEB J 13 Suppl 2, S261-5. 
Gonsior, S.M., Platz, S., Buchmeier, S., Scheer, U., Jockusch, B.M. and Hinssen, H. 
1999. Conformational difference between nuclear and cytoplasmic actin as detected by 
a monoclonal antibody. Journal of Cell Science, 112(6), pp.797-809.  
Gonzalez-Agosti, C., Xu, L., Pinney, D., Beauchamp, R., Hobbs, W., Gusella, J. and 
Ramesh, V. 1996. The merlin tumor suppressor localizes preferentially in membrane 
ruffles. Oncogene, 13(6), pp.1239.  
Grover-Páez, F. and Zavalza-Gómez, A.B. 2009. Endothelial dysfunction and 
cardiovascular risk factors. Diabetes Research and Clinical Practice, 84(1), pp.1-10.  
Grunewald, T.G., Kammerer, U., Kapp, M., Eck, M., Dietl, J., Butt, E. and Honig, A. 
2007. Nuclear localization and cytosolic overexpression of LASP-1 correlates with 
tumor size and nodal-positivity of human breast carcinoma. BMC Cancer, 7(1), pp.198.  
  
252 
 
Grunewald, T.G., Kammerer, U., Schulze, E., Schindler, D., Honig, A., Zimmer, M. and 
Butt, E. 2006. Silencing of LASP-1 influences zyxin localization, inhibits proliferation 
and reduces migration in breast cancer cells. Experimental Cell Research, 312(7), 
pp.974-982.  
Gryglewski, R.J. 1995. Interactions between endothelial mediators. Pharmacology & 
Toxicology, 77(1), pp.1-9.  
Gudi, S.R., Clark, C.B. and Frangos, J.A. 1996. Fluid Flow Rapidly Activates G 
Proteins in Human Endothelial Cells Involvement of G Proteins in Mechanochemical 
Signal Transduction. Circulation Research, 79(4), pp.834-839.  
Gudi, S., Huvar, I., White, C.R., McKnight, N.L., Dusserre, N., Boss, G.R. and Frangos, 
J.A. 2003. Rapid activation of Ras by fluid flow is mediated by Gαq and Gβγ subunits 
of heterotrimeric G proteins in human endothelial cells. Arteriosclerosis, Thrombosis, 
and Vascular Biology, 23(6), pp.994-1000.  
Gutmann, D.H., Giordano, M.J., Fishback, A.S. and Guha, A. 1997. Loss of merlin 
expression in sporadic meningiomas, ependymomas and schwannomas. Neurology, 
49(1), pp.267-270.  
Gutmann, D.H., Sherman, L., Seftor, L., Haipek, C., Lu, K.H. and Hendrix, M. 1999. 
Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell 
motility, adhesion and spreading. Human Molecular Genetics, 8(2), pp.267-275.  
Hadi, H.A., Carr, C.S. and Al Suwaidi, J. 2005. Endothelial dysfunction: cardiovascular 
risk factors, therapy, and outcome. Vascular Health and Risk Management, 1(3), 
pp.183.  
Hahn, C. and Schwartz, M.A. 2009. Mechanotransduction in vascular physiology and 
atherogenesis. Nature Reviews Molecular Cell Biology, 10(1), pp.53-62.  
Hamm, H.E. 1998. The many faces of G protein signaling. Journal of Biological 
Chemistry, 273(2), pp.669-672.  
Harris, A.K., Wild, P. and Stopak, D. 1980. Silicone rubber substrata: a new wrinkle in 
the study of cell locomotion. Science, 208(4440), pp.177-179.  
Heath, J.P. and Holifield, B.F. 1992. On the mechanisms of cortical actin flow and its 
role in cytoskeletal organisation of fibroblasts. IN: Symposia of the Society for 
Experimental Biology. 47:35-56. 
Hemmings, L., Rees, D., Ohanian, V., Bolton, S., Gilmore, A., Patel, B., Priddle, H., 
Trevithick, J., Hynes, R. and Critchley, D. 1996. Talin contains three actin-binding sites 
  
253 
 
each of which is adjacent to a vinculin-binding site. Journal of Cell Science, 109(11), 
pp.2715-2726.  
Hendrickson, R.J., Cahill, P.A., Sitzmann, J.V. and Redmond, E.M. 1999. Ethanol 
enhances basal and flow-stimulated nitric oxide synthase activity in vitro by activating 
an inhibitory guanine nucleotide binding protein. Journal of Pharmacology and 
Experimental Therapeutics, 289(3), pp.1293-1300.  
Herrlich, P., Morrison, H., Sleeman, J., ORIAN‐ROUSSEAU, V., König, H., 
WEG‐REMERS, S. and Ponta, H. 2000. CD44 Acts Both as a Growth‐and 
Invasiveness‐Promoting Molecule and as a Tumor‐Suppressing Cofactor. Annals of the 
New York Academy of Sciences, 910(1), pp.106-120.  
Hoffman, B.D., Grashoff, C. and Schwartz, M.A. 2011. Dynamic molecular processes 
mediate cellular mechanotransduction. Nature, 475(7356), pp.316-323.  
Hofmann, W., Reichart, B., Ewald, A., Müller, E., Schmitt, I., Stauber, R.H., Lottspeich, 
F., Jockusch, B.M., Scheer, U. and Hauber, J. 2001. Cofactor Requirements for Nuclear 
Export of Rev Response Element (Rre)–And Constitutive Transport Element 
(Cte)–Containing Retroviral Rnas An Unexpected Role for Actin. The Journal of Cell 
Biology, 152(5), pp.895-910.  
Huai, Q., Zhou, A., Lin, L., Mazar, A.P., Parry, G.C., Callahan, J., Shaw, D.E., Furie, B., 
Furie, B.C. and Huang, M. 2008. Crystal structures of two human vitronectin, urokinase 
and urokinase receptor complexes. Nature Structural & Molecular Biology, 15(4), 
pp.422-423.  
Huang, L., Ichimaru, E., Pestonjamasp, K., Cui, X., Nakamura, H., Lo, G.Y., Lin, F.I., 
Luna, E.J. and Furthmayr, H. 1998. Merlin differs from moesin in binding to F-actin 
and in its intra-and intermolecular interactions. Biochemical and Biophysical Research 
Communications, 248(3), pp.548-553.  
Humphries, J.D., Askari, J.A., Zhang, X., Takada, Y., Humphries, M.J. and Mould, A.P. 
2000. Molecular basis of ligand recognition by integrin alpha5beta 1. II. Specificity of 
arg-gly-Asp binding is determined by Trp157 of the alpha subunit.. Journal of 
Biological Chemistry, 275(27), pp.20337-20345.  
Hunt, B.J., Poston, L., Scachter, M. and Halliday, A. 2002. An introduction to vascular 
biology. Cambridge University Press. Online ISBN:9780511545948 
Huttenlocher, A. and Horwitz, A.R. 2011. Integrins in cell migration. Cold Spring 
Harbor Perspectives in Biology, 3(9),  
Huttenlocher, A., Sandborg, R.R. and Horwitz, A.F. 1995. Adhesion in cell migration. 
Current Opinion in Cell Biology, 7(5), pp.697-706.  
  
254 
 
Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 
69(1), pp.11-25.  
Ikeda, K., Saeki, Y., Gonzalez-Agosti, C., Ramesh, V. and Chiocca, E.A. 1999. 
Inhibition of NF2-negative and NF2-positive primary human meningioma cell 
proliferation by overexpression of merlin due to vector-mediated gene transfer. Journal 
of Neurosurgery, 91(1), pp.85-92.  
JA, A.G. 2002. Inhibition of FAK signaling activated by urokinase receptor induces 
dormancy in human carcinoma cells in vivo. Oncogene, 21(16), pp.2513-2524.  
Jankovics, F., Sinka, R., Lukácsovich, T. and Erdélyi, M. 2002. MOESIN Crosslinks 
Actin and Cell Membrane in Drosophila Oocytes and Is Required for OSKAR 
Anchoring. Current Biology, 12(23), pp.2060-2065.  
Jester, J.V., Huang, J., Barry–Lane, P.A., Kao, W.W., Petroll, W.M. and Cavanagh, 
H.D. 1999. Transforming Growth Factorβ–Mediated Corneal Myofibroblast 
Differentiation Requires Actin and Fibronectin Assembly. Investigative Ophthalmology 
& Visual Science, 40(9), pp.1959-1967.  
Jockusch, B.M., Schoenenberger, C., Stetefeld, J. and Aebi, U. 2006. Tracking down 
the different forms of nuclear actin. Trends in Cell Biology, 16(8), pp.391-396.  
Juliano, R.L. and Varner, J.A. 1993. Adhesion molecules in cancer: the role of integrins. 
Current Opinion in Cell Biology, 5(5), pp.812-818.  
Kamikubo, Y., Neels, J.G. and Degryse, B. 2009. Vitronectin inhibits plasminogen 
activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen 
activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein. The 
International Journal of Biochemistry & Cell Biology, 41(3), pp.578-585.  
Karagiosis, S.A. and Ready, D.F. 2004. Moesin contributes an essential structural role 
in Drosophila photoreceptor morphogenesis. Development, 131(4), pp.725-732.  
Katoh, H. and Negishi, M. 2003. RhoG activates Rac1 by direct interaction with the 
Dock180-binding protein Elmo. Nature, 424(6947), pp.461-464.  
Katsumi, A., Orr, A.W., Tzima, E. and Schwartz, M.A. 2004. Integrins in 
mechanotransduction. Journal of Biological Chemistry, 279(13), pp.12001-12004.  
Kaverina, I., Rottner, K. and Small, J.V. 1998. Targeting, capture, and stabilization of 
microtubules at early focal adhesions. The Journal of Cell Biology, 142(1), pp.181-190.  
Kikuchi, S., Hata, M., Fukumoto, K., Yamane, Y., Matsui, T., Tamura, A., Yonemura, 
S., Yamagishi, H., Keppler, D. and Tsukita, S. 2002. Radixin deficiency causes 
  
255 
 
conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. 
Nature Genetics, 31(3), pp.320-325.  
Kinashi, Y., Sakurai, Y., Masunaga, S., Suzuki, M., Akaboshi, M. and Ono, K. 2000. 
Dimethyl sulfoxide protects against thermal and epithermal neutron-induced cell death 
and mutagenesis of Chinese hamster ovary (CHO) cells. International Journal of 
Radiation Oncology* Biology* Physics, 47(5), pp.1371-1378.  
Kissil, J.L., Johnson, K.C., Eckman, M.S. and Jacks, T. 2002. Merlin phosphorylation 
by p21-activated kinase 2 and effects of phosphorylation on merlin localization. Journal 
of Biological Chemistry, 277(12), pp.10394-10399.  
Kitajiri, S., Fukumoto, K., Hata, M., Sasaki, H., Katsuno, T., Nakagawa, T., Ito, J., 
Tsukita, S. and Tsukita, S. 2004. Radixin deficiency causes deafness associated with 
progressive degeneration of cochlear stereocilia. The Journal of Cell Biology, 166(4), 
pp.559-570.  
Kjaergaard, M., Hansen, L.V., Jacobsen, B., Gardsvoll, H. and Ploug, M. 2008. 
Structure and ligand interactions of the urokinase receptor (uPAR). Frontiers in 
Bioscience : A Journal and Virtual Library, 13pp.5441-5461.  
Kjøller, L. and Hall, A. 2001. Rac mediates cytoskeletal rearrangements and increased 
cell motility induced by urokinase-type plasminogen activator receptor binding to 
vitronectin. The Journal of Cell Biology, 152(6), pp.1145-1158.  
Knezevic, N., Tauseef, M., Thennes, T. and Mehta, D. 2009. The G protein βγ subunit 
mediates reannealing of adherens junctions to reverse endothelial permeability increase 
by thrombin. The Journal of Experimental Medicine, 206(12), pp.2761-2777.  
Kris, A.S., Kamm, R.D. and Sieminski, A.L. 2008. VASP involvement in 
force-mediated adherens junction strengthening. Biochemical and Biophysical Research 
Communications, 375(1), pp.134-138.  
Kuchan, M. and Frangos, J. 1993. Shear stress regulates endothelin-1 release via protein 
kinase C and cGMP in cultured endothelial cells. American Journal of 
Physiology-Heart and Circulatory Physiology, 264(1), pp.H150-H156.  
Kunda, P., Pelling, A.E., Liu, T. and Baum, B. 2008. Moesin controls cortical rigidity, 
cell rounding, and spindle morphogenesis during mitosis. Current Biology, 18(2), 
pp.91-101.  
Kurokawa, K., Nakamura, T., Aoki, K. and Matsuda, M. 2005. Mechanism and role of 
localized activation of Rho-family GTPases in growth factor-stimulated fibroblasts and 
neuronal cells. Biochemical Society Transactions, 33(4), pp.631-634.  
  
256 
 
Kurokawa, K. and Matsuda, M. 2005. Localized RhoA activation as a requirement for 
the induction of membrane ruffling. Molecular Biology of the Cell, 16(9),pp.4294-4303.  
LaJeunesse, D.R., McCartney, B.M. and Fehon, R.G. 1998. Structural analysis of 
Drosophila merlin reveals functional domains important for growth control and 
subcellular localization. The Journal of Cell Biology, 141(7), pp.1589-1599.  
Lallemand, D., Curto, M., Saotome, I., Giovannini, M. and McClatchey, A.I. 2003. NF2 
deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. 
Genes & Development, 17(9), pp.1090-1100.  
Langille, B.L. and Adamson, S.L. 1981. Relationship between blood flow direction and 
endothelial cell orientation at arterial branch sites in rabbits and mice. Circulation 
Research, 48(4), pp.481-488.  
Laukaitis, C.M., Webb, D.J., Donais, K. and Horwitz, A.F. 2001. Differential dynamics 
of α5 integrin, paxillin, and α-actinin during formation and disassembly of adhesions in 
migrating cells. The Journal of Cell Biology, 153(7), pp.1427-1440.  
Lee, J. and Gotlieb, A. 2002. Microtubule–actin interactions may regulate endothelial 
integrity and repair. Cardiovascular Pathology, 11(3), pp.135-140.  
Lee, R.C., Feinbaum, R.L. and Ambros, V. 1993. The C. elegans heterochronic gene 
lin-4 encodes small RNAs with antisense complementarity to lin-14Cell, 75(5), 
pp.843-854.  
Lee, T.J. and Gotlieb, A.I. 2003. Microfilaments and microtubules maintain endothelial 
integrity. Microscopy Research and Technique, 60(1), pp.115-127.  
Lehoux, S. and Tedgui, A. 2003. Cellular mechanics and gene expression in blood 
vessels. Journal of Biomechanics, 36(5), pp.631-643.  
Leiss, M., Beckmann, K., Girós, A., Costell, M. and Fässler, R. 2008. The role of 
integrin binding sites in fibronectin matrix assembly in vivo. Current Opinion in Cell 
Biology, 20(5), pp.502-507.  
Leptin, M. 1986. Cell biology: The fibronectin receptor family. Nature, 321pp.728.  
Li, B., Zhuang, L. and Trueb, B. 2004. Zyxin interacts with the SH3 domains of the 
cytoskeletal proteins LIM-nebulette and Lasp-1. Journal of Biological Chemistry, 
279(19), pp.20401-20410.  
Lin, Y.H., Park, Z., Lin, D., Brahmbhatt, A.A., Rio, M., Yates, J.R. and Klemke, R.L. 
2004. Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. 
The Journal of Cell Biology, 165(3), pp.421-432.  
  
257 
 
Llinas, P., Le Du, M.H., Gårdsvoll, H., Danø, K., Ploug, M., Gilquin, B., Stura, E.A. 
and Ménez, A. 2005. Crystal structure of the human urokinase plasminogen activator 
receptor bound to an antagonist peptide. The EMBO Journal, 24(9), pp.1655-1663.  
Lodish,H. Berk, A. Kaiser C, Krieger, M. Scott, M. Bretscher, A. Ploegh, H. Matsudaira, 
P. (2007). Molecular Cell Biology. 6th ed. USA: W.H. Freeman and Company. 
p748-751. 
Loscalzo, J. and Welch, G. 1995. Nitric oxide and its role in the cardiovascular system. 
Progress in Cardiovascular Diseases, 38(2), pp.87-104.  
Lowell, C.A. and Mayadas, T.N. 2012. Overview: studying integrins in vivo IN: 
AnonymousIntegrin and Cell Adhesion Molecules. Springer, pp.369-397.  
Madsen, C.D. and Sidenius, N. 2008. The interaction between urokinase receptor and 
vitronectin in cell adhesion and signalling. European Journal of Cell Biology, 87(8), 
pp.617-629.  
Mallavarapu, A. and Mitchison, T. 1999. Regulated actin cytoskeleton assembly at 
filopodium tips controls their extension and retraction. The Journal of Cell Biology, 
146(5), pp.1097-1106.  
Mangeat, P., Roy, C. and Martin, M. 1999. ERM proteins in cell adhesion and 
membrane dynamics. Trends in Cell Biology, 9(5), pp.187-192.  
Martinac, B. 2004. Mechanosensitive ion channels: molecules of mechanotransduction. 
Journal of Cell Science, 117(12), pp.2449-2460.  
McClatchey, A.I. and Fehon, R.G. 2009. Merlin and the ERM proteins–regulators of 
receptor distribution and signaling at the cell cortex. Trends in Cell Biology, 19(5), 
pp.198-206.  
McClatchey, A.I., Saotome, I., Mercer, K., Crowley, D., Gusella, J.F., Bronson, R.T. 
and Jacks, T. 1998. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus 
develop a range of highly metastatic tumors. Genes & Development, 12(8), 
pp.1121-1133.  
McClatchey, A.I., Saotome, I., Ramesh, V., Gusella, J.F. and Jacks, T. 1997. The Nf2 
tumor suppressor gene product is essential for extraembryonic development 
immediately prior to gastrulation. Genes & Development, 11(10), pp.1253-1265.  
McCue, S., Dajnowiec, D., Xu, F., Zhang, M., Jackson, M.R. and Langille, B.L. 2006. 
Shear stress regulates forward and reverse planar cell polarity of vascular endothelium 
in vivo and in vitro. Circulation Research, 98(7), pp.939-946.  
  
258 
 
McGough, A., Way, M. and DeRosier, D. 1994. Determination of the 
alpha-actinin-binding site on actin filaments by cryoelectron microscopy and image 
analysis. The Journal of Cell Biology, 126(2), pp.433-443.  
Mohri, H. and Ohkubo, T. 1991. How vitronectin binds to activated glycoprotein 
IIb-IIIa complex and its function in platelet aggregation. American Journal of Clinical 
Pathology, 96(5), pp.605.  
Moissoglu, K. and Schwartz, M.A. 2006. Integrin signalling in directed cell migration. 
Biology of the Cell, 98(9), pp.547-555.  
Montecucco, F. and Mach, F. 2009. Atherosclerosis is an inflammatory disease. IN: 
Seminars in immunopathology. Springer.  
Montuori, N., Mattiello, A., Mancini, A., Santoli, M., Taglialatela, P., Caputi, M., Rossi, 
G. and Ragno, P. 2001. Urokinase-type plasminogen activator up-regulates the 
expression of its cellular receptor through a post-transcriptional mechanism. FEBS 
Letters, 508(3), pp.379-384.  
Morrison, H., Sherman, L.S., Legg, J., Banine, F., Isacke, C., Haipek, C.A., Gutmann, 
D.H., Ponta, H. and Herrlich, P. 2001. The NF2 tumor suppressor gene product, merlin, 
mediates contact inhibition of growth through interactions with CD44. Genes & 
Development, 15(8), pp.968-980.  
Mould, A. and Humphries, M. 1991. Identification of a novel recognition sequence for 
the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. 
The EMBO Journal, 10(13), pp.4089.  
Muranen, T., Grönholm, M., Lampin, A., Lallemand, D., Zhao, F., Giovannini, M. and 
Carpén, O. 2007. The tumor suppressor merlin interacts with microtubules and 
modulates Schwann cell microtubule cytoskeleton. Human Molecular Genetics, 16(14), 
pp.1742-1751.  
Nerem, R.M., Levesque, M.J. and Cornhill, J.F. 1981. Vascular endothelial morphology 
as an indicator of the pattern of blood flow. Journal of Biomechanical Engineering, 
103(3), pp.172-176.  
Nip, J., Shibata, H., Loskutoff, D.J., Cheresh, D.A. and Brodt, P. 1992. Human 
melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere 
to lymph node vitronectin. Journal of Clinical Investigation, 90(4), pp.1406.  
Nobes, C. and Hall, A. 1995. Rho, rac and cdc42 GTPases: regulators of actin structures, 
cell adhesion and motility. Biochemical Society Transactions, 23(3), pp.456-459.  
  
259 
 
Nolz, J.C., Nacusi, L.P., Segovis, C.M., Medeiros, R.B., Mitchell, J.S., Shimizu, Y. and 
Billadeau, D.D. 2008. The WAVE2 complex regulates T cell receptor signaling to 
integrins via Abl-and CrkL–C3G-mediated activation of Rap1. The Journal of Cell 
Biology, 182(6), pp.1231-1244.  
Obremski, V.J., Hall, A.M. and Fernandez‐Valle, C. 1998. Merlin, the 
neurofibromatosis type 2 gene product, and β1 integrin associate in isolated and 
differentiating Schwann cells. Journal of Neurobiology, 37(4), pp.487-501.  
Ohno, M., Gibbons, G.H., Dzau, V.J. and Cooke, J.P. 1993. Shear stress elevates 
endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation, 
88(1), pp.193-197.  
Olave, I.A., Reck-Peterson, S.L. and Crabtree, G.R. 2002. Nuclear actin and 
actin-related proteins in chromatin remodeling. Annual Review of Biochemistry, 71(1), 
pp.755-781.  
Olesen, S., Claphamt, D. and Davies, P. 1988. Haemodynamic shear stress activates a K 
current in vascular endothelial cells. Nature, 331(6152), pp.168-170.  
Orr, A.W., Helmke, B.P., Blackman, B.R. and Schwartz, M.A. 2006. Mechanisms of 
mechanotransduction. Developmental Cell, 10(1), pp.11-20.  
Ossowski, L. and Aguirre-Ghiso, J.A. 2000. Urokinase receptor and integrin partnership: 
coordination of signaling for cell adhesion, migration and growth. Current Opinion in 
Cell Biology, 12(5), pp.613-620.  
Papadaki, M. and Eskin, S.G. 1997. Effects of fluid shear stress on gene regulation of 
vascular cells. Biotechnology Progress, 13(3), pp.209-221.  
Parsons, J.T., Horwitz, A.R. and Schwartz, M.A. 2010. Cell adhesion: integrating 
cytoskeletal dynamics and cellular tension. Nature Reviews Molecular Cell Biology, 
11(9), pp.633-643.  
Pierschbacher, M.D. and Ruoslahti, E. 1984. Variants of the cell recognition site of 
fibronectin that retain attachment-promoting activity. Proceedings of the National 
Academy of Sciences, 81(19), pp.5985-5988.  
Pilot, F., Philippe, J., Lemmers, C. and Lecuit, T. 2006. Spatial control of actin 
organization at adherens junctions by a synaptotagmin-like protein. Nature, 442(7102), 
pp.580-584.  
Ploug, M. and Ellis, V. 1994. Structure—function relationships in the receptor for 
urokinase-type plasminogen activator Comparison to other members of the Ly-6 family 
and snake venom α-neurotoxins. FEBS Letters, 349(2), pp.163-168.  
  
260 
 
Polesello, C., Delon, I., Valenti, P., Ferrer, P. and Payre, F. 2002. Dmoesin controls 
actin-based cell shape and polarity during Drosophila melanogaster oogenesis. Nature 
Cell Biology, 4(10), pp.782-789.  
Pollard, T.D. and Beltzner, C.C. 2002. Structure and function of the Arp2/3 complex. 
Current Opinion in Structural Biology, 12(6), pp.768-774.  
Pottiez, G., Sevin, E., Cecchelli, R., Karamanos, Y. and Flahaut, C. 2009. Actin, 
gelsolin and filamin‐A are dynamic actors in the cytoskeleton remodelling contributing 
to the blood brain barrier phenotype. Proteomics, 9(5), pp.1207-1219.  
Prager, G.W., Breuss, J.M., Steurer, S., Mihaly, J. and Binder, B.R. 2004. Vascular 
endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on 
the surface of endothelial cells. Blood, 103(3), pp.955-962.  
Preissner, K.T. and Jenne, D. 1991. Vitronectin: a new molecular connection in 
haemostasis. Thrombosis and Haemostasis, 66(2), pp.189-194.  
Pytela, R., Pierschbacher, M.D., Ginsberg, M.H., Plow, E.F. and Ruoslahti, E. 1986. 
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific 
adhesion receptors. Science, 231(4745), pp.1559-1562.  
Pytela, R., Pierschbacher, M.D. and Ruoslahti, E. 1985a. A 125/115-kDa cell surface 
receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid 
adhesion sequence derived from fibronectin. Proceedings of the National Academy of 
Sciences, 82(17), pp.5766-5770.  
Pytela, R., Pierschbacher, M.D. and Ruoslahti, E. 1985b. Identification and isolation of 
a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. 
Cell, 40(1), pp.191-198.  
Ragno, P. 2006. The urokinase receptor: a ligand or a receptor? Story of a sociable 
molecule. Cellular and Molecular Life Sciences CMLS, 63(9), pp.1028-1037.  
Ramesh, V. 2004. Merlin and the ERM proteins in Schwann cells, neurons and growth 
cones. Nature Reviews Neuroscience, 5(6), pp.462-470.  
Ratnikov, B., Partridge, A. and Ginsberg, M. 2005. Integrin activation by talin. Journal 
of Thrombosis and Haemostasis, 3(8), pp.1783-1790.  
Redick, S.D., Settles, D.L., Briscoe, G. and Erickson, H.P. 2000. Defining fibronectin's 
cell adhesion synergy site by site-directed mutagenesis. The Journal of Cell Biology, 
149(2), pp.521-527.  
  
261 
 
Redmond, E.M., Cahill, P.A. and Sitzmann, J.V. 1998. Flow-mediated regulation of 
G-protein expression in cocultured vascular smooth muscle and endothelial cells. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 18(1), pp.75-83.  
Reed, N. and Gutmann, D.H. 2001. Tumorigenesis in neurofibromatosis: new insights 
and potential therapies. Trends in Molecular Medicine, 7(4), pp.157-162.  
Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F. and Fazioli, F. 1996. 
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced 
chemotactic effect. The EMBO Journal, 15(7), pp.1572.  
Resnick, N., Yahav, H., Shay-Salit, A., Shushy, M., Schubert, S., Zilberman, L.C.M. 
and Wofovitz, E. 2003. Fluid shear stress and the vascular endothelium: for better and 
for worse. Progress in Biophysics and Molecular Biology, 81(3), pp.177-199.  
Rid, R., Schiefermeier, N., Grigoriev, I., Small, J.V. and Kaverina, I. 2005. The last but 
not the least: the origin and significance of trailing adhesions in fibroblastic cells. Cell 
Motility and the Cytoskeleton, 61(3), pp.161-171.  
Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy, G., 
Parsons, J.T. and Horwitz, A.R. 2003. Cell migration: integrating signals from front to 
back. Science, 302(5651), pp.1704-1709.  
Rinnerthaler, G., Geiger, B. and Small, J. 1988. Contact formation during fibroblast 
locomotion: involvement of membrane ruffles and microtubules. J.Cell Biol, 
106pp.747-760.  
Ross, R., 1999. Atherosclerosis--an inflammatory diseas. N Engl J Med. 1999 Jan 
14;340(2):115-26. 
Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., 
Hoang-Xuan, K., Demczuk, S., Desmaze, C. and Plougastel, B. 1993. Alteration in a 
new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis 
type 2. Nature 363, 515 - 521 (10 June 1993); doi:10.1038/363515a0 
Rubanyi, G.M., Romero, J.C. and Vanhoutte, P.M. 1986. Flow-induced release of 
endothelium-derived relaxing factor. American Journal of Physiology-Heart and 
Circulatory Physiology, 250(6), pp.H1145-H1149.  
Sainio, M., Zhao, F., Heiska, L., Turunen, O., den Bakker, M., Zwarthoff, E., Lutchman, 
M., Rouleau, G.A., Jaaskelainen, J. and Vaheri, A. 1997. Neurofibromatosis 2 tumor 
suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing 
cytoskeleton. Journal of Cell Science, 110(18), pp.2249-2260.  
  
262 
 
Saldanha, R.G., Molloy, M.P., Bdeir, K., Cines, D.B., Song, X., Uitto, P.M., Weinreb, 
P.H., Violette, S.M. and Baker, M.S. 2007. Proteomic identification of lynchpin 
urokinase plasminogen activator receptor protein interactions associated with epithelial 
cancer malignancy. Journal of Proteome Research, 6(3), pp.1016-1028.  
Saotome, I., Curto, M. and McClatchey, A.I. 2004. Ezrin is essential for epithelial 
organization and villus morphogenesis in the developing intestine. Developmental Cell, 
6(6), pp.855-864.  
Sato, N., Funayama, N., Nagafuchi, A., Yonemura, S. and Tsukita, S. 1992. A gene 
family consisting of ezrin, radixin and moesin. Its specific localization at actin 
filament/plasma membrane association sites. Journal of Cell Science, 103(1), 
pp.131-143.  
Saydam, O., Senol, O., Würdinger, T., Mizrak, A., Ozdener, G.B., 
Stemmer-Rachamimov, A.O., Yi, M., Stephens, R.M., Krichevsky, A.M. and Saydam, 
N. 2011. miRNA-7 attenuation in Schwannoma tumors stimulates growth by 
upregulating three oncogenic signaling pathways. Cancer Research, 71(3), pp.852-861.  
Schiller, H.B., Szekeres, A., Binder, B.R., Stockinger, H. and Leksa, V. 2009. Mannose 
6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling 
αVβ3 integrin expression and proteolytic processing of urokinase-type plasminogen 
activator receptor. Molecular Biology of the Cell, 20(3), pp.745-756.  
Schoenenberger, C., Buchmeier, S., Boerries, M., Sütterlin, R., Aebi, U. and Jockusch, 
B. 2005. Conformation-specific antibodies reveal distinct actin structures in the nucleus 
and the cytoplasm. Journal of Structural Biology, 152(3), pp.157-168.  
Schreiber, V., Moog-Lutz, C. and RÃ, C. 1998. Lasp-1, a novel type of actin-binding 
protein accumulating in cell membrane extensions. Molecular Medicine, 4(10), pp.675.  
Schwartz, M.A. and Assoian, R.K. 2001. Integrins and cell proliferation regulation of 
cyclin-dependent kinases via cytoplasmic signaling pathways. Journal of Cell Science, 
114(14), pp.2553-2560.  
Scliwa, M. and Höner, B. 1993. Microtubules, centrosomes and intermediate filaments 
in directed cell movement. Trends in Cell Biology, 3(11), pp.377-380.  
Scoles, D.R. 2008. The merlin interacting proteins reveal multiple targets for NF2 
therapy. Biochimica Et Biophysica Acta (BBA)-Reviews on Cancer, 1785(1), pp.32-54.  
Shaw, R.J., McClatchey, A.I. and Jacks, T. 1998. Regulation of the neurofibromatosis 
type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. Journal 
of Biological Chemistry, 273(13), pp.7757-7764.  
  
263 
 
Sherman, L., Xu, H.M., Geist, R.T., Saporito-Irwin, S., Howells, N., Ponta, H., Herrlich, 
P. and Gutmann, D.H. 1997. Interdomain binding mediates tumor growth suppression 
by the NF2 gene product. Oncogene, 15(20), pp.2505-2509.  
Shimizu, T., Seto, A., Maita, N., Hamada, K., Tsukita, S., Tsukita, S. and Hakoshima, T. 
2002. Structural basis for neurofibromatosis type 2. Journal of Biological Chemistry, 
277(12), pp.10332-10336.  
Sima, A.V., Stancu, C.S. and Simionescu, M. 2009. Vascular endothelium in 
atherosclerosis. Cell and Tissue Research, 335(1), pp.191-203.  
Simon, D.I., Wei, Y., Zhang, L., Rao, N.K., Xu, H., Chen, Z., Liu, Q., Rosenberg, S. 
and Chapman, H.A. 2000. Identification of a urokinase receptor-integrin interaction site 
promiscuous regulator of integrin function. Journal of Biological Chemistry, 275(14), 
pp.10228-10234.  
Small, E.M. and Olson, E.N. 2011. Pervasive roles of microRNAs in cardiovascular 
biology. Nature, 469(7330), pp.336-342.  
Small, J.V. 1994. Lamellipodia architecture: actin filament turnover and the lateral flow 
of actin filaments during motility. IN: Seminars in cell biology. Elsevier.  
Small, J.V., Geiger, B., Kaverina, I. and Bershadsky, A. 2002. How do microtubules 
guide migrating cells? Nature Reviews Molecular Cell Biology, 3(12), pp.957-964.  
Speck, O., Hughes, S.C., Noren, N.K., Kulikauskas, R.M. and Fehon, R.G. 2003. 
Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity. 
Nature, 421(6918), pp.83-87.  
Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte 
emigration: the multistep paradigm. Cell, 76(2), pp.301-314.  
Stamenkovic, I. and Yu, Q. 2010. Merlin, a “magic” linker between the extracellular 
cues and intracellular signaling pathways that regulate cell motility, proliferation, and 
survival. Current Protein & Peptide Science, 11(6), pp.471.  
Stoneman, V.E. and Bennett, M.R. 2004. Role of apoptosis in atherosclerosis and its 
therapeutic implications. Clinical Science, 107(4), pp.343-354.  
Stossel, T.P., Condeelis, J., Cooley, L., Hartwig, J.H., Noegel, A., Schleicher, M. and 
Shapiro, S.S. 2001. Filamins as integrators of cell mechanics and signalling. Nature 
Reviews Molecular Cell Biology, 2(2), pp.138-145.  
Takada, Y., Ye, X. and Simon, S. 2007. The integrins. Genome Biol, 8(5), pp.215.  
  
264 
 
Tamura, A., Kikuchi, S., Hata, M., Katsuno, T., Matsui, T., Hayashi, H., Suzuki, Y., 
Noda, T., Tsukita, S. and Tsukita, S. 2005. Achlorhydria by ezrin knockdown defects in 
the formation/expansion of apical canaliculi in gastric parietal cells. The Journal of Cell 
Biology, 169(1), pp.21-28.  
Tapon, N. and Hall, A. 1997. Rho, Rac and Cdc42 GTPases regulate the organization of 
the actin cytoskeleton. Current Opinion in Cell Biology, 9(1), pp.86-92.  
Thiagarajan, P. and Kelly, K.L. 1988. Exposure of binding sites for vitronectin on 
platelets following stimulation. Journal of Biological Chemistry, 263(6), pp.3035-3038.  
Toffoletto, E. 1965. Discorso sul Malpighi. Editrice Nigrizia.  
Tomasetto, C., Moog-Lutz, C., Régnier, C.H., Schreiber, V., Basset, P. and Rio, M. 
1995. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the 
association of LIM and SH3 domains. FEBS Letters, 373(3), pp.245-249.  
Traub, O. and Berk, B.C. 1998. Laminar shear stress mechanisms by which endothelial 
cells transduce an atheroprotective force. Arteriosclerosis, Thrombosis, and Vascular 
Biology, 18(5), pp.677-685.  
Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., 
Eldridge, R., Kley, N., Menon, A.G. and Pulaski, K. 1993. A novel moesin-, ezrin-, 
radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 
72(5), pp.791-800.  
Tzima, E., del Pozo, M.A., Shattil, S.J., Chien, S. and Schwartz, M.A. 2001. Activation 
of integrins in endothelial cells by fluid shear stress mediates Rho-dependent 
cytoskeletal alignment. The EMBO Journal, 20(17), pp.4639-4647.  
Vanhoutte, P., Shimokawa, H., Tang, E. and Feletou, M. 2009. Endothelial dysfunction 
and vascular disease. Acta Physiologica, 196(2), pp.193-222.  
Vasiliev, J.M., Gelfand, I., Domnina, L., Ivanova, O.Y., Komm, S. and Olshevskaja, L. 
1970. Effect of colcemid on the locomotory behaviour of fibroblasts. Journal of 
Embryology and Experimental Morphology, 24(3), pp.625-640.  
Vial, E., Sahai, E. and Marshall, C.J. 2003. ERK-MAPK signaling coordinately 
regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell, 4(1), 
pp.67-79.  
Viel, A. and Branton, D. 1996. Spectrin: on the path from structure to function. Current 
Opinion in Cell Biology, 8(1), pp.49-55.  
  
265 
 
Virchow, R. 1989. As Based upon Physiological and Pathological Histology. Nutrition 
Reviews, 47(1), pp.23-25.  
Vita, J.A. and Keaney, J.F. 2002. Endothelial function a barometer for cardiovascular 
risk? Circulation, 106(6), pp.640-642.  
Vogel, V. 2006. Mechanotransduction involving multimodular proteins: converting 
force into biochemical signals. Annu.Rev.Biophys.Biomol.Struct., 35pp.459-488.  
Von Offenberg Sweeney, N., Cummins, P.M., Cotter, E.J., Fitzpatrick, P.A., Birney, 
Y.A., Redmond, E.M. and Cahill, P.A. 2005. Cyclic strain-mediated regulation of 
vascular endothelial cell migration and tube formation. Biochemical and Biophysical 
Research Communications, 329(2), pp.573-582.  
Waltz, D.A. and Chapman, H.A. 1994. Reversible cellular adhesion to vitronectin 
linked to urokinase receptor occupancy. Journal of Biological Chemistry, 269(20), 
pp.14746-14750.  
Watanabe, T., Noritake, J. and Kaibuchi, K. 2005. Regulation of microtubules in cell 
migration. Trends in Cell Biology, 15(2), pp.76-83.  
Wechezak, A., Viggers, R. and Sauvage, L. 1985. Fibronectin and F-actin redistribution 
in cultured endothelial cells exposed to shear stress. Laboratory Investigation; a 
Journal of Technical Methods and Pathology, 53(6), pp.639-647.  
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., 
Karumanchi, S.A., Yap, H. and Saleem, M. 2011. Circulating urokinase receptor as a 
cause of focal segmental glomerulosclerosis. Nature Medicine, 17(8), pp.952-960.  
Wei, C., Möller, C.C., Altintas, M.M., Li, J., Schwarz, K., Zacchigna, S., Xie, L., 
Henger, A., Schmid, H. and Rastaldi, M.P. 2007. Modification of kidney barrier 
function by the urokinase receptor. Nature Medicine, 14(1), pp.55-63.  
Wei, Y., Czekay, R., Robillard, L., Kugler, M.C., Zhang, F., Kim, K.K., Xiong, J., 
Humphries, M.J. and Chapman, H.A. 2005. Regulation of α5β1 integrin conformation 
and function by urokinase receptor binding. The Journal of Cell Biology, 168(3), 
pp.501-511.  
Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V. and 
Chapman, H.A. 1996. Regulation of integrin function by the urokinase receptor. Science, 
273(5281), pp.1551-1555.  
Wei, Y., Waltz, D.A., Rao, N., Drummond, R.J., Rosenberg, S. and Chapman, H.A. 
1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. 
Journal of Biological Chemistry, 269(51), pp.32380-32388.  
  
266 
 
Weis, S.M. 2007. Evaluating integrin function in models of angiogenesis and vascular 
permeability. Methods in Enzymology, 426pp.505-528.  
Wieland, T. and Mittmann, C. 2003. Regulators of G-protein signalling: multifunctional 
proteins with impact on signalling in the cardiovascular system. Pharmacology & 
Therapeutics, 97(2), pp.95-115.  
Wong, A.J., Pollard, T.D. and Herman, I.M. 1983. Actin filament stress fibers in 
vascular endothelial cells in vivo. Science, 219(4586), pp.867-869.  
Wu, M.H., Ustinova, E. and Granger, H.J. 2001. Integrin binding to fibronectin and 
vitronectin maintains the barrier function of isolated porcine coronary venules. The 
Journal of Physiology, 532(3), pp.785-791.  
Xiao, G., Chernoff, J. and Testa, J.R. 2003. NF2: the wizardry of merlin. Genes, 
Chromosomes and Cancer, 38(4), pp.389-399.  
Xu, H. and Gutmann, D.H. 1998. Merlin differentially associates with the microtubule 
and actin cytoskeleton. Journal of Neuroscience Research, 51(3), pp.403-415.  
Xu, W., Baribault, H. and Adamson, E.D. 1998. Vinculin knockout results in heart and 
brain defects during embryonic development. Development, 125(2), pp.327-337.  
Xue, W., Mizukami, I., Todd, R.F. and Petty, H.R. 1997. Urokinase-type plasminogen 
activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: dependence 
on extracellular matrix components. Cancer Research, 57(9), pp.1682-1689.  
Yelian, F.D., Edgeworth, N.A., Dong, L., Chung, A.E. and Armant, D.R. 1993. 
Recombinant entactin promotes mouse primary trophoblast cell adhesion and migration 
through the Arg-Gly-Asp (RGD) recognition sequence. The Journal of Cell Biology, 
121(4), pp.923-929.  
Zaidel-Bar, R. and Geiger, B. 2010. The switchable integrin adhesome. Journal of Cell 
Science, 123(9), pp.1385-1388.  
Zhang, X., Jiang, G., Cai, Y., Monkley, S.J., Critchley, D.R. and Sheetz, M.P. 2008. 
Talin depletion reveals independence of initial cell spreading from integrin activation 
and traction. Nature Cell Biology, 10(9), pp.1062-1068.  
Zhou, J., Chew, M., Ravn, H.B. and Falk, E. 1999. Plaque pathology and coronary 
thrombosis in the pathogenesis of acute coronary syndromes. Scandinavian Journal of 
Clinical & Laboratory Investigation, 59(S230), pp.3-11.  
Ziegler, W.H., Liddington, R.C. and Critchley, D.R. 2006. The structure and regulation 
of vinculin. Trends in Cell Biology, 16(9), pp.453-460.  
  
267 
 
Zimerman, B., Volberg, T. and Geiger, B. 2004. Early molecular events in the assembly 
of the focal adhesion‐stress fiber complex during fibroblast spreading. Cell Motility and 
the Cytoskeleton, 58(3), pp.143-159.  
 
